Interaction and passage of superparamagnetic iron oxide nanoparticles in an in vitro blood-brain barrier model by Gräfe, Christine
INTERACTION AND PASSAGE OF
SUPERPARAMAGNETIC IRON OXIDE
NANOPARTICLES IN AN in vitro
BLOOD-BRAIN BARRIER MODEL
Dissertation
zur Erlangung des akademischen Grades
doctor rerum naturalium (Dr. rer. nat.)
vorgelegt dem Rat der Medizinischen Fakultät der
Friedrich-Schiller-Universität Jena
von M.Sc. Christine Gräfe, geb. Gey
geboren am 03.11.1987 in Reichenbach im Vogtland
Gutachter
1. Prof. Dr. Andreas Hochhaus (Universitätsklinikum Jena, Jena)
2. Prof. Dr. Ferdinand von Eggeling (Universitätsklinikum Jena, Jena)
3. Prof. Ph.D. Urs Häfeli (University of British Columbia, Vancouver)
Tag der öffentlichen Verteidigung: 18. Dezember 2018
»Das Schönste, was wir entdecken können, ist das Geheimnisvolle. «
Albert Einstein (1879-1955)

Contents
Nomenclature IX
List of Figures XI
List of Tables XIII
Abstract 1
Zusammenfassung 2
1 Introduction 3
1.1 Nanomedicine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
1.1.1 Superparamagnetic Iron Oxide Nanoparticles . . . . . . . 7
1.1.2 Uptake Mechanisms for Nanoparticles . . . . . . . . . . . 9
1.1.3 Biologic and Cytotoxic Effects of Nanoparticles . . . . . . 11
1.1.4 Biodegradation and Excretion of Nanoparticles . . . . . . 13
1.1.5 Protein Corona . . . . . . . . . . . . . . . . . . . . . . . . . 14
1.2 Blood-Brain Barrier . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
1.2.1 General Structure . . . . . . . . . . . . . . . . . . . . . . . . 16
1.2.2 Ways across the Blood-Brain Barrier . . . . . . . . . . . . . 18
1.2.3 Model Systems Representing the Blood-Brain Barrier . . . 21
1.3 Aims of the Study . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
2 Methods and Materials 25
2.1 SPION- and Protein Corona Characterization . . . . . . . . . . . . 25
2.1.1 SDS-PAGE and Silver Staining . . . . . . . . . . . . . . . . 26
2.1.2 Physical SPION Characterization . . . . . . . . . . . . . . . 27
2.2 Cell Culture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.2.1 Cell Lines . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.2.2 Cell Cultivation . . . . . . . . . . . . . . . . . . . . . . . . . 28
V
2.2.3 Transwell-Based Generation of in vitro Blood-Brain Bar-
rier Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
2.2.4 Preparation of Astrocyte-Conditioned Medium . . . . . . 29
2.2.5 Differentiation of Progenitor Cells . . . . . . . . . . . . . . 29
2.3 Cell Viability Assays . . . . . . . . . . . . . . . . . . . . . . . . . . 30
2.3.1 PrestoBlue™ Assay . . . . . . . . . . . . . . . . . . . . . . . 30
2.3.2 SYTOX® Red Dead Cell Staining . . . . . . . . . . . . . . . 31
2.3.3 Real-Time Cell Analysis . . . . . . . . . . . . . . . . . . . . 31
2.4 Analysis of the Cell Layer Integrity . . . . . . . . . . . . . . . . . . 32
2.4.1 Transendothelial Electrical Resistance Measurements . . . 32
2.4.2 Molecular Permeability Assay . . . . . . . . . . . . . . . . 33
2.4.3 Histological Analysis of Cross Sections . . . . . . . . . . . 34
2.5 Cellular Staining . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
2.5.1 Prussian Blue Staining . . . . . . . . . . . . . . . . . . . . . 35
2.5.2 Pappenheim Staining . . . . . . . . . . . . . . . . . . . . . 36
2.6 Fluorescent Staining for Confocal Laser Scanning Microscopy . . 37
2.6.1 Phalloidin Staining . . . . . . . . . . . . . . . . . . . . . . . 37
2.6.2 Immunofluorescence Staining of zonula occludens-1 . . . . 38
2.7 Flow Cytometry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.7.1 Flow Cytometry-Based Particle-Cell Interaction . . . . . . 40
2.7.2 Surface Marker Expression of Differentiated Cells . . . . . 40
2.8 Detection and Quantification of SPIONs . . . . . . . . . . . . . . . 41
2.8.1 Magnetic Particle Spectroscopy . . . . . . . . . . . . . . . . 42
2.8.2 Atomic Absorption Spectroscopy . . . . . . . . . . . . . . . 43
2.9 Transmigration through Blood-Brain Barrier Model . . . . . . . . 44
2.10 Statistical Analyses . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
3 Results 47
3.1 Interaction of SPIONs with HBMEC . . . . . . . . . . . . . . . . . 48
3.1.1 SPION-associated Effect on Cell Viability . . . . . . . . . . 48
3.1.2 Binding of SPIONs to Cells and Particle Uptake . . . . . . 48
3.1.3 Protein Corona-associated Effects on Cytotoxicity and SPION
Interaction with Cells . . . . . . . . . . . . . . . . . . . . . 51
3.2 Establishing and Optimizing the Blood-Brain Barrier Model . . . 59
3.2.1 Testing of Transwell System and Cell Seeding Density . . . 59
VI
3.2.2 Influence of Cell Media Supplements on HBMEC Layer
Integrity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
3.3 Interaction of SPIONs with the Blood-Brain Barrier Model . . . . 63
3.3.1 SPION-associated Effects on Barrier Integrity . . . . . . . . 63
3.3.2 Passage of SPIONs through in vitro Blood-Brain Barrier
Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
3.4 SPION-induced Passage of Immune Cells trough Blood-Brain Bar-
rier Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
3.4.1 SPION-mediated Transmigration of neutrophil-like HL-
60 across Blood-Brain Barrier Model . . . . . . . . . . . . . 70
3.4.2 SPION-mediated Transmigration of monocytic THP-1 across
Blood-Brain Barrier Model . . . . . . . . . . . . . . . . . . 71
4 Discussion 75
4.1 General Biological Effects of SPIONs and Impact of the Protein
Corona . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
4.2 SPIONs and the Blood-Brain Barrier Model . . . . . . . . . . . . . 84
4.3 SPIONs and Barrier-penetrating Cells . . . . . . . . . . . . . . . . 92
5 Conclusion & Outlook 97
A Materials 101
B Supplement 107
B.1 Incubation Conditions Influence the SPION-associated Protein
Corona Formation . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
B.2 SPION-associated Cytotoxicity Depends on Proliferative State . . 108
B.3 Cationic SPIONs barely Pass Transwell Membranes . . . . . . . . 109
B.4 Endocytosis Inhibitors Affect Barrier Integrity . . . . . . . . . . . 109
B.5 SPION-induced Passage of Immune Cells trough Blood-Brain Bar-
rier Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
References 115
Acknowledgements
Ehrenwörtliche Erklärung
VII
VIII
Nomenclature
AAS atomic absorption spectroscopy
ABC ATP-binding cassette
ACM astrocyte-conditioned medium
APC allophycocyanin
aqua bidest. aqua bidestillata; twice distilled water
AU arbitrary unit
BBB blood-brain barrier
BMEC brain microvascular endothelial cells
BSA bovine serum albumin
CNS central nervous system
D-PBS Dulbecco’s phosphate-buffered saline
DEAE diethylamine ethyl
DMSO dimethyl sulfoxide
EDTA ethylenediaminetetraacetic acid
EGF epidermal growth factor
EMA European Medicines Agency
EPR enhanced permeability and retention
F-actin filamentous actin
FCS fetal calf serum; also denoted as fetal bovine serum (FBS)
FDA Food and Drug Administration
FGF fibroblast growth factor
FITC fluorescein isothiocyanate
fMLP N-Formylmethionyl-leucyl-phenylalanine
GDNF glial cell-derived neurotrophic factor
HBMEC human brain microvascular endothelial cells
HUVEC human umbilical vein endothelial cells
IX
IL interleukin
MAGUK membrane-associated guanylate kinase
MCP-1 monocyte chemoattractant protein-1; also known as CC-chemokine
ligand 2 (CCL2)
MPS magnetic particle spectroscopy
MRI magnetic resonance imaging
MRP multidrug resistance-associated protein
NaFl sodium fluorescein
P-gp P-glycoprotein
PAM polyacrylat-co-maleat
PdI polydispersion index
PE phycoerythrin
PE (buffer) D-PBS supplemented with EDTA (2 mM)
PEG polyethylene glycol
PEI polyethylenimine
PET polyethylene terephthalate
PMA phorbol 12-myristate 13-acetate; also known as 12-O-tetra-
decanoylphorbol-13-acetate (TPA)
PTFE polytetrafluoroethylene
RES reticuloendothelial system
RFU relative fluorescence units
RPMI Roswell Park Memorial Institute; cell culture medium
RT room temperature (19–23 °C)
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis
SPARC secreted protein acidic and rich in cysteine
SPION superparamagnetic iron oxide nanoparticle
SSC side scatter
TGF transforming growth factor
ZO-1 zonula occludens-1; tight junction-associated protein
ZONAB ZO-1-associated nucleic-acid binding protein
X
List of Figures
1.1 Diversity of nanoparticle design. . . . . . . . . . . . . . . . . . . . 4
1.2 Endocytotic pathways ingesting nanoparticle into mammalian cells. 10
1.3 Structure and effects of the protein corona on nanoparticles. . . . 15
1.4 Cellular components and structure of the neurovascular unit form-
ing the blood-brain barrier (BBB). . . . . . . . . . . . . . . . . . . . 17
3.1 PrestoBlue™ cell viability assays of HBMEC exposed to diverse
types of SPIONs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
3.2 Cellular interaction of diverse types of SPIONs with HBMEC. . . 50
3.3 Cellular uptake mechanisms of SPIONs analyzed by confocal laser
scanning microscopy. . . . . . . . . . . . . . . . . . . . . . . . . . . 52
3.4 Acute and long-term cell viability studies of HBMEC exposed to
SPIONs with varying levels of protein corona. . . . . . . . . . . . 53
3.5 Cellular interaction of SPIONs and cell viability of HBMEC upon
exposure, analyzed by flow cytometry. . . . . . . . . . . . . . . . . 56
3.6 Protein corona-associated uptake of SPIONs into HBMEC ana-
lyzed by confocal laser scanning microscopy. . . . . . . . . . . . . 57
3.7 Effect of the protein corona on cellular SPION uptake mecha-
nisms analyzed by flow cytometry and confocal laser scanning
microscopy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
3.8 In vitro blood-brain barrier models formed by HBMEC cultivated
on PET or PTFE membrane inserts. . . . . . . . . . . . . . . . . . . 60
3.9 Influence of cell culture media and media supplements on barrier
integrity parameters. . . . . . . . . . . . . . . . . . . . . . . . . . . 62
3.10 SPION-associated effects on barrier integrity parameters of HBMEC
layers. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
3.11 SPION distribution of distinct compartments of the in vitro blood-
brain barrier model analyzed by magnetic particle spectroscopy
(MPS). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
XI
3.12 SPION distribution of distinct compartments of the in vitro blood-
brain barrier model analyzed by atomic absorption spectroscopy
(AAS). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
3.13 Transmigration of differentiated, SPION-loaded HL-60 cells across
the in vitro blood brain barrier model. . . . . . . . . . . . . . . . . 73
3.14 Transmigration of differentiated, SPION-loaded THP-1 cells across
the in vitro blood brain barrier model. . . . . . . . . . . . . . . . . 74
B.1 Gel electrophoretic analysis of protein corona formation on SPI-
ONs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
B.2 Zeta potential measurements of SPIONs with diverse protein coro-
nas. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
B.3 Real-time cell analysis of HBMEC exposed to SPIONs. . . . . . . . 108
B.4 Analysis of membrane passage of cationic SPIONs by magnetic
particle spectroscopy (MPS). . . . . . . . . . . . . . . . . . . . . . . 109
B.5 Analysis of cell layer integrity under the influence of endocytosis
inhibitors. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
B.6 Analysis of differentiation of HL-60 and THP-1 by flow cytome-
try and microscopic investigation. . . . . . . . . . . . . . . . . . . 110
B.7 Cellular interaction of diverse types of SPIONs with HBMEC and
differentiated HL-60 and THP-1. . . . . . . . . . . . . . . . . . . . 111
B.8 PrestoBlue™ cell viability assays of HBMEC and differentiated
HL-60 and THP-1 exposed to diverse types of SPIONs. . . . . . . 111
B.9 Analysis of cell layer integrity under the influence of inflamma-
tory cytokines. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
B.10 Barrier integrity of cell layers and iron content of lower acceptor
compartments after passage of differentiated HL-60 and THP-1 . 113
XII
List of Tables
2.1 Characteristics of experimentally used SPIONs. . . . . . . . . . . 26
2.2 Dehydration steps performed by the automatic tissue processor. . 34
2.3 Paraffin removal and hydration or dehydration steps performed
during staining of histological cross sections. . . . . . . . . . . . . 35
2.4 Composition of the secondary antibody solution for immunoflu-
orescence ZO-1 staining. . . . . . . . . . . . . . . . . . . . . . . . . 39
2.5 Composition of the antibody mixture for characterizing mono-
cytic or neutrophilic surface markers. . . . . . . . . . . . . . . . . 41
A.1 List of used chemicals. . . . . . . . . . . . . . . . . . . . . . . . . . 101
A.2 List of used reagents and media. . . . . . . . . . . . . . . . . . . . 102
A.3 List of used fluorescent dyes and antibodies. . . . . . . . . . . . . 103
A.4 List of used Consumables. . . . . . . . . . . . . . . . . . . . . . . . 104
A.5 List of used technical devices and instruments. . . . . . . . . . . . 105
XIII
XIV
Abstract
Superparamagnetic iron oxide nanoparticles (SPIONs) represent a highly promising
class of nanoscale formulations offering great potential for various biomedical appli-
cations. While the large degree of freedom in SPION synthesis allows their tailor-
made preparation, the resulting particle multitude demands an adequate risk and im-
pact assessment for every individual formulation. Moreover, SPIONs’ unique physi-
cochemical properties often interfere with established examination methods. Hence,
appropriate in vitro models combined with convenient analysis methods are crucially
needed. Biological barriers influence cellular exposure and thus, intrinsic reactions to
SPIONs upon entry into the body. The effects of SPIONs on the barrier integrity are of
vital importance for the whole organism, too, whereby the blood-brain barrier (BBB) is
an indispensable example. Hence, in scope of this study a standardized in vitro model
representing the human BBB is established for the detailed evaluation of SPIONs’ in-
teractions.
For this purpose a transwell system based on human brain microvascular endothelial
cells (HBMEC) is established, whereby barrier integrity is evaluated by transendothelial
electrical resistance, molecular permeability assays, and microscopical analyses. SPI-
ONs of diverse surface coating and charge are tested. The application of magnetic par-
ticle spectroscopy for the direct and highly sensitive SPION detection is successfully
demonstrated in context of such biological models for the first time. For investigating
the cell-mediated SPION delivery across the BBB, HL-60 and THP-1 differentiated into
neutrophilic and monocytic cells are utilized.
Data indicate that starch-coated SPIONs traverse the barrier in a time-dependent man-
ner, which can be explained by clathrin-induced transcytosis. At the same time bar-
rier integrity remains unaffected apparently based on slow cellular accumulation of
these neutral particles. In contrast, anionic SEONBSA intensively accumulates within
the barrier-forming cells and affects the model in a barrier-disrupting manner. Ad-
dressing cell-mediated SPION delivery across the BBB by neutrophils and monocytes,
results clearly show that the engulfment of anionic SEONPAM by both cell types mas-
sively enhances cellular barrier penetration. It is further augmented upon stimulation
by a magnetic field. This migration-inducing effect of SPIONs emphasizes its partic-
ular consideration during the treatment of patients suffering from neuroinflammatory
diseases. Moreover, data on neutrophil-like HL-60 imply that they can deliver SPIONs
across this in vitro model, which can be exploited for targeted SPION delivery.
Taken together, the here presented thesis demonstrates a versatile and reliable in vitro
test system for the comprehensive analysis of SPIONs’ interactions at the BBB. Hence, it
offers a powerful platform for the detailed assessment of diverse SPIONs, which aids to
implement sophisticated and novel SPION-based biomedical applications to overcome
current medical problems.
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Zusammenfassung
Die Vielfältigkeit in der Gestaltung superparamagnetischer Eisenoxid-Nanopartikel
(SPIONs) erlaubt einerseits deren maßgeschneiderte Präparation, welche ein enormes
Potential für zahlreiche biomedizinische Anwendungen bietet. Andererseits bedingt
dies eine adäquate Risiko- und Folgenabschätzung für jede einzelne Partikelkompo-
sition. Weiterhin limitieren physikochemische Eigenschaften der SPIONs die Funk-
tionsweise bisher etablierter Untersuchungsmethoden. Besonders im Hinblick auf die
Analyse der Interaktion von SPIONs mit biologischen Barrieren sind daher geeignete
in vitro Modelle sowie angemessene Analysemethoden zwingend erforderlich. Hi-
erbei kommt der Blut-Hirn-Schranke (BBB) und der Wirkung von SPIONs auf diese
hinsichtlich Partikelexposition und Barriereintegrität eine besondere Bedeutung zu.
Im Rahmen dieser Dissertation wurde ein standardisiertes in vitro Modell etabliert,
welches die humane BBB repräsentiert und die eingehende Untersuchungen SPION-
assoziierter Interaktionen erlaubt.
Zu diesem Zweck wurde ein Transwell-System basierend auf human brain microvascular
endothelial cells (HBMEC) implementiert. Der Einflusses von SPIONs unterschiedlicher
Oberflächenbeschichtung und -ladung auf die Barriereintegrität erfolgte mittels trans-
endothelialem elektrischem Widerstand, molekularen Permeabilitätstests und mikro-
skopischen Analysen. Erstmals wurde Magnetpartikelspektroskopie zur hoch sensi-
tiven SPION-Detektion im Kontext biologischer Barrieremodelle erfolgreich angewen-
det. Zur Erforschung des Zell-vermittelten SPION-Transports über die BBB wurden
HL-60 bzw. THP-1 zu Neutrophilen bzw. monozytären Zellen differenziert.
Die Ergebnisse zeigen, dass stärkebeschichte SPIONs die Barriere zeitabhängig durch-
dringen, was vermutlich über Clathrin-vermittelte Transzytose erfolgt. Dabei bleibt
die Barriereintegrität weitgehend unbeeinträchtigt und ist auf die verlangsamte zel-
luläre Anlagerung dieser neutralen Partikel zurückzuführen. Im Gegensatz dazu akku-
mulieren anionische SEONBSA verstärkt an und in barriereformenden Zellen und stören
damit die Barriereintegrität. Außerdem zeigt sich, dass die Beladung von Neutrophilen
und Monozyten mit anionischen SEONPAM deren Barrieredurchdringung immens ver-
stärkt, was durch magnetische Stimulation zusätzlich gesteigert wird. Diese migra-
tionsinduzierende Wirkung der SPIONs muss daher zwingend bei der Therapierung
neuro-inflammatorischer Erkrankungen, berücksichtigt werden. Andererseits kann die
Tatsache, dass neutrophile HL-60 Zellen SPIONs durch das hier etablierte in vitro Bar-
rieremodell schleusen, zur gezielten Partikelauslieferung genutzt werden.
Zusammenfassend wird in dieser Arbeit ein vielseitiges und stabiles in vitro Testsystem
für die eingehende Untersuchung von Wechselmechanismen zwischen SPIONs und
der BBB vorgestellt. Damit trägt diese Plattform letztlich dazu bei, fortschrittliche und
neue SPION-basierte biomedizinische Anwendungen zu implementieren und aktuelle
Problemstellungen der Medizin zu überwinden.
2
CHAPTER 1
Introduction
Whereas nanotechnology is considered a young scientific field, first arisen in
the late 20th century, the production and utilization of nanoscale objects for spe-
cial demands has been carried out for over a thousand years, however most
likely unsuspectingly. The most prominent and oldest preserved example is
the Lycurgus Cup embodying a dichroic Roman glass cage cup from the 4th
century [1]. The probably accidental contamination of the glass with nano-
sized gold colloids along with silver nanoparticles during its production causes
an impressive effect: depending on the conditions of illumination the antique
cup appears red under transmitted light, while light shining from the outside
turns the cup green. In the course of time such coloring properties mediated by
metallic nanoparticles were utilized for staining glass for church windows dur-
ing the Medieval [2] and creating dyes decorating ceramics during the Renais-
sance period [3, 4]. In 2006, high-resolution transmission electron microscopy
revealed carbon nanotubes and cementite nanowires in Damascus steel, which
most likely cause the characteristic banding and exceptional sharp-cutting edges
of blades crafted from this steel more than 400 years ago [5]. Highlighted by
these examples, based on the large fraction of surface atoms and resulting high
surface energy, nano-scaled objects present extraordinary chemical, physical,
and mechanical properties, usually completely different from those of respec-
tive bulk materials [6, 7]. This is why, modern nanotechnology is an inter-
disciplinary field combining the natural sciences of physics, chemistry, biol-
ogy, and medicine as well as information technology and electrical engineering,
which has already resulted in numerous diverse commercial applications [8–
10]. Technically, the term "nanoparticle" is often limited to objects with sizes
of 1–100 nm in at least one dimension [11]. However, a strongly enhanced
3
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surface-to-volume-ratio of larger nano-scaled objects compared to bulk mate-
rial, still confers unique properties and causes the extension of the definition of
nanoparticles to several hundreds of nanometers [10, 12–14]. The occurrence of
nanoparticles spreads from natural sources including volcanic ashes, wind ero-
sion, and cosmic dust [15], to man-induced generation of byproducts such as
road-tire interaction or emissions from power plants and air crafts [16], and en-
gineered nanoparticle formulations. Today, we meet engineered nanoparticles
present in consumer products everywhere: silver and gold nanoparticles pro-
viding antibacterial and antimicrobial effects in tooth paste and food packaging
as well as in clothes [17]; titanium oxide and zinc oxide nanoparticles in sun-
screens absorbing UV light while making the lotion transparent [18]; carbon-
nanotubes in bicycles and rackets making them both stronger and lighter [19];
silicon nanowires in ever smaller batteries for electronic devices [20]; and many
more.
234 Chem. Soc. Rev., 2011, 40, 233–245 This journal is c The Royal Society of Chemistry 2011
dots across the cell membrane remains challenging.5,6
Equally important is sub-cellular targeting for nano-
particle-based therapeutics: direct targeting of cytoplasmic
organelles such as the mitochondria may improve photo-
sensitizer-induced damage in photodynamic therapies7,8 while
those carrying oligonucleotides for gene therapy must home in
on the cytosol and nuclei of cells to be therapeutically
eﬀective.9,10
Here we discuss the fundamental challenges of delivering
nanoparticles into cells and to the targeted organelles, and
summarize current strategies. We also describe some of the
limitations of studying intracellular uptake of nanoparticles
and provide a perspective on the development of this emerging
research sub-theme in the field of nanotechnology.
2. Challenges in nanoparticle delivery and
intracellular targeting
Portals of entry
The intracellular milieu is physically segregated from the
environment by the plasma membrane, an elastic lipid bilayer
embedded with domains of lipids, carbohydrates, and membrane
proteins. In order to deliver nanoparticles into cells and to their
subcellular targets, nanoparticles must first be able to traverse
this plasma membrane. Nanoparticles may be internalized either
by directly interacting with membrane-embedded receptors or
indirectly by associating with the lipid bilayer. In the first
approach, nanoparticles are functionalized with ligands that bind
to receptors on the cell with high aﬃnity and specificity. Ligands
can be selected or engineered to target over-expressed receptors
on healthy and diseased cells. Internalization of the resulting
receptor–ligand complexes then leads to receptor-mediated
endocytosis of the nanoparticles. Alternatively, nano-
particles can interact with the membrane via hydrophobic and
Fig. 1 Designing nanoparticles for intracellular applications. Nanoparticles can be modularly assembled from diﬀerent materials composition
with diﬀerent physical and chemical properties and functionalized with a myriad of ligands for biological targeting. Such flexibility in design
freedom enables researchers to tailor nanoparticle for specific intracellular applications as contrast agents, drug delivery vehicles, and therapeutics.
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Figure 1.1: Div rsity of nanoparticl d sign. Nanoparticles can be d signed modularly. Fea-
tures such as material composition, physical properties, surface chemistry, and ligand function-
alization can be tailored according to their application. Figure taken with permission from [21].
The vast diversity of nanoparticles as depicted in figure 1.1 can be accredited
to the various possibilities in particle design as parameters including core ma-
terial, shape, size, surface charge, and ad itional functionalization can be tai-
lored according to the implementation [21]. Nevertheless, due to this plethora
and omnipresence of engineered nanoscale o jects, the xposure of humans and
environment to these materials steadily i cr ases and in estigati ns regarding
biological consequences are lacking but more and more relevant.
4
1.1 Nanomedicine
1.1 Nanomedicine
A broad and highly promising branch of nanotechnology is covered by nano-
medicine—the field of health and medicine involving the development and ap-
plication of nanoscale objects for diagnostic and therapeutic purposes as well
as monitoring and preventing diseases. Thus, it is expected that nanomedicine
will improve early diagnosis and treatment of a wide range of diseases by the
development of better devices, highly specific and efficient drugs, and inno-
vative therapies [10]. More precisely, the utilization of nanoparticle formula-
tions and nanodrugs can help to overcome obstacles like the appearance of
in parts severe side effects, instability of drugs, drug delivery to difficult-to-
reach sites, and bioavailability, while at the same time increasing therapeutic
efficiencies [22]. Passive drug targeting usually is achieved by enhanced per-
meability and retention (EPR) effects often prevailing in fenestrated tissues and
leaky vessels of tumors combined with low lymphatic drainage [23]. By spe-
cific conjugation of nanoparticles with ligands directed towards cellular surface
or environmental markers, particles can be targeted actively to sites of inter-
est such as tumors, metastases, or inflammation [24]. A horizontal scan pub-
lished in 2015 by Noorlander and co-workers identified 43 and 71 clearly as-
signed nanomedicinal products already approved for clinical use by the Euro-
pean Medicines Agency (EMA) and Food and Drug Administration (FDA), re-
spectively, [25]. The authors identified most of the products being designated to
therapeutic applications, especially cancer treatment, whereas nanomedicinal
objects directed towards diagnosis and vaccines constitute a small percentage
only. For instance, human serum albumin nanoparticles loaded with paclitaxel
show enhanced efficacies compared to conventional taxane-based therapies in
the treatment of early stage and metastatic breast cancer patients and also in-
dicate to be beneficial for treatment of non-small cell lung cancer and pancreas
carcinoma [26]. Currently in clinical testing is a strategy to increase the efficacy
of imaging technologies for direct focal ablation of prostate tissue, where gold-
coated silica nanoparticles are used for directing laser irradiation in neoplasms
of the prostate [27]. Another promising application is based on the antibacterial
effects of nanoparticles, which can help to treat life-threatening bacterial infec-
tions to overcome antibiotic resistance [28].
In terms of medical diagnosis of diseases including cancer and genetic muta-
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tions, nanoparticles can be utilized for both laboratory-based testing and in
vivo imaging methods. By using nanoscaled objects, unique biological mark-
ers within patient samples can be screened or very small amounts of biolog-
ical samples can be investigated by lab-on-the-chip tools performing a whole
range of laboratory tasks and even single cell analysis [29, 30]. For instance,
mutational analysis can be realized highly sensitively and rapidly using nano-
technology as shown by Vanden Bon and colleagues [31]. They demonstrated
that phenylketonuria-associated mutations in DNA fragments of the phenylala-
nine hydroxylase-encoding gene alter the heat-transfer resistance of denaturing
DNA fragments immobilized on carboxyl-functionalized nanocristalline dia-
mond sensor electrodes. With regard to in vivo imaging, the visualization of
structures inside the human body presents a valuable resource for clinicians to
identify diseased tissues at an early stage and decide further treatment strate-
gies. In this context, computer tomography (CT), magnetic resonance imaging
(MRI), positron emission tomography (PET), single-photon emission computed
tomography (SPECT) and optical coherence tomography (OCT) are applica-
tions, where the use of nanoparticles as contrast agents considerably improves
the three-dimensional view of sites of interest [7, 10]. Licensed by the EMA are
nanoparticle formulations based on human serum albumin and radio-labeled
technetium-99m, which are used for lymphoscintigraphy and intravenous ad-
ministration for bone marrow scintigraphy or visualization of inflammatory
processes in areas other than the abdomen [32].
The highlights of nanomedicinal applications mentioned above, emphasize the
enormous potential of nanoparticles for a wide range of purposes to solve medi-
cal problems and improve clinical outcomes. However, despite the considerable
number of described and experimentally tested formulation, only few nanopar-
ticle formulations have been introduced into clinics [33]. As proposed by Pelaz
et al. a major scientific challenge is the lacking knowledge about the behavior of
nanoparticles inside living organisms [10]. In order to bridge the gap between
laboratory and clinics an intensive and multidisciplinary cooperation between
physicists, chemists, biologists, pharmacists, and physicians is of vital impor-
tance.
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1.1.1 Superparamagnetic Iron Oxide Nanoparticles
A special class of nanoparticles is constituted by superparamagnetic iron oxide
nanoparticles (SPIONs), whose magnetization appears to be zero in the absence
of an external magnetic field, whereas they behave similarly to a paramagnet
under the influence of an external magnetic field [34]. Cores of such parti-
cles are made of the two main forms, magnetite (Fe3O4) or its oxidized prod-
uct maghemite (γ-Fe2O3), and usually comprise multiple domains with single
magnetic domain sizes below 12–15 nm in order to achieve the superparamag-
netic character [35,36]. While its saturation magnetization is moderate only [37],
in contrast to other hard nanoparticles including cobalt and nickel the essential
element iron is naturally occurring in the human body and therefore not associ-
ated with any intrinsic risk [38]. The daily uptake of iron via dietary products is
estimated to 1-2 mg, whereby upon its metabolization it is used as essential co-
factor of several enzymes and proteins [39]. However, not only iron deficiency
constitutes a general problem in human health, but also iron excess and accu-
mulation within cells and organelles can result in pathological disorders [40].
Usually, SPIONs are equipped with an additional coating surrounding the iron
oxide core in order to maintain colloidal stability especially in aqueous solutions
and to protect the iron core from further oxidation. Such coatings are adopted
according to the application and are also important for particles’ biocompat-
ibility and biodegradability. Additionally, they open the possibility of ligand
conjugation for further functionalization [41, 42]. For instance, polymers such
as polysaccharides and polyethylene glycol (PEG) are frequently used materials
showing good biocompatibility [43], while silica coatings allow low loss rates of
transmitted light and therefore are widely used for bio-imaging and bio-sensing
purposes [44].
The superparamagnetic property of SPIONs opens up new and highly attractive
applications especially in the biomedical field. Thus, they can be utilized for
site-specific drug delivery during magnetic drug targeting, as contrast agents
for magnetic-based imaging techniques, as heat inducers in hyperthermia anti-
cancer therapy, in magnetic tissue engineering, and for cell labeling and in vivo
cell tracking [10, 41, 42, 45]. As the first nanomedicinal product, ferumoxil (also
known as Lumirem®)—a siloxane-coated SPION of 300 nm—was approved by
the EMA as an MRI contrast agent in 1994 and since then four more SPION
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products have been introduced into clinics until today [25]. The shortening
effect of SPIONs on especially transverse relaxation time T2 induces a signal
loss during MRI, which results in a negative (i.e., dark) contrast image [46].
In addition, approaches utilizing aminosilan-coated SPIONs together with ap-
plication cycles of alternating magnetic fields are approved for efficient hy-
perthermia treatment of tumor entities such as glioblastoma and other enti-
ties [47]. Thus, clinical trials revealed an improvement of median survival time
from 6.2 months to 13.4 months without any complications compared to con-
ventional therapy of glioblastoma [7]. Further studies indicate that hyperther-
mia treatment prior to radiotherapy induces a radiosensitizing effect on glioma
cells [46].
A currently arising new nanomedical sector is formed by the fusion of diagnos-
tic and therapeutic applications, called "theranostics" [48]. Particularly, thera-
nostics allows both monitoring of pharmacokinetics via methods such as imag-
ing and therapeutic treatment of diseases including cancer. Thereby, multi-step
procedures are eliminated, which in turn accelerate disease treatment, and pave
the way for individualized medicine. Especially SPIONs are highly predestined
candidates for theranostic implementations as their multifunctional potential
easily allows the combination of contrast-enhancing features in MRI with mag-
netic drug targeting and hyperthermia-based cancer therapy [41]. Impressively,
pre-clinical investigations performed by Hayashi et al. using SPIONs hetero-
functionalized with PEG and folic acid, demonstrated efficient particle accumu-
lation in myeloma cancer tissues of mice resulting in enhanced contrast during
MRI [49]. At the same time, the application of an external alternating magnetic
field specifically induced local hyperthermia, promoted tumor shrinkage and
significantly prolonged overall survival of diseased animals.
Despite the various beneficial and promising functions of SPIONs in biomedi-
cine, there are still several obstacles limiting their unconditional use. A major
aspect comprises the fact that studies have revealed that only a small proportion
of actively targeted SPIONs actually reach target tissue [24]. To overcome this
problem by magnetic drug targeting, magnetic field configurations allowing
elevated penetration depths are critical as the magnetic field strength shrinks
cubically with growing distance. Furthermore, premature burst of drug car-
goes, especially at instillation time points, impair delivery efficiencies to target
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sites and may evoke cytotoxic side effects [50]. The so-called protein corona
comprising an adsorptive layer of ambient proteins on the particles’ surface
immediately after contact with the environmental medium, can critically in-
fluence biological effects of SPIONs and thus, hamper intended purposes [51].
This phenomenon also impedes the comparability of data obtained from both
in vitro and in vivo studies using similar particle formulations and might induce
their premature immunologic clearance from the blood stream caused by the
reticuloendothelial system (RES). Finally, in several cases the fate of internalized
SPIONs into cells and its biodistribution are not clear, whereas for a safe and ef-
fective clinical application such information is of vital importance. Hence, more
standardized studies related to these issues are imperatively needed [41].
1.1.2 Uptake Mechanisms for Nanoparticles
Uptake mechanisms for nanoparticles into the human body are versatile as
they can enter via different routes such as the lungs after inhalation, the skin
by dermal application or by enteral resorption upon ingestion [52]. In terms
of biomedical applications, direct intravenous administration is widely used—
especially in case of cancer nanotherapeutics [53]. The nanoparticles’ biodis-
tribution upon this systemic administration modality is determined according
to particle size, shape, surface charge and other surface properties [54]. How-
ever, nanoparticle dissemination is predominantly confined to the vascular sys-
tem and organs of fenestrated endothelium such as liver, spleen, and kidneys
as well as tumors and other sites of inflammation as they are characterized by
leaky vessels and fenestrated endothelium, too [54]. While for passive target-
ing, advantage is taken of the EPR effect (see section 1.1), active targeting by
grafting distinctive ligands, markers, or functional groups onto particles’ sur-
face can considerably affect their accumulation and elevate local concentrations
at specific target sites. Similarly, magnetic drug targeting in case of SPIONs and
other magnetic nanoparticles displays another relevant option for actively di-
recting particle distribution. As a consequence of their size in a typical range of
subcellular components and biological molecules [55], nanoparticles can show
intensive cellular interactions and be taken up into cells via distinct endogenous
uptake mechanisms. Usually, nanoparticles are taken up into cells by active en-
docytotic pathways, though the cellular entry via passive diffusion has been
described as well, especially in case of cationic particle formulations [56, 57].
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While large particles with exceeding sizes of 500 nm can only be engulfed by
specialized cells including macrophages and neutrophils via phagocytosis, the
ingestion of smaller particles via pinocytotic vesicles can be actioned by vir-
tually all types of eukaryotic cells [58–60]. The binding affinity mediated by
A Phagocytosis BClathrin-mediated
endocytosis (CME)
CCaveolae-mediated
endocytosis (CvME)
DMacropinocytosis E Other clathrin- and
caveolae-independent 
endocytosis
Legend: Actin Opsonin Clathrin lattice Caveolin dimer Dynamin
Figure 1.2: Endocytotic pathways ingesting nanoparticle into mammalian cells. Phagocy-
tosis (A) primarily occurs in professional phagocytes. Clathrin-mediated endocytosis (B) de-
pends on the GTPase dynamin, while calveolae-mediated endocytosis (C) at caveolin-coated
pits does not necessarily require dynamin. Non-selective particle engulfment can also happen
via macropinocytosis (D) or other endocytotic pathways independent from clathrin and cave-
olin. Figure taken with permission from [61].
hydrophobic or electrostatic interactions and receptor-ligand binding to cellu-
lar surfaces plays a crucial role for the first step of particle internalization. In
this context, diverse studies revealed that cationic surface charges of nanopar-
ticles show intensive interactions with anionic phospholipids or protein do-
mains originating from the glycocalyx (e.g. sialic acids) of cellular plasma mem-
branes [62], whereas neutral and anionic nanoparticles show less-pronounced
membrane adsorption and subsequent particle internalization [57]. Addition-
ally, the elevated abundance of negatively charged phosphatidylserine in the
cytosolic leaflets of the plasma membrane, endosomes and lysosomes is thought
to strengthen the entry of cationic proteins to endocytotic pathways [63]. As in-
dicated by figure 1.2, subsequent endocytotic ingestion is distinguished into
macropinocytosis, caveolin-dependent endocytosis, clathrin-mediated endocy-
tosis, and pathways independent from both clathrin and caveolin with further
sub-classifications [64, 65]. Most studies focus on clathrin-mediated endocyto-
sis when investigating uptake mechanisms for particles below 200 nm [61, 66],
though other processes and even an interplay of several pathways might oc-
cur [67]. Regardless of whether particle internalization is induced via plasma
membrane invaginations at clathrin-coated pits (i.e., clathrin-mediated endocy-
tosis), cholesterol-rich domains (i.e., caveolin-dependent endocytosis), or other
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active processes, membrane-budded vesicles transfer the nanoparticle cargo
into early endosomes first [60]. Within these compartments, which possess a
mild acidified milieu, receptors can be recycled and digestion off the received
material by hydrolysis is initiated as well as its sorting into delivery to specific
intracellular compartments or transcytotic pathways [68]. Next, the cargo is
directed to acidic late endosomes with increasing proteolytic activity before it
finally enters lysosomes. For nanoparticle cargoes directed to distinct subcel-
lular targets, pathways avoiding the lysosomal destination of the nanoscaled
vehicle are indispensable for successful implementations. Indeed, endosomal
escape has been shown for some nanoparticle formulations [41, 69, 70]. Espe-
cially a strongly cationic particle surface charge seems to promote the escape
from endosomes to reach the cytoplasm via destabilization of endosomal mem-
branes by mechanisms including ion-pair formation with anionic lipids and en-
dosomal/lysosomal buffering, swelling, and rupture (i.e., the "proton sponge
effect") [71]. Besides the resulting cytosolic delivery, targeting of distinct cel-
lular compartments such as nucleus, mitochondria and Golgi have also been
pursued [53].
As mentioned earlier, besides surface chemistry, the level of nanoparticle in-
teraction with cells is significantly influenced by particles’ properties including
size and shape as well as the cellular type itself and the microenvironment as
it can induce the protein corona formation, which in turn provides the par-
ticle with a new biological identity [41, 56]. In terms of particle size, gath-
ered data emphasize that, in general, smaller particles are internalized more
intensively, although a minimum size seems beneficial for efficient induction
of particle uptake probably due to sufficient cross linking of membrane recep-
tors [56,59,66,72]. In this regard, Win and co-workers observed that polystyrene
nanoparticles of 100 nm show most pronounced particle internalization into
adenocarcinomal cells, while the uptake of larger (200–1000 nm) particles is
gradually decreased and lowest for 50 nm [73].
1.1.3 Biologic and Cytotoxic Effects of Nanoparticles
As the variety of biomedicinal nanoparticles is huge, so are their biological ef-
fects. According to the particle type, they can influence cell physiology in many
different ways. Obviously, particles characterized by an intensive cellular inter-
action bring along a great capability for influencing both vitality and physiology
11
Introduction
of cells. The particle’s ability to penetrate biological barriers and their resulting
biodistribution are crucial factors determining nanoparticle-induced outcomes
on the systemic level. Apart from particle size, shape, dose, incubation dura-
tion, and type of exposed cells, especially surface coating and functionalization
play a substantial role in determining biological effects [41, 74]. While on the
one hand they can enhance particle uptake increasing intracellular nanoparti-
cle concentrations, on the other hand they can promote intracellular trafficking
and endosomal escape as implied in section 1.1.2. Thus, many studies have
identified a cationic surface charge of nanoparticle formulations as decisive fac-
tor mediating cytotoxicity via various mechanisms [38, 74–76] including the in-
duction of nanoscale holes within plasma membranes, which promotes sub-
stantial membrane damage resulting in cell death [77]. Fischer et al. demon-
strated that besides the cationic surface net charge, the charge density and flex-
ibility of the three dimensional structure of the coating molecules also essen-
tially determine biological effects [75]. Endosomal escape of cationic nanopar-
ticle formulations explicitly results in the presence of bare particles within the
cytosol, which in turn can induce direct interaction of particles with cellular
organelles and proteins including the actin cytoskeleton inducing destabiliza-
tion and cell cycle arrest [38]. Apart from cationic surface charges, anionic
nanoparticles are associated with cytotoxic effects, too, whereas neutral par-
ticles are largely non-toxic [57, 76, 78]. A reasonable cause for this is provided
by respective studies which show the low adherence of particles coated by dex-
tran, starch or other neutral materials at the polar plasma membrane, whereas
anionic nanoparticles can still cluster at the sparse membrane areas constitut-
ing positive charges [57, 79]. Based on the fact, that the hydrodynamic size of
nanoparticles (and particle agglomerates) affects particles reactivity—whereby
large surface-to-volume ratios render elevated surface energies—small particles
tend to be more toxic compared to larger ones [70,76,80]. Finally, the formation
of a protein corona can also influence biological effects of distinct nanoparticles
as described in section 1.1.5.
After depletion of coating material, cells are exposed to the particle’s often in-
organic core, which in the case of SPIONs is per se considered as biocompatible
in contrast to silver, cadmium or other metals [38, 56]. However, during fur-
ther degradation, increasing contents of free iron ions can cross mitochondrial
membranes reacting with hydrogen peroxide and oxygen during the Fenton
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reaction giving rise to highly reactive hydroxyl radicals [38, 56]. The resulting
oxidative stress can provoke radical damage of DNA and other components
including the cytoskeleton, which brings on inflammatory processes and cyto-
toxic events [76]. Aside from reactions directly affecting viability, sustainable
impacts on cell physiology promoted by altered signal transduction profiles are
also critical. An enhanced expression of cell signaling proteins integrating extra-
cellular signaling from the membrane to the nucleus has been revealed by Berry
et al. [81]. Interestingly, another comprehensive study performed by Mahmoudi
and colleagues observed a particle charge-dependent effect on gene expression
levels in different cell lines [74]. Based on their experimental results, the ex-
posure of the cationic SPIONs strongly provoke oxidative stress, cell growth
inhibition, and finally can induce apoptosis.
1.1.4 Biodegradation and Excretion of Nanoparticles
The ideal and safe nanomedical product for in vivo applications does not cause
any off-target effects on the biological system after cargo delivery or related
implementation. Especially when using them as diagnostic agents this require-
ment seems even more reasonable as the nanomedicinal products might also
be applied to healthy individuals and in repetitive modes, too. Hence, vehi-
cles should rapidly and completely be eliminated from the human body pre-
venting non-specific nanoparticle accumulation in the long term. Actually, af-
ter intravenous administration of nano-scaled objects with sizes below 10 nm
a clearance via kidneys has been observed [54], whereas non-continuous fen-
estrated hepatic endothelium accounts for a substantial retention of particles
measuring 50-100 nm [82]. Splenic filtration quickly eliminates nanoparticles
between 200 nm and 500 nm from the blood stream and particles in the mi-
crometer range predominantly accumulate in capillaries of the lungs [83]. In
addition to this size-dependent endothelial permeability or barrier-rising ef-
fect of indicated organs, the RES with resident macrophages in liver, spleen,
lymphs, and lungs contributes to considerable particle uptake which is addi-
tionally fostered upon protein corona formation [54,84]. Thus, the risk of only a
small proportion reaching targeted tissues other than the ones just mentioned,
is high. Furthermore, surface charge and coating material influence blood cir-
culation half life, too. During in vivo studies in rodent-based experiments it
has been observed that cationic as well as anionic particles show shorter cir-
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culation times and increased liver uptake compared to neutral dextran-coated
ones [83, 85, 86]. Upon particle accumulation within liver or kidneys, excretion
from the body happens via bile and feces or via urine [42,87]. However several
studies have identified nanoparticle deposits present in liver and other tissues
several months after application [87–89]. Options for diminishing cellularly ac-
cumulated nanoparticles range from cellular proliferation as described by Pra-
painop et al. [90] to exocytosis and lysosomal degradation [42]. With regard
to SPIONs, iron cores are metabolized after degradation of the particles’ coat-
ings. Released iron is incorporated into the body’s iron pool and can be stored
within liver, spleen, or bone marrow as ferritin upon complexing with the iron-
binding protein apoferritin [87]. Via the transferrin complex, iron is mobilized
and carried to other tissues where it can be destined to erythropoiesis where
it constitutes the key element of hemoglobin [39]. However, as the long-term
toxicity of metal-containing nanoparticles still remains unclear, the transition
of such inorganic formulations from the laboratory into clinics relies on their
clearance from the human body [10].
1.1.5 Protein Corona
The protein corona constitutes a decisive factor affecting the cellular interaction
and internalization rates, thus, dedicating biological effects of nanoscaled ob-
jects [41, 53, 56]. Immediately upon contact with biological media, particularly
proteins residing on the nanoparticle, are adsorbed to the particle’s surface de-
pending on both protein abundance and adsorption affinity [91]. As schemed
in figure 1.3, this effect results in the formation of a hard layer of highly affine
proteins and a soft protein corona comprising loosely bound protein structures
extending total hydrodynamic diameters by 3–15 nm [92, 93]. According to
Walkey and Chan, 125 different proteins including lipid transporters, blood co-
agulation and complement proteins, have been observed to be involved in the
protein corona generation. They also point out that the composition of such
coronas is unique to each nanomaterial [94]. With a superior blood plasma
abundance between 85-90% albumin, this transport protein has been identi-
fied within the majority of protein coronas of diverse particle types [95–97],
where nanoparticles with hydrophobic and charged surfaces tend to adsorb
proteins more extensively compared to particles with neutral and hydrophilic
surfaces [10, 84, 92, 98]. However, analyses by Tenzer et al. revealed that the
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Figure 1.3: Structure and effects of the protein corona on nanoparticles. The protein corona
covering the particle surface is composed of a hard and soft layer of proteins (A). In turn, pro-
tein coating can mask cell-specific targeting ligands linked to nanoparticle surfaces (B) Figure
modified with permission from [92].
protein corona composition not simply reflects their relative abundance within
blood plasma but comprises enrichments of lipoproteins and proteins involved
in coagulation and complement pathways [96]. Comprehensive studies on the
effects of particle size and charge on protein adsorption were performed by
Mahmoudi and co-workers [95]. Upon the fetal calf serum (FCS)-based induc-
tion of a protein corona on anionic, cationic, or neutral SPIONs they could show
that proteins of elevated molecular weights preferably adsorb to larger parti-
cles. Furthermore, the authors emphasized the role of particle surface charge,
whereby large proteins are predominantly present in coronas of charged parti-
cles and coronas of cationic SPIONs constitute a bigger diversity in general. A
pronounced opsonization of nanomaterials with a protein corona, on the one
hand confers a rapid clearance of nanoparticles from the blood stream by the
RES and on the other hand masks targeting ligands impairing delivery effi-
ciency (see figure 1.3). Hypersensitivity reactions of patients upon a corona-
triggered massive activation of the complement system are critical complica-
tions, too [38,53]. Hence, particle coatings with hydrophilic biocompatible poly-
mers, including PEG, polyacrylic acid, and dextran, are frequently utilized to
induce a so-called stealth effect [41,53]. The latter is characterized by supplying
steric repulsion towards most adsorption proteins while switching to lipopro-
teins such as clusterin and apolipoprotein A-1, which in turn sufficiently re-
duce particle internalization by macrophages [53, 99]. In addition to clearance
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by the RES, the presence and distinct composition of a protein corona might
also affect intracellular trafficking and toxicity [53]. With respect to the latter,
decreasing cytotoxic effects based on the protein corona formation are partic-
ularly observed for cationic and bare inorganic particles, whereas enhancing
cytotoxicity is associated with protein corona formation with conformational
changes of protein contents uncovering epitopes [97, 100].
1.2 Blood-Brain Barrier
As the center of the central nervous system (CNS), the brain constitutes a highly
complex organ controlling all other body parts and functions. Despite its mass
with only 2% relative to the total body mass, its demand for 20% of the body’s
nutrients is considerably high [101]. For its sufficient supply on the one hand
and its protection from harmful stimuli on the other hand, the blood-brain bar-
rier (BBB) forms a selective physiologic barrier between the peripheral circula-
tory system and the CNS. Thus, the maintenance of homeostatic concentrations
of ions, such as Na+, K+, and Ca2+, are considered as essential prerequisite for
proper neuronal functions [102]. Furthermore, the well-controlled leukocyte
migration directed across the BBB is a critical factor playing a key role in the
physiologic immune surveillance, acute self-limiting inflammation, and anti-
gen recognition [103].
1.2.1 General Structure
The BBB is maintained by a complex interplay between several components
of the so-called "neurovascular unit" as depicted in figure 1.4. The central ele-
ment of this unit is embodied by the endothelial cells of cerebral microvessels,
also referred to as brain microvascular endothelial cells (BMEC). Compared
to peripheral endothelial cells, BMECs are featured by tight cell-cell junctions
lacking fenestration, increased contents in mitochondria, and minimal pinocy-
totic activity [102, 105]. In addition to ubiquitously abundant adherence junc-
tions, the presence of tight junctions sealing intercellular clefts between adja-
cent cells is characteristic for BMECs. According to figure 1.4, the formation
of such tight junctions is accomplished on the one hand by transmembrane
molecules such as junctional adhesion molecule (JAM)-1, occludin, and claudin,
and on the other hand by membrane-associated guanylate kinase (MAGUK)
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Figure 1.4: Cellular components and structure of the neurovascular unit forming the blood-
brain barrier (BBB). The neurovascular unit is formed by endothelial cells surrounded by per-
icytes, basal membrane, and astrocytic perivascular end feet. A characteristic element of the
BBB constitute tight junctions sealing intercellular clefts between adjacent endothelial cells.
Transmembrane proteins occludin, claudin and junctional adhesion molecule (JAM)-1 connect
junctions extracellularly, whereas zonula occludens (ZO)-1–3 link tight junctions to the actin cy-
toskeleton intracellularly. Figure modified with permission from [104]. ESAM - endothelial
selective adhesion molecule; PECAM - platelet-endothelial cell adhesion molecule; VE - vascu-
lar endothelial; ZONAB - ZO-1-associated nucleic acid binding protein.
proteins, which coordinate cytoplasmic protein-protein interactions via multi-
ple protein binding domains [102]. MAGUK proteins comprise zonula occlu-
dens (ZO) constructs with three subforms (ZO-1–3) joining transmembrane tight
junction units with the actin cytoskeleton. The first of these proteins positively
linked to tight junction was ZO-1, as its dissociation from the junctional com-
plex has been associated with enhanced BBB permeability, although it is broadly
distributed in non-epithelial cells, too [106]. Aside from BBB-strengthening
juxtamembrane localization, ZO-1 can also co-localize with the nuclear tran-
scription factor ZO-1-associated nucleic acid binding protein (ZONAB). There
it co-regulates expression levels of diverse genes including ERBB2, which con-
tributes to epithelial cell differentiation and maturation [106]. Furthermore, dis-
ruptions of BBB tight junctions by extracellular depletion of Ca2+ and increased
intracellular Ca2+ levels is characterized by a loss of ZO-1, ZO-2, and occludin
from cellular membranes, probably by interference of protein-protein interac-
tions upon activation of kinase signaling cascades such as NF-κb, c-fos, and
cAMP response element-binding protein. As tight junctions are located in apical
cellular segments, they not only restrict paracellular permeability to molecules
of a few nanometers only [70, 107] and induce strongly elevated transendothe-
lial electrical resistance (TEER; i.e., measurement of electrical resistance across
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cellular layer [108]), but also allow cell polarity and asymmetric distribution
of membrane constituents [102]. Caused by this asymmetric and site-specific
expression of receptors, transporters, and enzymes facing luminal (i.e., apical
membrane) or abluminal (i.e., basolateral membrane) sides, the BBB addition-
ally presents a metabolic barrier modulating the activity of toxic and neuroac-
tive compounds. With regards to TEER, the dense abundance of tight junctions
in BMECs mediates resistances of more than 1,000Ω·cm2 in vivo compared to
2–20Ω·cm2 in peripheral capillaries [109, 110]. As indicated in figure 1.4, apart
from endothelial cells (i.e., BMECs) further cell types are involved in the forma-
tion of the neurovascular unit. In this way, granular and filamentous pericytes
irregularly cover abluminal membranes of BMECs forming the closest associa-
tion with the endothelium. As pericytes possess contractile proteins, they are
believed to be involved in the regulation of capillary blood flow [102]. Ad-
ditionally, pericyte-derived angiopoetin has been shown to induce endothelial
expression of occludin enhancing BBB tightness [111]. The 30–40 nm thick basal
lamina encloses both pericytes and BMECs [112]. The composition of this lam-
ina is covered by collagen type IV, heparin sulfate, proteoglycans, laminin, fi-
bronectin, and other components of the extracellular matrix, and affects BMECs’
intracellular signaling pathways and tight junction expressions via interactions
with endothelial integrins [112]. Finally, astrocyte end feet connected to the
basal lamina support the BBB and provide the cellular link to neurons. There
is strong evidence that astrocytes influence BBB formation by regulating en-
dothelial expression of tight junction proteins, distinct transporters, and spe-
cialized enzyme systems via secreted factors including transforming growth
factor (TGF)-β, glial cell-derived neurotrophic factor (GDNF), and basic fibro-
blast growth factor (bFGF) [103, 104].
1.2.2 Ways across the Blood-Brain Barrier
For a sufficient supply of the brain with nutrients and the efficient efflux of
metabolic waste products on the one hand, and its protection from harmful
compounds on the other hand, the BBB constitutes not only a physical bar-
rier but also a metabolic- and transport barrier, too. Small gaseous molecules
such as O2 and CO2 can freely pass lipid membranes of the BBB as well as
small lipophilic agents including alcohol, cocaine base, and barbiturates. For
the transport of small hydrophilic compounds across the BBB specific trans-
18
1.2 Blood-Brain Barrier
port systems on luminal and abluminal endothelial surfaces are available. The
two major superfamilies of such transporters cover ATP-binding cassette (ABC)
transporters and solute carriers (SLCs). Both facilitate the active transport of
molecules against electrochemical gradients, whereby the first depends on ATP,
while the latter couples molecule transport to another ion or molecule down
its concentration gradient [113]. GLUT1 glucose carriers, several organic an-
ion or cation transporters such as L-type amino acid transporter (LAT)-1, trans-
porters for nucleosides and nucleobases, and many others are typical exam-
ples [114]. Whereas various of such transport systems operate bidirectional
(e.g., GLUT1, LAT1), some are distinctly located at luminal or abluminal en-
dothelial surfaces only, such as for instance abluminal Na+-dependent gluta-
mate transporters being responsible for glutamate efflux from the brain [104].
In contrast, luminal ABC transporters comprising P-glycoprotein (P-gp) and
multidrug resistance-associated proteins (MRPs) are efficient efflux pumps for
waste products, environmental toxicants, and xenobiotics as well as therapeu-
tic drugs [115]. In contrast to the transporter-mediated passage, hydrophilic
molecules larger than 400-500 Da such as peptides and proteins, usually are ex-
cluded from transcellular trafficking, unless they specifically undergo receptor-
or adsorptive-mediated transcytosis [46, 114]. Adsorption-mediated transcyto-
sis relies on non-specific interactions of ligands with surface moieties expressed
on luminal membrane sides of endothelial cells. It is predominantly mediated
by caveolae- and clathrin-mediated endocytotic processes as well as endocytotic
processes independent from clathrin and caveolin as described in section 1.1.2.
The specific binding of ligands to BMECs’ surface receptors such as insulin
receptors, transferrin receptors, and low density lipoprotein (LDL) receptor-
related proteins (LPR), are mandatory for receptor-mediated transcytosis. In
this way, the brain is efficiently supplied with insulin, transferrin-bound iron,
LDL, lactoferrin, and many more.
The tight regulation of transport systems across the BBB often constitutes a
considerable obstacle for efficient delivery of therapeutic drugs into the brain.
This holds true even when barrier impairments already pre-exist, which can
arise from inflammatory and pathological conditions including stroke, menin-
gitis, multiple sclerosis, diabetes, Alzheimer’s disease, and brain tumors [116].
Therefore, specific strategies for overcoming this hurdle have been developed.
The injection of hyperosmolar solutions of mannitol, lactamide, saline, or oth-
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ers into the brain-supplying carotid artery has been shown to transiently dis-
rupt cerebral tight junctions by shrinking endothelial cells, which in turn im-
proves the delivery of chemotherapeutic drugs into the CNS of patients with
various types of brain tumors [117]. Similarly, chemical destabilization of the
BBB by alkylglycerols efficiently limits BBB opening to 3–15 min [118]. An-
other strategy to temporarily access the brain, comprises acoustic cavitation of
polymer- or lipid-shelled microbubbles by focused ultrasound [119]. Result-
ing oscillations of microbubbles induce localized disintegration of tight junc-
tions conveying brain entry for co-applied drugs. Despite indicated conven-
tional approaches facilitating paracellular drug transport, strategies enhancing
transcellular carrying have also been developed. These include drug modifica-
tion towards a more lipophilic character as well as the use of prodrugs, such
as L-3,4-dihydroxyphenylalanine (L-DOPA), capable for crossing the BBB via
transport systems and being converted into active forms upon entry [120]. Re-
cently emerged approaches use nanoparticle carriers for enhanced drug de-
livery into the CNS [41, 70, 89, 114]. For instance, doxorubicin-loaded lipo-
somes functionalized with cationic surface peptides have been shown to ef-
ficiently cross the BBB via adsorption-mediated transcytosis in brain tumor-
bearing rats [121]. For metallic nanoparticles including SPIONs, passive dif-
fusion, clathrin-mediated transcytosis, and trans-synaptic transport have been
demonstrated as mechanisms for overcoming the BBB, whereby the additional
application of an external magnetic field enhances SPION accumulation in cere-
bral perivascular zones within mice [118]. The conjugation of nanoparticle for-
mulations with targeting moieties such as monoclonal antibodies, peptides, and
specific plasma proteins, encourage transcellular passage through BBB-forming
endothelial cells, too. Coupling of transferrin or transferrin-binding antibod-
ies to particle surfaces are typical candidates for promoting receptor-mediated
transcytosis [122]. Similarly, insulin, lactoferrin, folate, heparin-binding epider-
mal growth factor, and integrin αvβ3 have been utilized as ligands for CNS-
directed delivery [41, 89, 118, 122]. Another common attempt includes parti-
cle coating with polysorbate 80. This non-ionic surfactant is expected to ad-
sorb apolipoproteins A-I, B-100, and E, mimicking LDL particles, which inter-
act with LDL receptors leading to receptor-mediated transcytosis through BBB-
forming endothelial cells [123]. With respect to brain tumor-specific targeting,
lactoferrin, neutrophilin-1, epidermal growth factor (EGF), antibodies directed
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towards vascular endothelial growth factor (VEGF) or EGF receptors includ-
ing mutant EGF receptor variant III, and many others have been suggested as
tumor-directed ligands conjugated to nanoparticles’ surface [46]. Finally, hi-
jacking immune and stem cells as carriers of therapeutic drugs displays a novel
promising approach in hurdling the BBB [53,118]. Exploiting the tumor-trophic
and inflammation-mediated barrier penetration of monocytes/macrophages,
neutrophils, neural- and mesenchymal stem cells, therapeutics including genes,
cytokines, enzymes, and even nanoparticles can be delivered into the CNS [118,
124]. Hence, experimental studies using neural stem cells demonstrated the
transduction of soluble tumor necrosis factor-related apoptosis-inducing ligand
(TRAIL) to invasive metastatic tumor deposits in the brain of mice modeling
breast-to-brain metastasis [125]. Nevertheless, cell-mediated delivery of thera-
peutic drugs meets a number of challenges. Among others, cytotoxic effects of
the cargo on the cell carrier itself and the time and location-dependent release
of the therapeutic agent are major obstacles. Recent concepts combining the use
of cell-mediated delivery together with nanoparticles might provide a solution
to these problems, as they offer a platform for shielding carrier cells from toxic
drugs while allowing controlled drug release [118].
1.2.3 Model Systems Representing the Blood-Brain Barrier
As described in section 1.2.1, the BBB constitutes a complex network of sev-
eral collaborating components making a plain isolation for functional analyses
complicated. In order to experimentally study different aspects with regards
to BBB cell biology and screening for CNS drug permeability, diverse mod-
els have been developed. Especially high-throughput drug-screening draws
on parallel artificial membrane permeability assays (PAMPA) as non-cell-based
surrogate models composed of filters with lipid membranes [105]. In context
of functional studies, on the one hand, in vivo models include animal testing
usually using mice and rats as well as guinea pigs, rabbits, dogs, and mon-
keys [126]. Due to profound differences in anatomy, physiology, and genetics
obtained results can not be directly extrapolated to the human organism [7].
Though, approaches using freshly isolated capillaries from brain tissues have
been utilized for ex vivo studies for several decades [127, 128]. As the constant
availability of required human tissues is limited and animal testing should be
minimized, several cell culture-based in vitro models representing the BBB have
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been developed for multifunctional analyses. The deliberate isolation of pri-
mary BMECs from porcine, bovine, murine, or ratty sources and their imple-
mentation in transwell-based studies have contributed to valuable insights into
physiologic and pathophysiologic processes regarding the BBB [127, 129, 130].
Thereby, especially porcine and bovine models form tight endothelial monolay-
ers reaching particularly high TEER values (i.e., up to 2,500Ω· cm2) accompa-
nied by low molecular permeabilities as well as appropriate functional efflux
transporter activity and tight junction expression [127, 131]. The range of ex-
perimental settings covers transwell-membrane-based mono-cultured BMECs,
their co-cultivation with astrocytes or pericytes in direct contact or contact-
free manner, as well as the triple culture of BMECs, astrocytes, and pericytes.
Experimental data show, that elevated culturing techniques using more than
one cell type, often result in the generation of tighter cellular barriers but con-
flicting results have also been observed [105, 127, 131]. With regards to setups
representing the human BBB, only few models are available. These are either
based on stem cell-derived endothelial cells or immortalized human BMEC cell
lines [127]. For the latter case, the lentiviral-immortalized cell line hCMEC/D3
is most widely spread and well characterized. Whereas mono-cultured cell
layers of hCMEC/D3 gain TEER values of 30–50Ω·cm2, co-culture with as-
trocytes raise TEERs to 60Ω·cm2 [127, 131]. Anyway, a comparative study by
Eigenmann and colleagues comprising hCMEC/D3, human brain microvascu-
lar endothelial cells (HBMECs) and two other cell lines revealed that, while all
four endothelial cell lines specifically expressed the adherence junction protein
VE-cadherin, tight junction protein ZO-1 was only confirmed in hCMEC/D3
and HBMEC [131]. Focusing on TEER and molecular paracellular permeabil-
ity, the mono-culture of HBMEC attained cell layers of highest tightness in this
study. Advanced approaches applying shear stress to endothelial cells by the
integration of flow conditions to the apical and/or basolateral side superiorly
mimic the in vivo situation of the BBB. As a consequence, endothelial cells re-
spond by structural and functional remodeling, differentiation, and result in
higher TEER values as compared to static transwell models [105,132]. However,
no model exactly mimics the full expression pattern of enzymes, transporters,
receptors, and other structural proteins of an in vivo BBB [103, 127] and no gold
standard in vitro model exists. Hence, appropriate models have to be chosen
carefully according to the scientific question.
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1.3 Aims of the Study
The steadily-increasing diversity of superparamagnetic iron oxide nanoparti-
cles (SPIONs) opens up the possibility for advanced, personalized, and highly-
targeted biomedical applications, though represents a serious challenge for as-
sessing and predicting biological consequences for the organism. Critical issues
for a successful particle implementation are biodistribution, tissue penetration,
uptake, metabolism and storage of nanoparticles, as well as particle degrada-
tion and elimination. As all of these aspects are substantially driven by parti-
cles’ interaction with biological barriers, a reliable and controllable barrier test
system can help to systematically identify crucial factors involved.
That is why this study aimed to evaluate the following work packages:
1. Analysis of interaction of differently charged SPIONs with blood-brain
barrier (BBB)-forming cells especially in context of protein corona-associ-
ated effects on SPIONs’ biological activity.
2. Establishment of an appropriate in vitro model representing the human
BBB based on a transwell system using human brain microvascular en-
dothelial cells.
3. Investigation of the SPION-associated effects on the integrity of the in vitro
model with selection of SPIONs appropriate for further analyses regard-
ing particle passage through the barrier.
4. Analysis of the kinetics and quantity of SPION passage through the BBB-
representing model using direct detection methods.
5. Evaluation of SPION transport across the in vitro barrier model by barrier-
penetrating immune cells as well as the SPION-induced barrier penetra-
tion of immune cells.
Insights obtained from this study can thus contribute to a deep and functional
understanding of particle interaction with and passage across barriers and con-
sequences for barrier integrity. In turn, the experimental setup can be utilized
for further screening of nanoparticles and particle types in a systematic manner.
Finally, the gained knowledge may allow an efficient and safe implementation
of tailored nanoparticles in biomedicine.
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CHAPTER 2
Methods and Materials
This chapter includes a detailed description of all performed methods. Utilized
materials are indicated here or as a detailed list in the appendix (A).
2.1 SPION- and Protein Corona Characterization
Nanoparticles used in scope of this study are core-shell particles made of an
iron oxide (magnetite or maghemite) cores being coated by polymers or organic
acids. Both non-labeled fluidMAG and fluorescence-labeled nano-screenMAG-
G particles were purchased from chemicell AG, Berlin, Germany, whereby the
lipophilic fluorescent dye was located between the iron oxide core and the poly-
mer coating. In contrast, both SEON particles were friendly provided by Prof.
Dr. med. Christoph Alexiou from the Universitätsklinikum Erlangen, Germany.
Their synthesis was carried out as described previously [133–135].
As nanoparticles’ physicochemical properties decisively influence their reactiv-
ity and interaction with biological structures, a detailed characterization was
performed on all particles used in this study. To this end, both particle size and
surface charge were determined by means of dynamic light scattering and zeta
size measurements, whereas vibrating sample magnetometry was used for an-
alyzing magnetic properties regarding concentration determinations (see sec-
tion 2.1.2). Detailed information on all used SPIONs is shown in table 2.1.
In order to analyze the protein corona formation on particle surfaces in more
detail gel electrophoresis-based protein separation was performed on corona-
comprising particles (see section 2.1.1). Thereby the formation of a protein
corona was experimentally induced through incubation of 15 mg magnetic par-
ticles within 2.0 ml FCS—if necessary diluted with RPMI 1640 medium—at 37 °C
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Table 2.1: Characteristics of experimentally used SPIONs. BSA - bovine serum albumin;
DEAE - diethylamine ethyl; PAM - polyacrylat-co-maleat; PEI - polyethylenimine; PdI - poly-
dispersion index.
Name Coating Hydrodyn. Size (PdI) ζ-potential
fluidMAG-D starch 141 nm (0.108) -11±7 mV
nano-screenMAG-
G/D
starch,
fluorochrom
(476/490 nm)
139 nm (0.171) -10±4 mV
fluidMAG-DEAE strach/
DEAE
132 nm (0.098) +36±7 mV
fluidMAG-PEI PEI, 750 kDa 157 nm (0.113) +47±7 mV
nano-screenMAG-
G/PEI
PEI, 750 kDa,
fluorochrom
(476/490 nm)
135 nm (0.139) +54±9 mV
SEONBSA lauric acid/
BSA
157 nm (0.241) -19±4 mV
SEONPAM PAM 151 nm (0.297) -54±1 mV
for 10 min. Upon magnetic separation SPIONs were washed once with 1.0 ml
aqua bidest. and magnetically separated again before they were resuspended
within 1.0 ml aqua bidest.. Particles were stored at 4 °C until usage.
2.1.1 SDS-PAGE and Silver Staining
The qualitative and semi-quantitative analyses of the protein corona were eval-
uated by means of sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) as described earlier [136]. In short, secondary and tertiary struc-
ture of proteins were reduced by applying reducing agent and cracked by heat-
ing up to 95 °C for 5 min, followed by a separation of the denatured proteins by
molecular weight with PAGE. As references, a molecular weight standard pro-
tein collection Kaleidoscope marker (Bio-Rad Laboratories, Hercules USA) and
analogously treated FCS solutions were carried along. Next, protein bands were
stained by highly sensitive silver staining with SilverXpress Silver Staining Kit
(Thermo Fisher Scientific, Waltham, USA) and gray-scale gel images were an-
alyzed for optical densities using the ImageJ 1.50e software (Wayne Rasband,
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National Institutes of Health, USA). The transfer of gray-scaled imaged into al-
ternative color maps was performed utilizing the MATLAB® R2013a software
(MathWorks, Natick, USA).
2.1.2 Physical SPION Characterization
To determine the hydrodynamic diameter of SPIONs, dynamic light scattering
was applied using the Zetasizer nano series ZS (Malvern Instruments, Herren-
berg, Germany). Scattered He-Ne laser light (633 nm) detected at 173° dur-
ing three independent measurements with twelve replicates each was used to
determine intensity-weighted hydrodynamic diameters. Additionally, zeta po-
tentials were measured using the same instrument but based on laser Doppler
velocimetry. By measuring the magnetic properties of the prepared samples
by means of vibrating sample magnetometry particle concentrations were de-
termined. This was realized by using the PMC MicroMag 3900 VSM (Lakeshore
Cytotronics Inc., Westerville, USA) in the vibrating sample magnetometry mode.
2.2 Cell Culture
Cell culture preparations and respective solutions were handled under laminar
flow hoods. Equipment was autoclaved, sterilized by rapidly-acting ethanol-
based wipe disinfection or filtration by using 0.2 µm pore size membrane fil-
ters. If not stated otherwise all cells were cultured at 37°C in a water-saturated
atmosphere supplemented with 5% CO2.
2.2.1 Cell Lines
As a representative in vitro model an established cell line of human brain mi-
crovascular endothelial cells (HBMEC) was used. This adherent blood-brain
barrier-representing cell line originally isolated from cortical capillaries has been
immortalized by introduction of the SV40 large T antigen [137]. HBMEC were
kindly provided by Prof. Dr. rer. nat. Werner Reichardt from the Ernst-Abbe-
Hochschule Jena.
Likewise adherent, MCF-7 (DSMZ no. ACC 115) cells constitute an epithelial
cell line derived from the pleural effusion of a female patient with a mammary
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gland adenocarcinoma. Monocytic THP-1 (DSMZ no. ACC 16) and promyelo-
blastic HL-60 (DSMZ no. ACC 3) are suspension cell lines both derived from
peripheral blood of patients affected with acute monocytic or acute myeloid
leukemia, respectively. THP-1, HL-60 as well as MCF-7 cell lines were pur-
chased from the Leibniz Institute DSMZ - German Collection of Microorgan-
isms and Cell Cultures, Braunschweig, Germany.
2.2.2 Cell Cultivation
HBMEC, THP-1, and HL-60 were cultivated using RPMI 1640 cell culture medi-
um supplemented with 10% (v/v) FCS whereas for MCF-7 cells DMEM medium
provided with 10% (v/v) FCS was used. Every three to four days subconfluent
HBMEC and MCF-7 were trypsinized using 0.05% trypsin-EDTA and subcul-
tured at a ratio between 1:5 and 1:12 with fresh cell culture medium. Every
three to four days the suspension cells THP-1 and HL-60 were passaged at a
ratio of 1:3 with fresh cell culture medium. In regular intervals cell cultures
were tested regarding mycoplasmic contaminations using the commercial PCR-
based Venor™ Gem mycoplasma detection kit (Sigma-Aldrich Chemie GmbH,
Steinheim, Germany).
2.2.3 Transwell-Based Generation of in vitro Blood-Brain
Barrier Model
In order to generate the in vitro BBB model sub-confluent HBMEC were har-
vested and resuspended in seeding medium being composed of RPMI 1640 sup-
plied with 10% (v/v) FCS, 100 U/ml penicillin, and 0.1 mg/ml streptomycin.
After 30-minute equilibration of 24-well transwell inserts within seeding medi-
um, equilibration medium was removed and per insert 100 µl containing
240,000 cells were added into the insert (= apical membrane site/donor com-
partment). Subsequently, the cell-equipped transwell inserts were carefully
placed into 24-well companion plates filled with 600 µl/well seeding medium
(= basolateral site/acceptor compartment). When the effect of different cell cul-
ture media and media supplements was investigated, 24 h after seeding the
seeding medium was replaced by respective cell culture medium. Depleted
cell culture medium was renewed every other day. Cellular growth and cell
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layer integrity were verified regularly by means of transendothelial electrical
resistance (TEER) measurements (see section 2.4.1).
For transmigration experiments of SPION-loaded THP-1 or HL-60 cells through
the BBB model, 240,000 cells HBMEC were seeded analogously on 24-well
FluoroBlok transwell inserts, whereas apical seeding medium volumes and ba-
solateral volumes were adjusted to 300 µl and 1000 µl, respectively.
2.2.4 Preparation of Astrocyte-Conditioned Medium
In a monoculture-based BBB-representing cell culture system astrocyte condi-
tioned medium (ACM) might be favorable in order to enhance the integrity
of the biological barrier [132]. In order to evaluate its effect in the here pre-
sented transwell system ACM was obtained from primary astrocytes isolated
from the spinal cord of mouse E13 embryos. Cultivated on 24 well plates us-
ing DMEM/Ham’s F-12 medium supplemented with 10% (v/v) FCS, 100 U/ml
penicillin, and 0.1 mg/ml streptomycin medium was collected every four days.
Before use it was centrifuged (10 min at 1,000 rcf), sterile filtered (0.2 µm pore
size), and stored at 4 °C.
2.2.5 Differentiation of Progenitor Cells
For the analysis of SPION-induced migration of immune cells across the
HBMEC-based in vitro BBB model, established progenitor cell lines were chem-
ically stimulated to induce differentiation. As described earlier, 1.4% (v/v)
DMSO dissolved in RPMI 1640 cell culture medium containing 10% (v/v) FCS
was used to stimulate the differentiation of HL-60 to neutrophilic-like cells [138–
140]. Every other day 1/3 of medium was replaced by fresh medium sup-
plemented with 1.4% (v/v) DMSO. Analogously, as stated by Park et al. [141]
monocytic differentiation of THP-1 was induced by incubation with 5 ng/ml
PMA dissolved in RPMI 1640 cell culture medium with 10% (v/v) FCS for five
days. Every other day 1/3 of medium was replaced by fresh PMA-containing
medium. Differentiated cells were either characterized by flow cytometric a-
nalysis upon immunological staining (see section 2.7.2) or Pappenheim staining
(see section 2.5.2). Moreover, the adherent fraction of differentiated THP-1 and
the suspended fraction of HL-60 cells were subjected to transmigration assays
(see section 2.9).
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2.3 Cell Viability Assays
Different assays were used in order to verify cellular viability of HBMEC after
exposure to diverse types of SPIONs. While acute cytotoxicity for SPION incu-
bations of up to 24 h was investigated using biochemical and flow cytometry-
based assays (see sections 2.3.1 and 2.3.2), SPION-associated long-term effects
on cell viability were analyzed by means of real-time cell analysis using the
xCELLigence system (see section 2.3.3).
2.3.1 PrestoBlue™ Assay
The PrestoBlue™ assay is a biochemical test designed to determine the amount
of viable cells based on their metabolic activity. Thereby the PrestoBlue™ rea-
gent resembles non-fluorescent resazurin which in the presence of the reducing
environment present within living cells is reduced to the highly fluorescent re-
sofurin. As this dye conversion is proportional to the number of metabolically
active cells it can be utilized for cell viability quantification.
In order to test the SPION-specific cytotoxic effect on HBMEC, per well of a
96-well black-walled µ-Clear® plate 15,000 cells resuspended within RPMI 1640
cell culture medium supplied with 10% (v/v) FCS —and if necessary 100 U/ml
penicillin and 0.1 mg/ml streptomycin—were seeded in triplicates. Upon culti-
vation over night, SPIONs dispersed within 18 µl aqua bidest. were added result-
ing in final concentrations of 5–100 µg/cm2 (corresponding to 19–378 µg/ml)
and incubated for 3 h or 24 h. For approaches analyzing the protein corona-
related effect on particle cytotoxicity, cell culture medium was removed and
cells were carefully washed twice by using D-PBS before fresh serum-free RPMI
1640 cell culture medium and 18 µl SPIONs were added per well. Positive and
negative controls were always obtained by adding 18 µl aqua bidest. only or
0.1% triton X-100 to cell-seeded wells, respectively. Additionally, cell-free wells
containing cell culture medium and 18 µl respective SPION formulations were
carried along as background controls.
According to the manufacturer’s protocol PrestoBlue™ reagent supplied as a
10× solution was added into each well and incubated at 37 °C for 30–60 min
before emitted fluorescence at 600 nm (10–40 nm bandwidth) upon excitation
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with 545 nm (20 nm bandwidth) was detected using the CLARIOstar microplate
reader (BMG LABTECH GmbH, Orthenberg, Germany).
2.3.2 SYTOX® Red Dead Cell Staining
The principle of the SYTOX® Dead Cell Staining is based on the inability of a
high affinity, nucleic acid-intercalating fluorescent dye to pass intact cell mem-
branes whereas cells with compromised plasma membranes are easily pene-
trated. Thus, damaged and dead cells can be identified by bright fluorescence
signals and can be distinguished from non-stained vital cells.
Samples were prepared as specified in section 2.7.1. Pelleted cells were resus-
pended within 500 µl of 2.5 nM SYTOX® Red (diluted in PE buffer) and incu-
bated at 4 °C for 15 min. Pure SPION solutions were stained analogously in
order to verify both non-specific interactions between particles and dye and the
spectral overlap of fluorescent-labeled SPIONs into the SYTOX® Red channel.
Additionally, these only-SPION-containing samples were utilized for setting
up gates excluding free particles from data acquisition during flow cytomet-
ric analysis. Without washing, at least 10,000 cellular events/sample were ana-
lyzed by the use of FACS CALIBUR (BD Bioscience, Singapore) with SYTOX®
Red staining detected with a 661/16 nm bandpass filter upon excitation with
633 nm and fluorescent-labeled SPIONs detected with a 585/42 nm bandpass
filter upon excitation with 488 nm.
2.3.3 Real-Time Cell Analysis
The real-time cell analysis via the xCELLigence DP (Omni Life Science GmbH
& Co. KG, Bremen, Germany) presents a non-invasive approach for monitoring
cellular proliferation, size, morphology, and attachment. The principle of this
method is based on impedance measurements, where adherent cells seeded on
gold electrodes integrated into the bottom of multiwell plates act as insulators
in response to an applied voltage of about 20 mV. As the measured impedance
in each well is influenced by electrode geometry, ion concentration, and attach-
ment of cells onto the surface, increasing numbers of vital, adhering cells are
accompanied with elevated impedance measurements. Vice versa, decreasing
impedance values indicate cell shrinkage and cellular detachment from the sur-
face and are associated with cytotoxic events. Thus, this method was used in
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order to analyze the dynamic effects of SPIONs on cell proliferation and viabil-
ity especially for long-term incubations. at
HBMEC resuspended within RPMI 1640 medium supplied with 2% or 10%
(v/v) FCS—and if necessary 100 U/ml penicillin and 0.1 mg/ml streptomycin—
were seeded into 16-well E plates in duplicates. The real-time cell analysis was
started and following 24 h (log phase with exponential cell growth) or 48 h (sta-
tionary phase with equilibrium of proliferation- and death rate) cultivation SPI-
ONs dispersed within 10 µl aqua bisdest. were added resulting in final concen-
trations of 25–100 µg/cm2 (corresponding to 25–100 µg/ml). Alternatively, neg-
ative control cells were incubated with 10 µl aqua bidest. only whereas cell-free
wells containing cell culture medium were treated with respective SPION solu-
tions as background controls. Cell index progression was monitored for further
72 h.
2.4 Analysis of the Cell Layer Integrity
The cell layer integrity of HBMEC seeded on transwell membranes resembles a
critical aspect in verifying the in vitro BBB model’s condition and quality. While
repetitive TEER measurements were used in order to monitor the progression
of this tightness parameter in vital cell cultures, end-point determinations such
as molecular permeability assays or microscopic analysis of fixed cells with sub-
sequent fluorescent staining (see section 2.6) or histological cross sections (see
section 2.4.3) were used to get a more complete insight into the cell layer func-
tionality and composition.
2.4.1 Transendothelial Electrical Resistance Measurements
For continuously verifying the tightness of a cellular barrier measuring the
transendothelial electrical resistance (TEER) is a well-established method and
vitally important for the evaluation of in vitro BBB models [129]. As permeabil-
ity barriers restrict the movement of ions through the cell layer, an increased
TEER indicates an in vitro barrier of elevated tightness.
By using chopstick electrodes connected to an epithelial voltohmmeter, the TEER
of HBMEC layers cultivated as described in section 2.2.3 were determined. Thus,
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per insert the mean of three TEER measurements determined at three differ-
ent positions was aligned to the effective membrane area (i.e., 0.33 cm2 mem-
brane area including pores). Further, reference TEER measurements of cell-free
membrane inserts with respective cell culture media served as background re-
sistances and were subtracted from sample values.
2.4.2 Molecular Permeability Assay
The determination of paracellular permeability of cellular barriers was per-
formed using sodium fluorescein (NaFl, 376 Da). As NaFl is small, freely dif-
fusible, and non-toxic this fluorescent molecule is frequently utilized as a highly
sensitive paracellular tracer for both in vitro and in vivo studies [129, 142].
HBMEC-cultivated inserts as specified in section 2.2.3 were incubated with
100 µl of 2.5 µM NaFl diluted within phenol red-free RPMI 1640 medium, 10%
(v/v) FCS, 100 U/ml penicillin, and 0.1 mg/ml streptomycin at the apical site,
whereas companion plates at the basolateral site were filled with 600 µl phe-
nol red-free RPMI 1640 medium supplied with 10% (v/v) FCS, 100 U/ml peni-
cillin, and 0.1 mg/ml streptomycin. The NaFl-exposed inserts were incubated at
37 °C under orbital shaking (90 rpm, 30 mm amplitude) for 10–60 min whereby
at defined time points, inserts including incubation medium were transfered
to a new well containing 600 µl of fresh phenol red-free RPMI 1640 medium
with 10% (v/v) FCS, 100 U/ml penicillin, and 0.1 mg/ml streptomycin and in-
cubation was continued as stated above. Fluorescence intensities of samples
obtained from basolateral medium upon 10-, 30-, and 60-minute incubation
were transferred into black-walled 96-well µ-Clear® plates in triplicates and
measured by using the CLARIOstar microplate reader ( λex = 460/9 nm, λem =
515/20 nm). NaFl permeability coefficients PNaFl were calculated from applied
and detected concentrations (c in nM) and volumes (V in cm3) as described by
Audus and Borchardt [143] according to the following equation:
PNaFl =
cacceptor ·Vacceptor
t · A · cdonor
with t and A defining the incubation time (s) and the effective diffusion area
(cm2), respectively. Alternatively, NaFl restraints were calculated from NaFl
permeability coefficients as ratio of cell-free and cell-grown inserts membranes.
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Table 2.2: Dehydration steps performed by the automatic tissue processor. RT - room tempera-
ture.
No. of cycles Reagent Reaction conditions
2 70% ethanol 1 h, RT
2 96% ethanol 1 h, RT
3 100% ethanol 1 h, RT
1 100% ethanol : 100% xylene (1:1) 1 h, RT
2 100% xylene 1 h, RT
2 paraffin 1 h, 70 °C
2.4.3 Histological Analysis of Cross Sections
In order to gain an insight into the structural integrity and condition of the
transwell-grown HBMEC layers (see section 2.2.3) inserts were washed twice
using D-PBS before they were fixed with 10% formalin solution at room temper-
ature (RT) for 15 min. Membranes were carefully cut out of the insert and em-
bedded perpendicularly into a 1% agarose solution (dissolved in D-PBS) within
a truncated 1.5 ml tube. Upon agarose hardening at 4 °C for 10–20 min, the
membrane-containing agarose block was removed from the 1.5 ml tube, trans-
ferred to embedding cassettes, and stored within 10% formalin solution at RT
for 1–2 days. Upon removal of formalin and four aqua bidest. washing steps for
15 min each, samples were dehydrated and transferred into paraffin as listed in
table 2.2 by using the automatic tissue processor Leica TP1020 (Leica Biosystems
Nussloch GmbH, Nussloch, Germany).
Subsequently, paraffined samples were embedded into paraffin using a Leica
EG1160 embedding center (Leica Biosystems) before sections of 15 µm were
generated from pre-cooled sample-paraffin blocks by means of the Leica RM
2165 automated rotary microtome (Leica Biosystems). Microtomic cross sec-
tions were spread with the help of a 5-minute incubation within a 40 °C-water
bath. Next, they were applied to microscopic slides and dried over night at
37 °C.
For microscopic analysis the cross sections were de-paraffined and hydrated by
incubating the samples in xylene followed by a decreasing alcoholic series as
summarized in table 2.3. In order to visualize SPIONs within the samples a
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Table 2.3: Paraffin removal and hydration or dehydration steps performed during staining of
histological cross sections by descending and ascending alcoholic series, respectively.
Descending alcoholic series Ascending alcoholic series
Condition Reagent Condition Reagent
2x10 min 100% xylene 1x30 s 50% ethanol
2x5 min 100% ethanol 1x30 s 70% ethanol
1x2 min 96% ethanol 1x30 s 96% ethanol
1x2 min 70% ethanol 1x30 s 100% ethanol
1x2 min 50% ethanol 1x120 s 100% xylene
Prussian blue staining using a 2% (w/v) potassium ferrocyanide solution was
performed as described in section 2.5.1. Next, samples were rinsed twice with
aqua bidest. and cell nuclei counterstained by a 10-minute incubation with Nu-
clear Fast Red solution at 37 °C. Excessive staining solution was removed and
samples were rinsed using running tab water for 1 min before undertaking a de-
hydrating, ascending alcoholic series followed by an incubation within xylene
(see table 2.3) and embedding with water-free mounting medium.
2.5 Cellular Staining
In order to evaluate cellular conditions such as morphology, viability, integrity,
differentiation, and subcellular localization of specific proteins or SPIONs, di-
verse cellular staining procedures were applied followed by microscopic analy-
sis. Thus, Prussian blue staining was used to visualize the interaction of non-
labeled SPIONs with cells by light microscopy, whereas fluorescence staining
of cells and specific subcellular structures was made use of for analyzing local-
izations of fluorescence-labeled SPIONs during fluorescence microscopy. Addi-
tionally, by means of confocal laser scanning microscopy a detailed insight into
the spatial distribution of the labeled objects within the cell was achieved.
2.5.1 Prussian Blue Staining
Prussian blue resembles a dark blue pigment generated by the iron chelating
reaction of ferrocyanides. Thus, the staining is commonly used to visualize
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ferric iron within biological samples, such as iron-based nanoparticles within
cellular environments.
In order to stain SPIONs in cellular samples a protocol adapted from Schlorf et
al. [144] was used. In detail, samples fixed by incubation with 10% formalin so-
lution for 15 min were permeabilized by a 10-minute incubation in 0.1% triton
X-100 (dissolved in D-PBS) and washed twice with D-PBS. Next, a freshly pre-
pared solution of 2% (w/v) potassium ferrocyanide dissolved in 1 M hydrochlo-
ric acid was applied and incubated at 37 °C for 10 min before two washing steps
using D-PBS were carried out. Unless otherwise stated, cells were counter-
stained by sample incubation with the eosin Y-containing DiffQuick II solution
for 30 s. As the resulting cytoplasmic red staining was not stable, microscopic
images were acquired immediately. Alternatively, cells were counterstained us-
ing Nuclear Fast Red solution and subtracted to a dehydrating alcoholic series
as described in section 2.4.3 in order to achieve a stable dyeing.
2.5.2 Pappenheim Staining
The Pappenheim staining combines both May-Grünwald- and Giemsa staining
and resembles the method of choice for panoptic staining of blood smears in
hematology.
In this context, the Pappenheim staining was applied for evaluating the dif-
ferentiation of both THP-1 and HL-60 cells to monocytic and neutrophilic ap-
pearance, respectively. Initially, smear preparations of THP-1 and HL-60 cells
differentiated as described in section 2.2.5 and resuspended within FCS (ap-
prox. 500.000 cells/30 µl) were generated and air-dried for 30–60 min. The Pap-
penheim staining was performed with the automatic stainer SP-10 (Sysmex
Deutschland GmbH, Norderstedt, Germany). Briefly, samples were treated with
May-Grünwald solution (1:2 diluted with D-PBS) for 4 min. Upon a D-PBS-
based rinsing, Giemsa solution (1:6 diluted with D-PBS, filtered upon dilution)
was added and incubated for 15 min. Again, samples were washed using aqua
bidest. and air-dried without mounting with coverslips before they were viewed
microscopically.
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2.6 Fluorescent Staining for Confocal Laser
Scanning Microscopy
Confocal laser scanning microscopy upon (immuno-)fluorescence staining of-
fers the possibility to specifically view distinct cellular structures and their three-
dimensional distribution. The spatial pinhole allows the acquisition of signals
from the confocal plain only, thus eliminating out-of-focus light. On the one
hand cytoskeletal staining was used for the sake of studying both the cell in-
tegrity and the cellular uptake of fluorescence labeled SPIONs. On the other
hand the expression and distribution of the tight junction protein ZO-1 upon
immunofluorescence staining was additionally used in order to assess the tight-
ness of transwell-cultured HBMEC layers (see section 2.4). Furthermore, trans-
migration of THP-1 or HL-60 cells through HBMEC layers was also verified by
laser scanning microscopy (see section 2.9). For all approaches the confocal laser
scanning microscope LSM 510 META and the appendant software ZEN 2009 6.0
SP2 (both Carl Zeiss Microscopy GmbH, Jena, Germany) were used.
2.6.1 Phalloidin Staining
Phalloidin is a bicyclic heptapeptide strongly binding filamentous actin (F-actin)
preventing its depolymerization. Labeled with a fluorescent tag this molecular
dye is prevalently used for the visualization of F-actin in vitro.
For the investigation of the uptake mechanism of SPIONs into HBMEC,
200,000 cells resuspended in RPMI 1640 cell culture medium with 10% (v/v)
FCS were seeded on glass cover slips which had been flamed and placed into
24-well plates. Upon cell cultivation over night, endocytosis inhibitors were
added as indicated and pre-incubated for 60 min before 50 µg/cm2 (correspond-
ing to 100 µg/ml) nano-screenMAG-G/D were applied and incubated for 3 h.
Samples were washed three times with D-PBS before they were fixed at RT
by applying a 10% formalin solution for 15 min. Next, formalin was removed
by another three washing steps with D-PBS and cells were permeabilized by
a 10-minute treatment with 0.1% triton X-100 (diluted with D-PBS). Samples
were incubated with the D-PBS-based staining solution containing 19 ng/ml
Alexa Fluor® 633 Phalloidin (Invitrogen) and either 10 ng/ml DAPI I (Abbot
Laboratories) or 12 µg/ml Hoechst 33258 (Invitrogen). Afterwards, cells were
37
Methods and Materials
washed with D-PBS again and analyzed microscopically without embedding.
Cells were scanned layer by layer with a constant slice distance of 1 µm each re-
sulting in z-stacked images of 10-18 slices. Acquired image stacks were quanti-
tatively analyzed using MATLAB® R2013a software (MathWorks, Natick, USA)
where the amount of internalized SPIONs was calculated from overlapping sig-
nals derived from the cytoskeletal F-actin and the SPION channels. Actin chan-
nels were binarized using the threshold algorithm as described by N. Otsu [145],
multiplied with original SPION channels, and integrated to total SPION inten-
sities per image slice. For comparability of multiple microscopic field views
containing divergent numbers of cells, particle amounts were normalized to the
cell-representing F-actin signal.
For transwell-cultured HBMEC layers which had been cultivated and incubated
with fluorescence labeled SPIONs analogously as described in sections 2.2.3
and 2.8 F-actin was stained as stated above. However, as the transwell mem-
brane interfered with the nuclear staining by DAPI, Hoechst 33258 counterstain
was used in order to visualize cell nuclei in this case. Moreover, upon staining
cell-layered membranes were cut out off retainers and embedded on glass slides
using water-based mounting medium prior to microscopic analysis.
2.6.2 Immunofluorescence Staining of zonula occludens-1
As peripherally located ZO-1 functions as a scaffold of the transmembrane tight
junction proteins and the F-actin cytoskeleton, it is an integral component of
the tight junction complex [146]. That is why its immunostaining is prevalently
used in order to verify the paracellular permeability of cellular barriers.
To this end, samples cultivated as described in section 2.2.3 were fixed and per-
meabilized as specified above (see section 2.6.1). Next, non-specific epitopes
were blocked by incubating the samples with 5% BSA (dissolved in 0.1% triton
X-100) before the primary rabbit α-ZO-1 antibody (1:200 diluted with 1% BSA
dissolved in 0.1% triton X-100) was applied and incubated at 37 °C for 60 min.
The samples were washed twice using D-PBS and the staining solution contain-
ing the secondary antibody (see table 2.4) was added for 60 min (37 °C). More-
over, samples stained without primary antibodies and samples not stained with
primary nor secondary antibodies were carried along and served as controls for
specific secondary antibody binding and autofluorescence, respectively.
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Table 2.4: Composition of the secondary antibody solution for immunofluorescence zonula oc-
cludens (ZO-1) staining diluted in D-PBS. BSA - bovine serum albumin.
Final Concentration Component
4 µg/ml goat α-rabbit antibody
19 ng/ml Alexa Fluor® 633 Phalloidin
12 µg/ml Hoechst 33258
50 µg/ml BSA
Upon staining samples were washed with D-PBS, membranes were cut out off
retainers and embedded on glass slides using water-based mounting medium
prior to microscopic analysis.
2.7 Flow Cytometry
Flow cytometry is a powerful technology facilitating the rapid analysis of thou-
sands of cells on a single-cell level. Thereby, various physical parameters in-
cluding relative size and relative granularity can be measured and analyzed
simultaneously. The principle of this approach is based on a fluid stream car-
rying suspended cells to a laser intercept from which both incident scatter light
and emitted fluorescence signals can be detected. According to cellular size and
internal complexity both forward and sideward scatters are influenced, respec-
tively. Additionally, fluorescence labels can be measured resulting in relative
fluorescence intensities.
This method was used in order to analyze cell viabilities upon SYTOX® Red
Dead Cell Staining as specified in section 2.3.2. Flow cytometric analysis was
also used to investigate the interaction of fluorescence labeled SPIONs with
HBMEC (see section 2.7.1) and the differentiation analysis of progenitor im-
mune cells (see section 2.7.2). For all analyses the FACS CALIBUR (BD Bio-
science, Singapore) was used. Per sample at least 10,000 cellular events were
recorded and analyzed via the FlowJo® software (FLOWJO, LLC, Ashland, USA).
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2.7.1 Flow Cytometry-Based Particle-Cell Interaction
For the purpose of investigating the interaction of fluorescence labeled SPIONs
with HBMEC and its correlation to cell viability, 80,000 cells/cm2 resuspended
within RPMI 1640 cell culture medium with 10% (v/v) FCS—and if necessary
100 U/ml penicillin and 0.1 mg/ml streptomycin—were seeded into 12-well
plates in duplicates. Following over-night-culture, cells were incubated with
fluorescent-labeled SPIONs dispersed within 100 µl aqua bidest. resulting in fi-
nal concentrations of 25 µg/cm2 or 50 µg/cm2 (corresponding to 94.5 µg/ml or
189 µg/ml) for up to 24 h. For approaches analyzing the protein corona-related
effect on particle cytotoxicity, cell culture medium was removed and cells were
carefully washed twice by using D-PBS before fresh serum-free RPMI 1640 cell
culture medium and 100 µl SPION solution were added per well. Negative con-
trols were treated analogously using 100 µl aqua bidest. only. After incubation
time was completed, sample cell culture media were collected and cells har-
vested using HyQ®Tase™. Next, cells were spun down by a 5-minute centrifu-
gation step at 300 rcf (4 °C), washed with ice-cold PE buffer, and centrifuged as
mentioned before. For investigating the correlation between SPION interaction
with cells and cytotoxicity, cell pellets were additionally treated with SYTOX®
dead cell staining and directly analyzed as described in section 2.3.2. Otherwise
cell pellets were fixed using 10% formalin for 15 min, washed using ice-cold PE
buffer and resuspended in 500 µl PE buffer again. Finally, per samples at least
10,000 cellular events were analyzed by flow cytometry, where cellular load-
ing with fluorescence labeled SPIONs was detected with a 585/42 nm bandpass
filter upon excitation with 488 nm. Additionally, cell-free samples containing
SPIONs only were utilized for setting up gates, excluding free particles from
data acquisition during flow cytometric analysis.
2.7.2 Surface Marker Expression of Differentiated Cells
In order to verify the differentiation of both THP-1 and HL-60 cells to mono-
cytic and neutrophilic phenotypes respectively, the expression of characteristic
surface markers was analyzed by means of flow cytometry. To this end, cells
differentiated as described in section 2.2.5 were harvested, whereby for THP-1
HyQ®Tase™ was applied. Approximately 500,000 cells were spun down by
a 5-minute centrifugation step at 300 rcf, washed twice with PE buffer, and
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Table 2.5: Composition of the antibody mixture for characterizing monocytic or neutrophilic
surface markers. APC - allophycocyanin; CD - cluster of differentiation; FITC - fluorescein
isothiocyanate; PE - phycoerythrin; PE (buffer) - D-PBS supplemented with EDTA (2 mM).
Neutrophilic phenotype (HL-60) Monocytic phenotype (THP-1)
Volume Component Volume Component
10 µl CD13-FITC 10 µl CD34-FITC
10 µl CD16-PE 10 µl CD40-PE
10 µl CD11b-APC 10 µl CD14-APC
70 µl PE buffer 10 µl PE buffer
centrifuged as mentioned previously. Cell pellets were resuspended in 100 µl
of respective antibody solutions (see table 2.5). After a 20-minute incubation
time at RT, 3 ml PE buffer were added and cells were centrifuged again (5 min,
300 rcf). Cells were resuspended in 300 µl PE buffer and measured at the FACS
CALIBUR whereby FITC- and PE labels were detected with a 530/30 nm and
a 585/42 nm bandpass filter upon excitation with 488 nm. In contrast for APC
labels the excitation with 633 nm was used in combination with an emission
bandpass filter of 661/16 nm. Moreover, non-stained cell samples and single-
stained compensation beads served as autofluorescence controls and references
for compensating fluorochrome spill over to other channels, respectively.
2.8 Detection and Quantification of SPIONs
For studying the passage of SPIONs through HBMEC layers complete basolat-
eral acceptor compartments were analyzed for the presence of SPIONs either by
magnetic particle- or atomic absorption spectroscopy. Both approaches resem-
ble highly sensitive methods of quantifying superparamagnetic or elementary
iron, respectively.
For the experimental investigations HBMEC were plated out on transwell mem-
branes as specified in section 2.2.3. After five days of cultivation, barrier tight-
ness was confirmed by means of TEER measurements (see section 2.4.1). If in-
dicated, one day prior to the particle incubation MCF-7 cells with a density of
350,000 cells/well were seeded into 24 well plates and cultivated over night.
On the day of incubation experiment HBMEC-grown inserts were transferred
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to implied MCF-7-grown or cell-free 24 well companion plates each contain-
ing 600 µl RPMI 1640 medium supplemented with 10% (v/v) FCS, 100 U/ml
penicillin, and 0.1 mg/ml streptomycin. Unless stated otherwise, 100 µg/cm2
SPIONs dissolved within 165 µl (equal to 200 µg/ml) RPMI 1640 medium sup-
plemented with 10% FCS (v/v), 100 U/ml penicillin, and 0.1 mg/ml strepto-
mycin were added. For the first 30 min, particle incubation was carried out on
top of a block magnet (210 mT at 3 mm distance, field gradient 6.8 T/m) in order
to bring the particles in close proximity to the cell layer localized on the trans-
well membrane. Thereafter, the incubation was continued without the magnet
until indicated incubation time was complete. In order to precisely quantify
the amount of SPIONs in the respective compartments, samples were analyzed
by magnetic particle spectroscopy and atomic absorption spectroscopy as de-
scribed in sections 2.8.1 and 2.8.2. Additionally, HBMEC layer integrity upon
SPION exposure was verified as specified in section 2.4 as well as by micro-
scopic analysis upon fluorescence staining (see section 2.6).
2.8.1 Magnetic Particle Spectroscopy
Magnetic particle spectroscopy (MPS) represents a sensitive magnetic detection
method that allows for the quantification of the superparamagnetic nanoparti-
cle iron content without being affected by biological components such as cells
or suspension medium [147–149]. It is based on the nonlinear magnetic sus-
ceptibility response of magnetic nanoparticles exposed to an oscillating mag-
netic field. Thus, odd harmonics of magnetic moments Ai of the detected time-
dependent signal are Fourier transformed yielding the MPS spectrum. As the
SPION-specific amplitude signal is proportional to the applied SPION amounts,
MPS provides the opportunity to precisely determine SPION contents of biolog-
ical samples [150].
For the quantification of SPIONs within the distinct compartments of the trans-
well system, samples were processed as described by Gräfe et al. [151]. Briefly,
complete apical donor and basolateral acceptor compartment media were col-
lected upon incubation time. By avoiding the application of any metallic ma-
terials during preparations porous membranes including cellular layers were
cut off retainers and homogenized within 800 µl aqua bidest. by using a ceramic
scalpel and the gentleMACS™ dissociator. Finally, sample volumes were re-
duced to 20–50 µl by centrifugal vacuum concentration using the SpeedVac™
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SPD111 (Thermo Fisher Scientific Inc., Waltham, USA) at 100 g and 40 °C) before
MPS spectra were measured using a commercial MPS device (Brucker Biospin,
Rheinstetten, Germany) operating at an oscillating magnetic field Bdrive of 25 mT
and a frequency f0 of 25 kHz. The third harmonic A3 of the MPS spectrum
was used for iron quantification by normalization to the corresponding A3,re f
of a reference sample of known iron amount. In turn, reference sample’s iron
amount was cross-validated by photometry (510 nm) upon phenantroline stain-
ing by dissolving in hydrochloric acid, reduction by hydroxylamine, and addi-
tion of 1,10-phenantroline monohydrate. Furthermore, A5/A3 were recorded in
order to verify the magnetic behavior including particle agglomeration. Analo-
gous samples without the addition of SPIONs served as background controls
from which the limit of detection (LOD) was calculated according to:
LOD = Xbackground + 3 · STDVbackground
where X and STDV represent mean and standard deviation of background
measurements according to McNaught and Wilkinson [152].
2.8.2 Atomic Absorption Spectroscopy
In addition to the quantitative estimation of SPIONs via MPS, atomic absorption
spectroscopy (AAS) was applied in order to verify the SPIONs’ interaction with
and passage through HBMEC layers based on the spectroanalytical detection
of elementary iron. Thus, iron concentrations of analyzed samples were deter-
mined upon measuring the absorbance at the characteristic and highly sensitive
wavelength of 248.3 nm.
To this end, complete media of both donor and acceptor compartments were
collected and SPIONs were pelleted by centrifugation at 20,000 g for 45 min
Upon discarding excessive supernatant, 25 µl of the sediment-containing solu-
tion were dissolved in 162.5 µl of 32% HCl. In contrast, MCF-7 cells seeded
into bottom wells of 24-well companion plates as well as cut outs of HBMEC-
containing transwell membranes were directly dissolved in 187.5 µl of 32% HCl.
Samples were supplemented with 62.5 µl of 10% TCA and incubated for 5 min
at RT before precipitated proteins and debris were removed by a 5-minute cen-
trifugation at 3,600 g. Finally, supernatants were transfered into conic AAS
tubes and iron contents analyzed by using the AAS-5 FL supplied by Analytik
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Jena AG, Jena, Germany. The LOD was calculated as described above (see sec-
tion 2.8.1).
2.9 Transmigration through Blood-Brain Barrier
Model
The transmigratory kinetics of differentiated neutrophilic HL-60 and monocytic
THP-1 cells (see section 2.2.5) both being labeled by a fluorescent dye were in-
vestigated by the dynamic fluorescence-based detection of transmigrated cells
via a microplate reader. Additionally, migratory effects were verified by end-
point fluorescence microscopy of fixed and Hoechst 33258-counterstained
FluoroBlok membranes (see section 2.6.1 ) as well as Prussian blue staining com-
bined with the treatment of Nuclear Fast Red (see section 2.5.1) upon spinning
of acceptor compartment-obtained cells on microscopic slides by using the Cy-
tospin Rotofix at 35 rcf for 5 min).
For the generation of a HBMEC layer on FluoroBlok inserts, HBMEC were
seeded and cultivated as described in section 2.2.3 for five days. By the ap-
plication of 10 µM CellTracker™ red CMTPX (diluted in RPMI 1640 cell culture
medium) at 37 °C for 30 min, HBMEC were pre-stained prior to the transmigra-
tion assay. For 120 min indicated cell layers were exposed to inflammatory stim-
uli based on the addition of 5 ng/ml IL-1β into both the apical donor- and ba-
solateral acceptor compartment containing RPMI 1640 medium supplied with
10% (v/v) FCS, 100 U/ml penicillin, and 0.1 mg/ml streptomycin.
In parallel to the preparation of HBMEC layers differentiated HL-60 and THP-
1 cells were harvested and pre-labeled by a 30-minute staining with 10 µM
CellTracker™ Green BODIPY® diluted within RPMI 1640 cell culture medium
at 37 °C. Upon a 5-minute centrifugation at 300 rcf cells were resuspended in
RPMI 1640 medium supplied with 10% (v/v) FCS and 1.4% DMSO or 5 ng/ml
PMA in case of HL-60 or THP-1 cells, respectively, and plated into 6- or 12-
well plates according to a cell density of approx. 680,000 cells/cm2. Cells were
allowed to settle for 30 min before they were incubated with 50 µg/cm2 (cor-
responding to 189 µg/ml) SPIONs for 120 min. Next, suspension HL-60 cells
were centrifugation with 200 rcf for 5 min. In contrast, adherent THP-1 cells
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incubation medium was removed by aspiration and cells were harvested as de-
scribed above. Next, pelleted HL-60 and THP-1 cells were resuspended in RPMI
1640 medium supplied with 0.1% BSA, 100 U/ml penicillin, 0.1 mg/ml strepto-
mycin, and 1.4% DMSO or 5 ng/ml PMA, respectively, resulting in a concen-
tration of 500,000 HL-60/300µl or 300,000 THP-1/300µl. Upon the transfer of
300 µl cell suspension to HBMEC-seeded or cell-free FluoroBlok inserts each
supplied with 1,000 µl corresponding medium within the basolateral acceptor
compartment, cells were allowed to settle down for further 30 min. With HL-60
or THP-1-assembled inserts were carefully transferred to companion plates e-
quipped with RPMI 1640 medium, 0.1% BSA, 100 U/ml penicillin, 0.1 mg/ml
streptomycin, and 1.4% DMSO or 5 ng/ml PMA, respectively. If necessary, me-
dia were additionally supplemented with chemoattractants (10 nM fMLP for
HL-60 or 100 ng/ml MCP-1 for THP-1) and/or 5 ng/ml IL-1β. Where applica-
ble inserts were incubated on top af a MagnetoFACTOR 24-well plate (310 mT
at 2 mm distance, field gradient 38.4 T/m) for 30 min before transmigration was
monitored using the CLARIOstar microplate for at least 1,400 min with an exci-
tation of λex = 490/15 nm and detection at λem = 535/20 nm where the temper-
ature was kept at 37 °C and CO2 at 5%.).
2.10 Statistical Analyses
Data of repetitive independent experiments with multiple replicates each are
presented as weighted mean ± (weighted) standard deviation. Statistical sig-
nificance tests were performed using the Prism 6 (GraphPad Software, La Jolla,
USA) applying a one- or two-way analysis of variance (ANOVA) with 95% con-
fidence intervals followed by a multiple comparison test and correction accord-
ing to Dunnett [153, 154], Tukey [155], or Sidak [156]. Differences are consid-
ered as statistically significant for p < 0.05 (*), p < 0.01(**), p < 0.001 (***), or
p < 0.0001(****).
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Results
SPIONs are highly attractive candidates for various biomedical applications
such as hyperthermia anti-tumor therapies, as drug delivery systems, and as
contrast agents for magnetic-based imaging. The wide range of possibilities for
SPION design regarding tuning in size, shape, and coating material as well as
additional surface functionalization led to a huge diversity of SPION types. By
now, several SPION-related products are already medically approved and oc-
casionally used in clinical settings. However, this particle diversity results in
major challenges, as the functionalities of specific SPIONs have to be verified in
context of biological effects within the whole organism they are applied to. A
detailed understanding of how such particles interact with cells and whether or
how they penetrate biological barriers is crucial for their safe, targeted, and ef-
fective biomedical implementation. Therefore, in this study, the human cell line
HBMEC was utilized for initial testing of diverse types of SPIONs for cytotoxic
effects. Furthermore, SPION-specific particle binding to the cells and uptake
into the cells were investigated in detail. In order to analyze the particle pas-
sage through a biological barrier, an HBMEC-based in vitro model simulating
the human blood-brain barrier (BBB) was established and optimized in a next
step. Using this transwell barrier system, SPION-induced effects on the barrier
integrity and the particle passage through the cellular layer were studied in de-
tail. Finally, the SPION-mediated passage of cells as well as the cell-mediated
particle delivery across the BBB model were investigated in order to give a com-
prehensive insight into how SPIONs affect and cross such biological barriers.
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3.1 Interaction of SPIONs with HBMEC
Investigations were performed in order to gain an insight into the general con-
sequences of various types of SPIONs on both the cellular interaction and cell
viability of HBMEC. On the one hand, the effect of diverse particle coatings
comprising different particle surface charges were tested regarding their bio-
logical effects. Based on these initial experiments, particle types suitable for
subsequent barrier passaging experiments were identified. On the other hand,
the effect of the protein corona formed on the particle surface and its influence
on biocompatibility and cellular interaction were investigated, analogously.
3.1.1 SPION-associated Effect on Cell Viability
The acute cytotoxic effects of SPION exposure of HBMEC for 3 h and 24 h was
tested using the PrestoBlue™ assay. Results are shown in figure 3.1. For con-
centrations of up to 100 µg/cm2 no noticeable effect on HBMECs’ viability can
be observed after 3 h or 24 h incubation with neutral fluidMAG-D and anionic
SEONBSA particles resulting in a relative cell viability of 90.0±2.5% and
79.7±1.9% after 24 h incubation with respective SPIONs. The exposure of
HBMEC to up to 100 µg/cm2 of cationic fluidMAG-DEAE for 24 h induced
a slight concentration-dependent reduction in cellular viability to 67.1±4.2%
compared to controls. Likewise cationic PEI-coated SPIONs strongly impede
cell viabilities as incubations of 100 µg/cm2 for 3 h and 24 h trigger a relative
decrease to 49.4±3.6% and 13.1±1.7%, respectively.
3.1.2 Binding of SPIONs to Cells and Particle Uptake
Cellular binding and uptake of SPIONs are closely connected with cytotoxicity.
Whereas highly-interactive particle types are usually associated with cytotoxic
effects, biocompatible particles are often characterized by lower cellular affini-
ties. In order to study these aspects for selected SPIONs, both Prussian blue
staining and flow cytometry were applied. Figure 3.2 shows microscopic im-
ages of HBMEC incubated with indicated SPIONs and reveals that within a
3-hour incubation the cellular binding of neutral fluidMAG-D particles is low.
In contrast, cells exposed to anionic SEONBSA, cationic DEAE- and PEI-coated
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Figure 3.1: PrestoBlue™ cell viability assays of HBMEC exposed to diverse types of SPIONs.
HBMEC seeded into 96-well plates in triplicates with a seeding density of 15,000 cells/well
were exposed to indicated SPION types in final concentrations of 5–100 µg/cm2 (corresponding
to 19–378 µg/ml). Negative and positive control cells were treated with aqua bidest. or 0.02%
triton X-100 final concentration. Upon incubation for 3 h (A) and 24 h (B) PrestoBlue™ assays
were performed. Shown are weighted means ± standard deviation of two to four independent
experiments.
SPIONs show a strong Prussian blue stain with the highest intensity for the lat-
ter. After 24 h the extensive Prussian blue staining of fluidMAG-D-incubated
HBMEC reveals an enhanced cellular binding of these neutral particles com-
pared to exposures for 3 h. Similarly, anionic SEONBSA and cationic fluidMAG-
DEAE and -PEI show a pronounced particle adherence as indicated by the more
intense staining pattern upon 24 h. In all cases the particles seem to form clus-
ters, whereby fluidMAG-PEI are again most notable.
In order to monitor the temporal progress of cellular SPION loading in context
of quantity, flow cytometry of HBMEC exposed to fluorescence-labeled SPIONs
was performed. Panels B and C of figure 3.2 give an overview of the results
obtained for the—according to the Prussian blue staining—low-affinity starch-
coated and high-affinity PEI-coated particles. HBMEC incubated with neu-
tral nano-screenMAG-G/D show low fluorescence upon incubation for 5 min
(11±1 RFU), which gradually increases during incubation for 30 min and
180 min with cellular fluorescences of 37±4 RFU and 228±22 RFU, respectively.
Additional to cellular fluorescence labeling, side scatters (SSC) were recorded
in order to monitor SPION loading via this granularity-representing param-
eter. However, for nano-screenMAG-G/D incubation for up to 180 min, the
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Figure 3.2: Cellular interaction of diverse types of SPIONs with HBMEC. A HBMEC seeded
into 24-well plates with seeding densities of 165,000 cells/cm2 were incubated with 50 µg/cm2
(corresponding to 60 µg/ml) for 3 h and 24 h. SPIONs were stained by Prussian blue. HBMEC
(pink) were counterstained with eosin Y-containing DiffQuick II solution. B-C HBMEC seeded
into 12-well plates in duplicate with seeding densities of 80,000 cells/cm2 were incubated with
50 µg/cm2 (corresponding to 189 µg/ml) fluorescence-labeled nano-screenMAG-G/D (B) or
nano-screenMAG-G/PEI (C) for 5 min to 24 h. Supernatant and harvested cells were fixed and
analyzed by flow cytometry with 10,000 cellular events per sample. Shown are means ± stan-
dard deviation of one representative of two independent experiments. AU - arbitrary unit;
FL-1-H - SPION-labeled fluorescence intensity; RFU - relative fluorescence units; SSC-H - side
scatter intensity.
SSC shows only minor changes to 173±10 AU compared to control cells with
162±11 AU. After particle incubation for 24 h both the cellular fluorescence load-
ing and the SSC strongly expand to 877±68 RFU and 329±20 AU, respectively.
In contrast, cationic fluidMAG-PEI show the highest cellular labeling affini-
ties of 2878±156 RFU immediately after particle addition to the cells (5 min)
with a gradual decrease during 30 min, 60 min, and 180 min to 2273±291 RFU,
1834±65 RFU, and 719±504 RFU, respectively. Analogously, SSC rapidly in-
creases from 162±11 AU to 896±34 AU upon incubation with nano-screenMAG-
G/PEI for 5 min and subsequently decreases to 651±2 AU upon the 180-minute
incubation.
Flow cytometry allows the analysis of cellular SPION loadings in a (semi-)quan-
titative manner. However, it is not possible to gain information of the actual
particle uptake into the cells. This is why in the next step confocal laser scanning
microscopy was used in order to identify the spatial distribution of fluorescence-
labeled SPIONs within fixed, fluorescently stained HBMEC. By specifically
blocking endocytotic pathways with diverse inhibitors, the uptake mechanisms
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for both starch- and PEI-coated SPIONs were investigated in detail. Figure 3.3
summarizes this analysis, whereby the image acquisition layer-by-layer was
used to study the co-localization of SPIONs with the intracellular F-actin cy-
toskeleton within the limits of optical resolution. Based on this premise, internal
SPIONs were quantified by integrating the particles’ fluorescence intensities of
F-actin overlapping signals. During microscopic analysis SPIONs have not been
observed co-located with the cell’s nucleus. The effects of specific inhibitors on
the internalization of neutral fluidMAG-D into HBMEC is presented in panel A.
Notably, the SPION uptake into HBMEC is massively compromised by approx.
90% when particle incubation is carried out at 4 °C instead of 37 °C indicating
an energy-dependent uptake mechanism for this particle type. Through block-
ing of caveolin- and clathrin-dependent endocytotic pathways by filipin and
chlorpromazine, the amount of internalized starch-coated particles is signifi-
cantly reduced to 39±10% and 53±34%, respectively. Whereas the single drug
treatment of HBMEC with cytochalasin D does not impair particle uptake sig-
nificantly (61±29%), the combination of this F-actin depolymerizing substance
with chlorpromazine efficiently decreases the SPION internalization by 82%. In
contrast, the reduction of the incubation temperature from 37 °C to 4 °C does
not impair the presence if internalized nano-screenMAG-G/PEI into HBMEC
as relative SPION internalization is 100±3% and 114±17%, respectively (see
figure 3.3 panel B).
3.1.3 Protein Corona-associated Effects on Cytotoxicity and
SPION Interaction with Cells
The large surface-to-volume ratio of SPIONs evokes a high reactivity leading to
an intensive interaction with their environment. Based on that, immediately af-
ter the contact of such particles with biological fluids a protein corona is formed,
providing the SPIONs with a new biological identity. In order to investigate the
magnitude of this effect, cationic PEI-coated particles were used. To achieve
various levels of surface protein coronas, PEI particles were incubated in dilu-
tions of specific FCS concentrations and analyzed for both cytotoxicity, cellular
interaction, and uptake mechanisms. Thereby, serum-free or serum-reduced
conditions for cell cultivation and -incubations were used in order to not influ-
ence the particles’ protein corona additionally.
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Figure 3.3: Cellular uptake mechanisms of SPIONs analyzed by confocal laser scanning mi-
croscopy. HBMEC were seeded on glass cover slips placed within 24-well plates with a seeding
density of 165,000 cells/cm2. After pre-incubation of cells with indicated inhibitors for 60 min
nano-screenMAG-G/D or -G/PEI were added resulting in a final concentration of 50 µg/cm2
(corresponding to 60 µg/ml) and incubated for 3 h. Cells were fixed, permeabilized and stained
with DAPI and Alexa Fluor® 633 Phalloidin. Internalized SPIONs were identified by SPION-
derived fluorescence overlapping with cells’ actin-derived signals. A Quantitative analysis of
internalized nano-screenMAG-G/D into HBMEC subjected to indicated incubation conditions.
B Quantitative analysis of internalized nano-screenMAG-G/PEI into HBMEC subjected to indi-
cated incubation conditions. Shown are means± standard deviation of two independent exper-
iments with three microscopic fields of view each. Statistical significance of indicated samples
compared to controls was tested by one-way ANOVA followed by Dunnett’s multiple compar-
ison, where differences are considered as statistically significant for p < 0.05 (*), p < 0.01(**),
p < 0.001 (***), and p < 0.0001(****).
Figure 3.4 demonstrates the immediate concentration-dependent cytotoxic ef-
fect related to respective amounts of protein corona in panel A. The presented
data reveal that cell viability of HBMEC exposed to 100 µg/cm2 of the origi-
nal corona-free fluidMAG-PEI particles is reduced to 36±9% compared to neg-
ative control cells, whereas a comprehensive protein corona in PEI particles
(100% FCS) preserves cell viability at 84±8%. Remarkably, the gradual ele-
vation of protein corona contents on the particles’ surface is associated with
increasing cell viability. Additionally, long-term analysis of cytotoxic effects of
SPIONs shown in panel B show cell indices of HBMEC exposed to corona-free
fluidMAG-PEI continuously reduced by more than 83±4% for up to 96 h. Con-
trary, HBMECs’ indices continue on a stable level of 100–105% for up to 72 h
before slightly decreasing to 85±10%, 96 h after the addition of PEI particles
pre-incubated in FCS.
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Figure 3.4: Acute and long-term cell viability studies of HBMEC exposed to SPIONs with
varying levels of protein corona. A HBMEC seeded into 96-well plates in triplicates with a
seeding density of 15,000 cells/well were subjected to serum-free conditions. FluidMAG-PEI
particles pre-incubated within indicated concentrations of FCS (diluted in RPMI medium) were
added resulting in final concentrations of 5–100 µg/cm2 (corresponding to 19–378 µg/ml). Neg-
ative and positive control cells were treated with aqua bidest. or 0.02% triton X-100 final concen-
tration. Upon incubation for 3 h, PrestoBlue™ assays were performed. Shown are means ±
standard deviation of one representative from four independent experiments. B HBMEC were
seeded into 16-well plates in duplicates under serum-reduced conditions (i.e.„ RPMI supple-
mented with 2% (v/v) FCS) with a seeding density of 10,000 cells/well. At time point 0 (dotted
vertical line) fluidMAG-PEI or -D pre-incubated within indicated FCS concentrations (diluted
with RPMI medium) were added resulting in final concentrations of 100 µg/cm2 (correspond-
ing to 100 µg/ml). Negative control cells were treated with aqua bidest.. Shown are means of
one representative of three independent experiments.
In order to investigate the protein corona-associated effects on cellular interac-
tion of SPIONs and additionally correlate these findings to cytotoxicity, HBMEC
incubated with fluorescence-labeled particles were analyzed by flow cytom-
etry, whereby cells with compromised cell membranes were identified using
the SYTOX® Red staining. Figure 3.5 summarizes the time-dependent SPION-
associated fluorescence loading of cells according to the protein corona on nano-
screenMAG-G/PEI in panel A, and the relative proportion of indicated popula-
tions in panels B–D. Data show for 5-minute incubations that cells are strongly
loaded with PEI particles without a protein corona resulting in an intense cellu-
lar labeling (465.9±2.1 RFU), whereas the stepwise evolution of a protein corona
reduces this cellular labeling gradually to a geometric mean of 33.1±0.2 RFU
for 100% FCS. This observation is reflected by the respective cellular positive
fraction for SPION-associated fluorescence (SPION+), which is 98.7±4.6% and
55.3±2.5% for 0% FCS and 100% FCS, respectively. Simultaneously, the propor-
tion of cells negatively stained for the SYTOX® Red (SYTOX −) are 23.0±3.2%
and 88.6±2.7% for PEI particles without (0% FCS) or with a complete (100%
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FCS) protein corona. The cellular fraction being positive for both SPIONs and
SYTOX® Red is largest (76.9±3.2%) for particles of 0% FCS and decreases to
8.9±1.7% for PEI particles pre-treated with 100%FCS. Similarly, after a par-
ticle exposure of 30 min, cellular SPION-associated fluorescence intensities of
cells gradually increase to 472.9±10.6 RFU and 54.2±1.1 RFU for 0% FCS and
100% FCS, respectively. Simultaneously, the SPION+ cell fractions decrease
and SYTOX− increase with elevated protein corona contents. However, after
incubation of particles possessing different protein corona contents for 180 min,
both cellular SPION load and ratios of SPION+ or SYTOX− increasingly come
into line. Thus, the fractions of SPION+ cells are 97.9±1.9% for protein-free
particles and 97.6±2.0% for 100% FCS particles, whereas geometric means of
cellular SPION-associated fluorescence are 330.9±33.2 RFU and 218.4±2.8 RFU,
respectively. Remarkably, the percentage of cells positive for both SPIONs and
SYTOX® Red strongly decreases to 21.4±1.5% for PEI particles pre-incubated
in 0% FCS and slightly increases to 11.8±1.3% for PEI particles possessing a
complete protein corona (100% FCS).
In addition to general flow cytometry-based interaction studies, particle-incu-
bated cells were analyzed for internalized SPIONs by confocal laser scanning
microscopy, too. The results shown in figure 3.6 demonstrate that for an in-
cubation of 5 min only low particle amounts between 0.087±0.030 (0% FCS)
and 0.050±0.06 (100% FCS) relative to the cellular area are detected intracellu-
larly. Extending the incubation time to 30 min strongly increases the intracellu-
lar particle signals especially for non-corona particles (0% FCS) to 0.358±0.010
whereas the stepwise protein corona induction significantly and gradually re-
duces the relative internal SPIONs amounting in lower values of 0.123±0.005
for PEI particles pre-incubated in 100% FCS. For particle incubations of 180 min
the relative amount of internalized SPIONs pre-incubated in 100% FCS increases
to 0.349±0.080 and slightly decreases in case of PEI particles without protein
corona (0.280±0.010). However, values do not significantly differ from one an-
other.
As analyses of cellular particle interaction and uptake by flow cytometry and
confocal laser scanning microscopy revealed a pronounced dependence on the
level of protein corona on PEI-coated SPIONs, the corona-associated influence
on uptake mechanisms itself was investigated next. In order to analyze the
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energy-dependence of this process, nano-screenMAG-G/PEI with no (0% FCS)
or a complete (100% FCS) protein corona were added to HBMEC under serum-
free conditions and a 180-minute incubation was carried out at either 37 °C or
4 °C (see figure 3.7). Subsequent analyses by flow cytometry presented in pan-
els A-C indicate that the cellular particle-associated fluorescence loading for
corona-free particles is 330.9±33.2 RFU for 37 °C and 489.0±4.3 RFU for 4 °C,
and thus even slightly increases rather than decreases upon temperature reduc-
tion. In contrast, energy deprivation during cellular incubation with protein
corona-possessing PEI particles strongly reduces this SPION-associated fluo-
rescence from 218.4±2.8 RFU (37 °C) to 88.5±3.9 RFU (4 °C). Analogously, the
cellular fraction negative for SYTOX® Red (SYTOX−) is significantly higher
for HBMEC exposed to corona-containing particles (87.7±7.6%) compared to
corona-free particles (69.3±11.4%) for an incubation temperature of 4 °C, where-
as the fraction positive for both SPIONs and SYTOX® Red significantly increases
from 8.7±4.6% (100% FCS) to 45.7±18.3% (0% FCS). Further microscopic stud-
ies focused on the detection of intracellular SPIONs, reflect similar situation
(see figure 3.7 panels D-E). Data demonstrate that for an incubation tempera-
ture of 37 °C the amount of internalized SPIONs relative to the cell area is on
similar levels for both particle formulations, whereas the SPION incubation at
4 °C significantly reduces this amount from 0.337±0.009% to 0.081±0.030% for
PEI particles without or with protein corona, respectively.
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Figure 3.5: Cellular interaction of SPIONs and cell viability of HBMEC upon exposure, an-
alyzed by flow cytometry. HBMEC seeded into 12-well plates in duplicates with seeding den-
sities of 80,000 cells/cm2 were subjected to serum-free conditions. Nano-screenMAG-G/PEI
particles pre-incubated within indicated concentrations of FCS (diluted in RPMI medium) were
added, resulting in final concentrations of 25 µg/cm2 (corresponding to 94.5 µg/ml). After 5–
180 min supernatant and harvested cells were stained with SYTOX® Red and analyzed by flow
cytometry with 10,000 cellular events per sample. Presented are histograms of cellular SPION-
associated fluorescence loading (A) or indicated cell fractions (B-D). Shown are means ± stan-
dard deviation of one representative of two independent experiments. Statistical significance
of grouped samples compared among each other was tested by two-way ANOVA followed by
Dunnett’s multiple comparison, where differences are considered as statistically significant for
p < 0.05 (*), p < 0.01(**), p < 0.001 (***), and p < 0.0001(****). FCS - fetal calf serum; FL-1-H -
SPION-labeled fluorescence intensity; RFU- relative fluorescence units.
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Figure 3.6: Protein corona-associated uptake of SPIONs into HBMEC analyzed by confo-
cal laser scanning microscopy. HBMEC seeded on glass cover slips placed into 24-well plates
with a seeding density of 165,000 cells/cm2 were subjected to serum-free conditions. Nano-
screenMAG-G/PEI particles (green) pre-incubated with indicated concentrations of FCS (di-
luted in RPMI medium) were added resulting in final concentrations of 25 µg/cm2 (correspond-
ing to 50 µg/ml) and incubated for 5–180 min. Cells were fixed, permeabilized and stained with
DAPI (blue) and Alexa Fluor® 633 Phalloidin (red). A Microscopic images of SPIONs alone or
merged with other channels. B Quantitative analysis of internalized nano-screenMAG-G/PEI
into HBMEC dependent on the protein corona on SPIONs’ surface. Shown are means ± stan-
dard deviation of two independent experiments with two to three microscopic fields of view
each. Statistical significance among grouped samples was tested by two-way ANOVA followed
by Dunnett’s multiple comparison, where differences are considered as statistically significant
for p < 0.01(**) and p < 0.0001(****). Levels of statistical significance are indicated for total
SPIONs in gray and for internal SPIONs in black. Figure taken with permission and data ex-
tended from [157]. FCS - fetal calf serum.
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Figure 3.7: Effect of the protein corona on cellular SPION uptake mechanisms analyzed
by flow cytometry and confocal laser scanning microscopy. HBMEC were seeded into 12-
well plates (A-C) or to cover slips placed within 24-well plates with seeding densities of
80,000 cells/cm2 or 165,000 cells/cm2, respectively. Cells were subjected to serum-free con-
ditions and nano-screenMAG-G/PEI particles pre-incubated with indicated concentrations of
FCS (diluted in RPMI medium) were added, resulting in final concentrations of 25 µg/cm2 (cor-
responding to 94.5 µg/ml or 50 µg/ml). A-C After 180 min supernatant and harvested cells
were stained with SYTOX® Red and analyzed by flow cytometry with 10,000 cellular events
per sample. Presented are histograms of cellular SPION-associated fluorescence loading (A) or
indicated cell fractions (B-C). Shown are means ± standard deviation of two independent ex-
periments. D-E Cells were fixed, permeabilized and stained with DAPI (blue) and Alexa Fluor®
633 Phalloidin (red). D Microscopic images of SPIONs alone or merged with other channels. E
Quantitative analysis of internalized nano-screenMAG-G/PEI into HBMEC dependent on the
protein corona on SPIONs’ surface. Shown are means± standard deviation of two independent
experiments with three microscopic fields of view each. Statistical significance among grouped
samples was tested by two-way ANOVA followed by Sidak’s multiple comparison, where dif-
ferences are considered as statistically significant for p < 0.05 (*), p < 0.01(**) and p < 0.001 (***).
Levels of statistical significance are indicated for total SPIONs in gray and for internal SPIONs
in black. FCS - fetal calf serum; FL-1-H - SPION-labeled fluorescence intensity; RFU- relative
fluorescence units.
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3.2 Establishing and Optimizing the Blood-Brain
Barrier Model
In order to obtain a BBB-representing in vitro test model the human cell line
HBMEC was utilized. Thereby, transwell inserts comprising a porous mem-
brane were used for generating HBMEC layers separating the upper donor
compartment from the lower acceptor compartment. As the barrier integrity is
a critical factor for all further investigations regarding particle interaction and
passage through the barrier cells, initial experiments revealing optimal cell cul-
ture conditions were performed.
3.2.1 Testing of Transwell System and Cell Seeding Density
Different types of membranes and additional coatings for transwell inserts are
available for the generation of a cellular transwell barrier system. Testing colla-
gen-coated PTFE- and tissue culture-treated PET membranes each seeded with
cell numbers of 160,000–300,000 cells/insert, indicates distinct differences be-
tween the two transwell types (figure 3.8). While cells seeded on PTFE mem-
branes can easily be imaged by bright field microscopy, the optically visible
pores of PET membranes strongly impede the microscopic evaluation of cellular
growth on the latter membrane type. However, investigating the cell barrier in-
tegrity regarding TEER revealed that HBMEC seeded on the PET membrane—
irrespectively of the cell seeding number—reach higher TEER values compared
to HBMEC seeded on PTFE membrane inserts. For instance, seven days af-
ter seeding 240,000 cells/insert HBMEC cultivated on PET membranes achieve
TEER values of 53±2Ω· cm2 whereas PTFE-cultivated cells remain at
26±1Ω· cm2. Based on these findings PET membrane inserts and a cell seeding
number of 240,000 cells/insert were used for all further experiments in order to
obtain cellular barriers with appropriate characteristics.
3.2.2 Influence of Cell Media Supplements on HBMEC Layer
Integrity
The influence of different cell media and media supplements on HBMEC layers
was tested in context of their effect on diverse barrier integrity parameters. Fig.
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Figure 3.8: In vitro blood-brain barrier models formed by HBMEC cultivated on PET or
PTFE membrane inserts. HBMEC were seeded and cultivated on collagen-coated PTFE-
or tissue culture-treated PET membrane inserts with a cell density of 160,000, 240,000 or
300,000 cells/insert. A Microscopic bright field images of blank and cell-seeded membranes.
B Transendothelial electrical resistance (TEER) measurements of HBMEC layers on respective
membrane inserts. Shown are means of two replicate transwell inserts with three measure-
ments each and background correction with cell-free membrane inserts. PET - polyethylene
terephthalate; PTFE - polytetrafluoroethylene.
3.9 summarizes the results of these investigations. The Nuclear Fast Red stain-
ing of histological cross sections prepared from HBMEC layers cultivated under
indicated media conditions (see figure 3.9 panel A) demonstrates that for non-
supplemented RPMI medium a loose cell cluster is formed. By using astrocyte-
conditioned medium (ACM) a more connected but tenuous cell layer is devel-
oped, whereas the addition of 10% (v/v) FCS to ACM seems to strengthen the
cellular layer to a more consolidated appearance. However, the cultivation of
HBMEC transwell systems with RPMI medium containing 10% (v/v) FCS in-
duces the formation of a dense, continuous, and uniform cell barrier. Both the
cytoskeletal and ZO-1 staining of HBMEC layers cultivated under the very same
conditions shown in figure 3.9 panel B give similar results, whereby cells cul-
tivated with non-supplemented RPMI appear rounded and sparse in cell-cell
contacts without ZO-1 proteins located in the peripheral cell areas. In compar-
ison, ACM-cultivated HBMEC layers seem to be flat and connected intercellu-
larly which is highlighted in particular by the increased presence of ZO-1 at the
cell margins. For both RPMI and ACM the addition of 10% (v/v) FCS seems to
enhance the three-dimensional assembly of a tight cellular network whereas the
peripheral ZO-1 localization is still present but slightly less intense. By repeti-
tive TEER measurements the tightness of developing HBMEC layers was quan-
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tified over time (see figure 3.9 panel C). Notably, TEER values strongly increase
during the first days after cell seeding and seem to reach a plateau between day
five and seven. Whereas on day six non-supplemented RPMI medium results in
the lowest TEER values of 24.0±0.7Ω· cm2, plain ACM-treated HBMEC achieve
a TEER of 31.9±0.8Ω· cm2. The FCS supplementation of ACM and RPMI ele-
vates the prospective TEER values to 36.4±0.6Ω· cm2 and 46.9±0.7Ω· cm2, re-
spectively. The HBMEC layer’s retention to the small molecular dye NaFl was
tested as another integrity parameter. Results shown in figure 3.9 panel D in-
dicate that both non-supplemented RPMI and ACM only allow a low barrier
tightness with a 12.8±3.4 - and 7.1±0.4 -fold increase of the NaFl retention rela-
tive to cell-free transwell inserts after ten-minute incubation with the molecular
dye. Again the addition of 10% (v/v) FCS to ACM and RPMI medium showed
the most pronounced effects with elevations of the cell layer’s molecular reten-
tion of 37.0±3.4 - and 31.4±9.2 -fold, respectively.
Taking into account all the results regarding the analysis of the influence of
cultivation conditions on barrier integrity, for all further transwell experiments
HBMEC layers were prepared by using RPMI medium supplemented with 10%
FCS and cultivation for five to six days.
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Figure 3.9: Influence of cell culture media and media supplements on barrier integrity param-
eters. HBMEC were seeded on transwell inserts and cultured for up to nine days. One day after
cell seeding media were replaced by indicated fresh media and cultivated further. A Nuclear
Fast Red-stained histological cross sections of cell layers cultivated under indicated conditions
for five days. B Fluorescent staining of filamentous actin (red) and zonula occludens-1 (green)
of cell layers cultivated under indicated conditions for six days. C Transendothelial electrical
resistance (TEER) measurements of HBMEC layers. Shown are means of two replicate trans-
well inserts with three measurements each and background correction with cell-free membrane
inserts. D Molecular retention of cell layers to sodium fluorescein (NaFl) upon dye incubation
for 10, 30 or 60 min. Shown are means of two replicate transwell inserts cultivated for six days
relative to cell-free inserts. Statistical significance among grouped samples was tested by two-
way ANOVA followed by Dunnett’s multiple comparison, where differences are considered as
statistical significant for p < 0.001 (***). Parts of the figure taken with permission from [151].
ACM - astrocyte-conditioned medium.
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3.3 Interaction of SPIONs with the Blood-Brain
Barrier Model
After having established an appropriate in vitro BBB model based on an HBMEC-
seeded transwell system as described in section 3.2, the system was used for
SPION interaction studies. On the one hand, the particles’ effects on barrier in-
tegrity were tested by various methods in a time-dependent manner in order to
gain an insight into the consequences for the barrier itself. On the other hand,
SPION passage through the barrier-forming cells was analyzed and quantified
in a next step for evaluating the particles’ barrier-penetrating ability.
3.3.1 SPION-associated Effects on Barrier Integrity
Maintaining the physiological integrity of the BBB is an essential premise for
keeping the brain’s homeostasis. In order to investigate consequences of SPION
exposure on the HBMEC-based in vitro model, TEER measurements before and
after incubation with diverse types of SPIONs as well as molecular permeability
assays and microscopic analysis of histological cross-sections were performed.
Data summarized in figure 3.10 show that SPIONs differently affect the bar-
rier integrity after particle exposure for 180 min. Both TEER measurements and
molecular retentions to NaFl shown in panels A and B reveal strong and signif-
icant alterations under the influence of cationic fluidMAG-PEI with a decrease
of TEER values (relative to initial values) to 0.80±0.03 and NaFl retentions to
0.40±0.02 (relative to control cells). Whereas a slight but significant decrease
of TEER values to 0.94±0.01 is observed for fluidMAG-DEAE particles, no in-
fluence of these cationic particles is detected by molecular permeability assays
based on NaFl. While for exposure of HBMEC layers to fluidMAG-D for 3 h
and 24 h, TEER values do not show any significant changes, NaFl retentions
are slightly but significantly reduced to 0.79±0.07 and 0.78±0.10, respectively.
However, in case of incubation with SEONBSA relative TEER values are signif-
icantly reduced to 0.86±0.03, whereas the cell layer’s retention towards NaFl
elevates the NaFl retention to 1.38±0.08 for three-hour incubations. An in-
cubation of 24 h with these anionic particles is characterized by a strong and
significant reduction of both relative TEER values (0.63±0.08) and NaFl reten-
tions (0.41±0.24). Stained histological cross sections of particle-incubated trans-
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well systems shown in panels C-D provide a more comprehensive insight into
the cell layers’ conditions after particle exposure to neutral fluidMAG-D and
anionic SEONBSA. Microscopic images imply that after the incubation with
fluidMAG-D, HBMEC layers keep an intact and continuous appearance for in-
cubation times of up to 24 h. In contrast, cross sections of SEONBSA-incubated
cells seem already slightly diminished after 3 h and strongly compromised af-
ter 24 h, where the layer’s continuity is barely visible. Notably, HBMEC layers
are not located directly on the transwell membrane, which might be a result of
the multi-step sample preparation for this method. Focusing on Prussian blue-
stained SPIONs detected within the cross sections it is striking that fluidMAG-D
is hardly detectable in samples obtained after an incubation for 3 h but inten-
sively abundant upon a 24-hour incubation. In contrast, cellular layers exposed
to SEONBSA show extensive SPION staining as soon as 3 h after particle addi-
tion.
3.3.2 Passage of SPIONs through in vitro Blood-Brain Barrier
Model
As data presented in section 3.3.1 indicate that starch-coated fluidMAG-D min-
imally affect barrier integrities of HBMEC-based transwell models, the pas-
sage of these neutral particles was investigated in detail for incubation times
of up to 3 h. To this end, MPS was used for directly detecting and quanti-
fying SPIONs within the distinct compartments of the transwell system with
a high sensitivity. Figure 3.11 sums up the experimental data obtained. The
particle standard curve presented in panel A implies a close correlation of uti-
lized fluidMAG-D and its detection and quantification via this magnetization
response-based method over multiple orders of magnitude ranging from few
ng to several hundred µg. Thus, the LOD is as small as 1.85 ng iron for the bio-
logical sample. Analyses of compartment-specific contents of SPION-associated
magnetic iron shown in panel B demonstrate that with an average of 92.2±1.5%
the great majority but not all utilized particles are recovered via this method in-
cluding sample preparation. Furthermore, data imply that fluidMAG-D is pre-
dominantly found within the lower acceptor compartment after a three-hour
incubation of cell-free transwell inserts with 100 µg/cm2 and 200 µg/cm2, as
83.3±9.4% (14.68±1.66 µg) and 93.1±11.3% (31.46±3.83 µg) of detected SPION-
associated iron are found here, respectively. In the presence of HBMEC layers
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Figure 3.10: SPION-associated effects on barrier integrity parameters of HBMEC layers.
HBMEC were seeded on transwell inserts and cultured for five days. Indicated SPIONs were
added resulting in a final concentration of 100 µg/cm2 (corresponding to 200 µg/ml) and incu-
bated for 3 h or 24 h as indicated, whereby the first 30 min were carried out on top of a block
magnet. A Ratios of transendothelial electrical resistance (TEER) measurements of cell layers
before and after SPION incubation. Shown are means of two to four independent experiments
with two replicate inserts each. B Molecular retention of SPION-incubated cell layers to sodium
fluorescein (NaFl). Shown are means of two to four independent experiments with two repli-
cate inserts each. Statistical significance of indicated samples compared to controls was tested
by one-way ANOVA for fluidMAG-DEAE and -PEI and two-way ANOVA for fluidMAG-D
and SEONBSA. Both cases were followed by Dunnett’s multiple comparison, where differ-
ences are considered as statistically significant for p < 0.05 (*), p < 0.01(**), p < 0.001 (***), and
p < 0.0001(****). C-D Nuclear Fast Red- and Prussian blue-stained histological cross sections of
cell layers incubated with fluidMAG-D (C) or SEONBSA (D) as stated above.
on the transwell membrane most (95.9%-99.3%) of the fluidMAG-D are detected
within the upper donor compartment. During the incubation of blank trans-
well inserts with 100 µg/cm2 fluidMAG-D, particle amounts recovered within
the cell-free membranes are 7.3±5.4 ng, whereas for cell-studded inserts the
amount of magnetic iron within this compartment is significantly increased to
112.8±17.4 ng and 371.9±198.4 ng after 0.5 h and 3 h, respectively. A detailed
analysis of lower acceptor medium of HBMEC-grown inserts incubated with
100 µg/cm2 indicate a low (0.7±2.1 ng) amount of magnetic iron after 0.5 h,
though below the LOD. However, extending the incubation time to 3 h results
in the significant increase of magnetic iron to 5.8±3.0 ng within this compart-
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ment. Strikingly, neither for the three-hour incubation with 50 µg/cm2 nor for
200 µg/cm2 fluidMAG-D such pronounced increases are detectable (2.2±1.6 ng
and 1.6±2.0 ng).
In order to verify the results of particle passage through the in vitro barrier
model by MPS-based quantification of magnetic iron, AAS was applied, which
allows the quantification of total iron. In addition to the detailed analysis of
SPION presence within the barrier-forming HBMEC layer and lower accep-
tor medium, a second cell type located on bottom wells mimicking underly-
ing tissues was applied and analyzed for iron. Furthermore, the passage of
fluidMAG-D was compared to that of SEONBSA in a time-dependent manner.
Results summarized in figure 3.12 show the standard curve for fluidMAG-D
derived from AAS quantification. While the linear correlation of utilized iron
and AAS-detected signals are indicated for these particles in panel A, the de-
tection range is limited to a maximum of 3 µg implicating additional dilution
steps for quantifications of elevated iron amounts. The LOD of this method is
2 ng. The compartment-specific iron contents shown in panel B indicate again
that the highest amounts of fluidMAG-D are found within the lower accep-
tor compartment and lower cells if cell-free transwell inserts are incubated for
3 h (20.51±4.71 µg and 2.81±1.16 µg) or 24 h (15.39±5.75 µg and 7.95±2.68 µg).
Compared to that, the amount of analogously applied anionic SEONBSA to cell-
free inserts is 5.24±7.41 µg and 4.26±2.68 µg for 3 h and increases to
9.53±0.17 µg and 6.24±6.02 µg for 24 h. However, if membrane inserts are cov-
ered with HBMEC layers, most detected SPIONs are present within the barrier-
forming HBMEC compartment. Thus, an incubation with fluidMAG-D increas-
es to an iron accumulation of 3.12±0.30 µg after 24 h, whereas in case of
SEONBSA iron amounts within this compartment are significantly elevated to
9.95±7.15 µg after 3 h and 10.88±4.34 µg after 24 h. Focusing on iron contents
detected within the lower acceptor medium, data imply that a three-hour incu-
bation with fluidMAG-D results in a significant increase of iron (25.2±12.7 ng)
compared to control inserts without SPION treatments, while for SEONBSA an
elevated tendency is observed but without statistical evidence. Extending in-
cubation times for both particle types to 24 h significantly elevates iron con-
tents of lower medium compartments especially for anionic SEONBSA. Simi-
larly, enhanced iron levels in well bottom-seeded lower cells are detectable with
statistical evidence after 24 h for both fluidMAG-D (8.5±3.6 ng) and SEONBSA
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(11.2±6.6 ng), while for an incubation time of 3 h a statistically significant in-
crease is observable for SEONBSA-treated conditions only. Additionally to the
MPS- and AAS-based quantification of iron within the distinct compartments
of the transwell system, microscopic analyses of both upper barrier-forming
HBMEC and underlaying lower cells after the incubation with fluorescence-
labeled starch particles were performed. On the one hand, images presented
in panel C demonstrate the presence of green particle signals in HBMEC layers
after a three-hour incubation, which is further enhanced after 24 h. Remarkably,
nano-screenMAG-G/D co-localizes with intracellular F-actin staining for both
incubation times. On the other hand, analogous SPION signals co-localizing
with F-actin staining of lower cells beyond the barrier can microscopically be
detected very rarely after both 3 h and 24 h (see panel D).
Taken together, the passage of SPIONs trough the BBB-representing in vitro
model is demonstrated by diverse methods comprising MPS and AAS for highly
sensitive quantification and confocal laser-scanning microscopy for the optical
detection and verification of particle internalization.
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Figure 3.11: SPION distribution of distinct compartments of the in vitro blood-brain barrier
model analyzed by magnetic particle spectroscopy (MPS). HBMEC were seeded on transwell
inserts and cultured for five days. FluidMAG-D were added resulting in a final concentration of
50-200 µg/cm2 (corresponding to 100-400 µg/ml) and incubated for up to 3 h, whereby the first
30 min were carried out on top of a block magnet. A Standard correlation curve of fluidMAG-D
diluted in cell culture medium measured by MPS. B Compartment-specific contents of magnetic
iron determined by MPS. Shown are means ± standard deviation of three independent experi-
ments with three replicate inserts each. Statistical significance of samples compared to controls
without SPIONs and amongst each other was tested by one-way ANOVA followed by Tukey’s
multiple comparison, where differences are considered as statistically significant for p < 0.05
(*), p < 0.01 (**), p < 0.001 (***), and p < 0.0001(****). Parts of the figure taken with permission
from [151].
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Figure 3.12: SPION distribution of distinct compartments of the in vitro blood-brain barrier
model analyzed by atomic absorption spectroscopy (AAS). HBMEC were seeded on transwell
inserts and cultured for five days. Indicated SPIONs were added resulting in a final concentra-
tion of 100 µg/cm2 (corresponding to 200 µg/ml) and incubated for 3 h or 24 h, whereby the first
30 min were carried out on top of a block magnet. A Standard correlation curve of fluidMAG-D
diluted in cell culture medium measured by AAS. B Compartment-specific contents of total iron
determined by AAS. Shown are means ± standard deviation of three independent experiments
with three replicate inserts each. C-D Fluorescent staining of barrier-forming HBMEC (upper
cells/membrane, C) and MCF-7 cells seeded into well bottoms (lower cells, D) after incubation
with nano-screenMAG-G/D (green). Nuclei and filamentous actin are stained with DAPI (blue)
and Alexa Fluor® 633 Phalloidin (red), respectively. Samples were analyzed by confocal laser
scanning microscopy. Statistical significance of grouped samples compared to controls without
SPIONs and among each other was tested by two-way ANOVA followed by Dunnett’s multi-
ple comparison, where differences are considered as statistically significant for p < 0.05 (*), p <
0.01(**), p < 0.001 (***), and p < 0.0001(****).
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3.4 SPION-induced Passage of Immune Cells trough
Blood-Brain Barrier Model
The obvious route for SPIONs to cross biological barriers is their direct passage
through barrier-forming cells. This option is demonstrated in detail for two
different particle types in section 3.3.2 by utilizing the presented in vitro BBB
model. However, there is also the possibility of other cells taking up SPIONs
and subsequently transmigrating trough the biological barrier resulting in a
cell-mediated delivery of particles. In order to investigate this relevant issue,
immune cells characterized by either monocytic or neutrophil-like phenotypes
were generated from THP-1 and HL-60 cells, respectively, as shown in supple-
mental figure B.6. For an effective cellular loading with SPIONs, SEONPAM par-
ticles were added to differentiated THP1 (diffTHP-1) and HL-60 (diffHL-60) cells
resulting in a final concentration of 50 µg/cm2 (corresponding to 189 µg/ml)
and incubated for 120 min (see supplemental figure B.7). These SPION-loaded
cells were added to barrier-forming HBMEC layers cultivated on FluoroBlok
inserts and transmigration of diffTHP-1 and diffHL-60 monitored depending on
the presence of SPIONs themselves, the influence of an magnetic field, and the
impact of an inflammatory stimulus.
3.4.1 SPION-mediated Transmigration of neutrophil-like
HL-60 across Blood-Brain Barrier Model
As neutrophilic granulocytes constitute the most abundant fraction of leuko-
cytes, they are likely being exposed to SPIONs present within the blood stream
or other tissues. That is why the influence of diffHL-60’s cellular loading with
SPIONs was investigated respective to their transmigration across the HBMEC-
based in vitro BBB model. Figure 3.13 summarizes the experimental outcome of
these studies with continuous fluorescence measurements indicating transmi-
gration kinetics of diffHL-60 across the biological barrier shown in panel A. Data
show that non-loaded diffHL-60 ("blind neg. control") only slowly cross cell-free
insert membranes, while upon the loading with SEONPAM ("blind SPIONs")
transmigration is more than doubled from 0.80±0.21 to 1.66±0.07 (relative to
control conditions) after an incubation for 1,400 min. Strikingly, in the presence
of HBMEC layers, the same particle pre-incubations of diffHL-60 ("SPIONs") el-
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evate the passage of these neutrophil-like cells by approximately 89%, whereby
especially for earlier incubation times the migration curve is steeper compared
to non-loaded controls ("controls w/o SPIONs"). Additionally, applying a mag-
netic field for 30 min stimulates the presence of fluorescence-labeled diffHL-60
within the lower acceptor compartment by 58±5% and even 102±7% relative
to control cells at measurement time points of 30 min and 1,400 min, respec-
tively. Similarly, during the presence of the inflammatory cytokine IL-1β the
migratory kinetics of diffHL-60 across the HBMEC layer is raised to 1.98±0.02
and 2.04±0.01 without and with the influence of an additional magnetic field.
Upon having continuously monitored the cellular transmigration by fluores-
cence measurements for 1,400 min, microscopic analysis of fixed and counter-
stained membranes was performed in order to gain a more complete picture of
ongoing events. Microscopic images of both upper and lower membrane sides
are presented in panel B. Thereby, orange-labeled HBMEC cells are visible on
upper apical membranes, whereas they are not detectable on lower basolateral
membrane sides. diffHL-60-representing green fluorescence signals, occasion-
ally appearing on the apical and rarely on the basolateral membrane site, indi-
cate the presence of these cells on the HBMEC layers or membrane before and
after the transmigration However, only a low number of directly attached cells
is detectable. Further results of lower acceptor compartments regarding the
presence of diffHL-60 beyond the HBMEC-formed barrier are shown in panel
C. The presence of Nuclear Fast Red-stained diffHL-60 in microscopic images
verifies their transmigration across the BBB model. Remarkably, some Prus-
sian blue-labeled SPIONs (indicated by arrows) can be detected within these
cells in case of "SPIONs" samples, whereas the application of a magnetic field
and/or IL-1β strongly elevates the presence of microscopically detectable cells
and SPIONs within this compartment.
3.4.2 SPION-mediated Transmigration of monocytic THP-1
across Blood-Brain Barrier Model
In addition to neutrophil-like cells, monocytic cells form a class of phagocytos-
ing leukocytes potentially being exposed to SPIONs. In order to study their
ability to cross the BBB model upon loading with SEONPAM, various analy-
ses presented in figure 3.14 were performed using THP-1 cells differentiated
to monocytic phenotypes (diffTHP-1). The time-dependent detection of fluo-
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rescently labeled cells within the lower acceptor compartment under indicated
conditions is shown in panel A. Data indicate that diffTHP-1 only marginally
cross blank transwell membranes in the absence of HBMEC layers (0.44±0.08
of control conditions). However, the SPION loading of these monocytic cells
strongly enhances the transmigration by 57% aligning to "control w/o SPIONs".
In the presence of HBMEC layers, the migration of SPION-loaded diffTHP-1 into
lower acceptor compartments is sharply increased compared to controls espe-
cially for early incubation times as an 130-minute incubation induces an ele-
vation from 0.29±0.06 to 0.58±0.04 for non-loaded and SEONPAM-loaded cells,
respectively. After an incubation for 1,400 min differences of 39±3% between
these two conditions are still detectable. Additionally, applying a magnetic
force to the system enhances the transmigration of SEONPAM-loaded diffTHP-
1 to 1.56±0.08. Noticeably, the presence of IL-1β does not essentially affect
the migration curve compared to analogous conditions without inflammatory
stimulation. As seen previously, the microscopic analysis of fixed and counter-
stained transwell membrane samples presented in panel B reveal an even dis-
tribution of orange-labeled HBMEC cells covering upper apical membranes but
not lower basolateral membrane sides. Whereas diffTHP-1 labeled with green
fluorescence are barely detectable on apical membrane sides, their abundant
presence on lower basolateral sides implies an effective attachment of diffTHP-1
after transmigration of HBMEC layers. In accordance to this observation, sus-
pensious diffTHP-1 are barely detectable within lower acceptor compartments’
media as depicted in panel C. Furthermore, SPIONs are not visible within these
few Prussian blue-stained cells.
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Figure 3.13: Transmigration of differentiated, SPION-loaded HL-60 cells across the in vitro
blood brain barrier model. HBMEC were seeded on FluoroBlok transwell inserts and stained
using CellTracker™ red CMTPX (orange) upon cultivation for five days. HL-60 differentiated
with 1.4% DMSO (six days) were stained by CellTracker™ Green BODIPY® (green) and incu-
bated with 50 µg/cm2 (corresponding to 189 µg/ml) of SEONPAM for 120 min. SPION-loaded
HL-60 were added to HBMEC-seeded transwells with a density of 500,000 cells/insert. If in-
dicated, HBMEC layers were pre-treated with 5 ng/ml IL-1β for 120 min before SPION-loaded
immune cells were added. In order to chemically attract differentiated HL-60, acceptor com-
partments were provided with 10 nM (fMLP). For selected samples the first 30 min of incuba-
tion were carried out on top of a 24-well magnetic plate (indicated as "MF") before transmi-
gration was monitored by fluorescence measurements of the lower compartment using a mi-
croplate reader. A Time-dependent relative fluorescence detected within the lower acceptor
compartment. B After 1,400 min of transmigration transwell membranes were fixed, cell nuclei
counterstained using Hoechst 33258 (blue), embedded on cover slips, and analyzed by confocal
laser scanning microscopy. C Cells suspended in the lower acceptor compartment were trans-
ferred to microscopic slides by cytospin, fixed, and stained by Nuclear Fast Red. Additionally,
SPIONs were stained with Prussian blue (indicated by black arrows). DMSO - dimethyl sulfox-
ide; fMLP - N-Formylmethionyl-leucyl-phenylalanine; MF - magnetic field; PAM - polyacrylat-
co-maleat.
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Figure 3.14: Transmigration of differentiated, SPION-loaded THP-1 cells across the in vitro
blood brain barrier model. HBMEC were seeded on FluoroBlok transwell inserts and stained
using CellTracker™ red CMTPX (orange) upon cultivation for five days. THP-1 differentiated
with 5 ng/ml PMA (five days) were stained by CellTracker™ Green BODIPY® (green) and incu-
bated with 50 µg/cm2 (corresponding to 189 µg/ml) of SEONPAM for 120 min. SPION-loaded
THP-1 were added to HBMEC-seeded transwells with a density of 300,000 cells/insert. If in-
dicated, HBMEC layers were pre-treated with 5 ng/ml IL-1β for 120 min before SPION-loaded
immune cells were added. In order to chemically attract differentiated THP-1, acceptor com-
partments were provided with 100 ng/ml MCP-1. For selected samples the first 30 min of in-
cubation time were carried out on top of a 24-well magnetic plate (indicated as "MF") before
transmigration was monitored by fluorescence measurements of the lower compartment using
a microplate reader.A Time-dependent relative fluorescence detected within the lower acceptor
compartment. B After 1,400 min of transmigration, transwell membranes were fixed, cell nuclei
counterstained using Hoechst 33258 (blue), embedded on cover slips, and analyzed by con-
focal laser scanning microscopy. C Cells suspended in the lower acceptor compartment were
transferred to microscopic slides by cytospin, fixed, and stained by Nuclear Fast Red. Addi-
tionally, SPIONs were stained with Prussian blue. MCP-1 - monocytic chemotactic protein-1;
MF - magnetic field; PAM - polyacrylat-co-maleat; PMA - phorbol 12-myristate 13-acetate.
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Discussion
The utilization of nanomaterials for various applications is prevalent and stea-
dily-increasing, which gives rise to an ever-expanding number of particle for-
mulations [21]. In context of biomedical implementations, especially super-
paramagnetic iron oxide nanoparticles (SPIONs) are highly promising candi-
dates, as they can be applied as contrast agents in magnetic imaging methods,
as drug delivery systems with magnetic targeting, and for hyperthermia anti-
tumor therapy during the presence of an alternating external magnetic field
as well as many others [10, 41, 42]. To date, several SPION-based products
are already clinically approved and commercially available [25], while even
more are in the pipeline or under development for advanced biomedical ap-
plications [10]. On the one hand, the large degree of freedom in particle syn-
thesis allows their tailored design and functionalization according to specific
needs [21]. On the other hand, the great particle diversity demands an ade-
quate risk and impact assessment for every individual formulation in order to
achieve an efficient and safe implementation [74]. Both variabilities between
different SPION batches and particle aging predominantly caused by oxidation
present great challenges, too [158]. Moreover, a precise evaluation is frequently
impeded by unique SPION properties such as optical properties, hydropho-
bicity, and catalytic activities, which often interfere with examination meth-
ods commonly used for studying other substance classes [74, 158, 159]. The
introduction of SPIONs into biological systems embodies a challenging step
along their way from scientific reports into clinical application. Prior to animal-
based in vivo studies and clinical trials, convenient cell culture-based models
combined with validated analyses represent powerful tools for efficient test-
ing of biological effects of such substances in both mechanistic investigations
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and high-throughput practice. In consequence, in vitro pre-screening substan-
tially contributes to the reduction of animal experiments in compliance with the
principle of the "Three Rs" (i.e., Replacement, Reduction, Refinement accord-
ing to Altman [160]) [158, 161] and provides valuable insights into the biology
of physiologic and pathophysiologic processes [127, 129, 130]. In the past, di-
verse cell lines have been utilized for the evaluation of nanoparticles including
SPIONs [51, 162, 163]. In context of a whole organism, biological barriers em-
body striking structures essentially affecting biodistribution, tissue penetration,
uptake, metabolism and storage of nanoparticles, as well as particle degrada-
tion and elimination [7]. In this context an important question is whether the
biological barrier can act as a tight boundary layer protecting underlying tis-
sue, such as the central nervous system (CNS), upon exposure to SPIONs. If
not, the particle-induced impairment of barrier integrity may convey devastat-
ing effects such as influx of toxins, vasoactive substances as well as neuroin-
flammatory molecules [70]. Conversely it is important to evaluate if the barrier
embodies an insuperable hurdle for SPIONs preventing their delivery during
targeted therapy. These are fundamental questions, which need to be answered
beyond doubt in order to achieve a safe and efficient biomedical particle im-
plementation. Hence, the detailed understanding of which particle parame-
ters affect barrier-penetrating, -disrupting, or -repulsing properties would take
biomedicine a step further to the tailor-made design of SPIONs, which in turn
accelerates the transfer of developed particles into clinical application. That is
why in scope of this study a cell culture-based system representing a biologi-
cal barrier is established and investigated in detail for the passage of SPIONs.
Emphasis is put on a human brain microvascular endothelial cells (HBMEC)-
based model representing the human blood-brain barrier (BBB), which embod-
ies a highly sensitive and crucial interface between blood and the CNS. SPION
formulations of different kinds comprising anionic, neutral, or cationic surface
charges are tested. Besides particle passage through the barrier, SPION-induced
consequences for barrier integrity are examined. The identification of reliable
methods for the direct and highly sensitive SPION detection within the test sys-
tem is focused on, too. In addition to the passage of free SPIONs through the
BBB model, the ability of SPION delivery by barrier-penetrating immune cells,
as well as the capacity of SPIONs to induce the barrier penetration by such im-
mune cells, is evaluated.
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4.1 General Biological Effects of SPIONs and
Impact of the Protein Corona
In order to identify appropriate SPION candidates for the establishment of a
reliable test system studying particle penetration through biological barriers,
various types of SPIONs were analyzed for their effects on cellular interaction
and cell viability. In accordance with data from literature [75, 159], both Prus-
sian blue stain and flow cytometry (see figure 3.2) reveal that especially SPIONs
coated with polyethylenimine (PEI, 750 kDa) exhibit intense interactions with
HBMEC. Additionally, PrestoBlue™ assays (see figure 3.1) show pronounced
cytotoxicity. These effects can predominantly be explained by the high cationic
surface charge of these particles, which is assessed to +47±7 mV and +54±9 mV
for non-labeled and fluorochrome-labeled PEI particles used in the presented
study, respectively (see table 2.1). The considerably elevated positive zeta po-
tential mediates a strong adsorption to negatively charged glycocalix and phos-
pholipid membranes of cells and enhanced cellular loading with SPIONs [63].
The kinetic analysis of SPION loading by fluorescence-based flow cytometry
implies a highly intense affinity to HBMEC immediately after addition to the
cells. Remarkably, this interaction seems to decrease during the incubation pro-
cess, indicated by both attenuated cellular fluorescence labeling and side scatter
(SSC) signals detected. A reason for that decline might be found in the cyto-
toxic nature of these particles. Thus, heavily loaded cells severely disrupted
from the impact of PEI-coated SPIONs are excluded from the cytometric de-
tection of cellular events reducing the median cellular fluorescence signal. Ad-
ditionally, the presence of fetal calf serum (FCS) within the incubation medium
might induce the evolution of a protein corona on the surface of PEI particles. In
turn, the cellular interaction of SPIONs can be reduced gradually and deceler-
ated as discussed in detail later within this section. Fischer et al. demonstrated
that besides the cationic surface net charge, charge density and flexibility of
the three dimensional structure of the coating molecules also essentially deter-
mine biological effects [75]. They showed that the high-molecular-weight coat-
ing with 500 kDa diethylamine ethyl (DEAE)-dextran possessing low cationic
charge densities shows good biocompatibility. In contrast, nanoparticles with
polymer coating of similar molecular weight (600 kDa) of branched PEI, ex-
hibit strong cytotoxicity based on the pronounced charge density. Given that
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fact, together with the moderately cationic zeta potential (+36±7 mV, see ta-
ble 2.1) of fluidMAG-DEAE used in scope of this thesis, the elevated cellular
adherence of DEAE-coated SPIONs revealed by Prussian blue stain accompa-
nied by the slight cytotoxic effects observed during PrestoBlue™ assays can
be explained. In contrast, anionic SEONBSA do not demonstrate any signifi-
cant effects on cell viability when evaluated by PrestoBlue™, whereas micro-
scopic analyses of Prussian blue-stained HBMEC indicate a substantial cellu-
lar affinity already noted after a 3-hour incubation. Similar observations were
made by Zaloga and colleagues, who detected that the exposure of primary
human umbilical vein endothelial cells (HUVECs) to up to 75 µg/ml SEONBSA
did not reduce viable cell count, while flow cytometry data suggested suffi-
cient cellular binding and/or particle uptake [133]. Interestingly, the authors
could find significantly decreased SSC signals representing cellular SPION con-
tent, when comparing the particles to same formulations without an additional
BSA coating. As both SPION types used by Zaloga et al. showed similar sur-
face charges, the reduced cellular adherence of SEONBSA was explained by the
protein corona-induced decelerating effect on particle binding and uptake, too.
With respect to neutral starch-coated SPIONs analyzed within the here pre-
sented thesis, no cytotoxic events are found during PrestoBlue™-based viability
studies for up to 100 µg/cm2 (equal to 378 µg/ml) for 24 h. This is accompa-
nied by low cellular interactions shown by Prussian blue stain and flow cytom-
etry during the first three hours of incubation, while a 24-hour exposure re-
sults in extensive cellular accumulation of fluidMAG-D and nano-screenMAG-
G/D, respectively. Thus, the biocompatible phenotype of such starch-coated
SPIONs may be mediated by the slow and gentle cell accumulation. In fact,
neutral SPIONs are usually barely associated with cytotoxic events in previous
literature [57, 78, 159], where a rational reason can be found in the low adher-
ence at the polar plasma membrane [76]. This seems plausible especially when
considering cellular interaction and cytotoxicity of biocompatible, less cell ad-
hering neutral starch-coated and cytotoxic intensively interacting cationic PEI
particles as discussed earlier in this section. Detecting the cellular accumula-
tion of nanoparticles by flow cytometry-obtained SSC intensities has been de-
scribed before [164–166]. Though comprehensive data achieved within this the-
sis clearly show, that the sensitivity of this internal complexity-associated SSC
parameter is limited. Focusing on cells exposed to nano-screenMAG-G/D for
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up to 3 h, geometric means of cellular fluorescence labeling indicate gradually
increasing cellular particle accumulation, while SSC signals do not change sig-
nificantly or even slightly decrease. Only for strong particle accumulation upon
incubations for 24 h elevated SSC is detectable agreeing with fluorescence sig-
nals. Vice versa, fluorescence-based data of nano-screenMAG-G/PEI-incubated
cells reveal a clear decrease in mean cellular particle content after 180 min com-
pared to 60 min incubation time, whereas SSC is not affected. Bringing these
findings in context to biocompatibility data discussed earlier in this section,
cytotoxic events inducing altered cellular morphology and internal complex-
ity, such as nuclear fragmentation, cytosolic condensation, membrane blebbing
and others [167], can interfere with a precise detection of cellular particle bind-
ing based on SSC. Moreover, particle aggregation and agglutination affect SSC
signals too, which again impede the evaluation of cellular SPION loading ex-
clusively based on SSC signals.
The determination of nanoparticle internalization by methods such as flow cy-
tometry and SPION quantification procedures including ultraviolet spectros-
copy, magnetic particle spectroscopy (MPS), and atomic absorption spectrosco-
py (AAS) is occasionally claimed [164, 165]. However, virtually no discrimina-
tion between surface-bound and actually internalized particles can be made, as
even after several washing steps strongly bound SPIONs might remain on ex-
ternal plasma membranes. Consequently, they are detected during subsequent
SPION quantification. Hence, in scope of this thesis, confocal laser scanning
microscopy was used in order to gain information on the spatial distribution
of cell-associated SPIONs to specifically identify internal particles. Thereby,
SPIONs are defined as "internal" when co-localized with fluorescence-stained
intracellular structures, such as the filamentous (F)-actin-based cytoskeleton.
Thus, the additional treatment with distinct endocytosis inhibitors reveals that
starch-coated nano-screenMAG-G/D are taken up into cells via energy-depen-
dent mechanisms (see figure 3.3). As the cellular incubation with F-actin-
depolymerizing cytochalasin D substantially reduces the uptake of the starch-
coated particles, clathrin-dependent endocytosis seems to be predominantly in-
volved in the particle uptake. This finding appears reasonable due to the supe-
rior role of clathrin-coated pits on brain microvascular endothelial cell (BMEC)
membranes compared to only rarely abundant caveolin, which has been de-
scribed before [70]. Moreover, similar studies identified clathrin-dependent
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endocytosis of diverse nanoparticle formulations [56, 57, 76] and the common
clathrin-mediated transport of molecules at the BBB [168] as well. However, the
fact that the additional presence of chlorpromazine further decreases the cellu-
lar incorporation of these starch-coated SPIONs indicates the ancillary involve-
ment of more endocytotic processes. These might include other clathrin- and
caveolae-independent pathways, as filipin incubation additional to cytocha-
lasin D and chlorpromazine does not further attenuate the level of SPIONs
found co-localized with intracellular F-actin. Indeed, the active clathrin and
caveolae-independent uptake of other nanoparticles and polymers has been
shown previously [169–171] and seems to be associated with electrostatically
neutral or anionic formulations. Interestingly, this process was demonstrated
to bypass Rab5-positive early endosomes/lysosomes and transport to the en-
doplasmic reticulum [170], which offers the possibility of particle transcytosis.
In contrast to that, uptake mechanism studies of nano-screenMAG-G/PEI con-
ducted within this thesis in presence of 4 °C, clearly demonstrate the energy-
independent nature of this process. This implies that PEI particles are not taken
up into cells by canonical endocytotic mechanisms but rather penetrate cellular
membranes independent from intrinsic active internalization pathways. One
possible route PEI particles may take can be based on the perturbation of the
plasma membrane upon electrostatic adsorption. The induction of transient
nanoholes within cellular membranes mediated by PEI polymers has been de-
scribed before [57, 77]. Furthermore, the fact that PEI particle-treated cells are
characterized by a strongly elevated positive stain with SYTOX® Red especially
during early incubation (see figure 3.5) supports this hypothesis as discussed in
detail later in this section. Another option for the internalization of PEI-coated
SPIONs into cells might happen by facilitated diffusion via selective membrane
protein channels. For cationic cargoes, membrane penetration through porines
has been observed, though—based on channel geometry—its occurrence is re-
stricted to particle sizes of up to 30 nm [172,173]. However, a number of studies
already revealed that nanoparticles of up to 600 nm show passive transporta-
tion into red blood cells lacking the endocytotic machinery [174,175]. The exact
mechanism and the question whether specific carrier proteins mediating pas-
sive transport are involved, has not been fully clarified yet.
The protein corona formed on the surface of nanoparticles in context of biologi-
cal consequences has been focused on in several studies [95, 96, 176]. While it is
80
4.1 General Biological Effects of SPIONs and Impact of the Protein Corona
clear that nanoparticle-protein interactions are highly dependent on particles’
physicochemical properties, exposure time, and the protein source itself, the
picture of how protein adsorption and nanoparticle properties correlate with
cellular responses and subsequent mechanisms is still incomplete [53]. Nev-
ertheless, the substantial influence of the protein corona, which can shield tar-
geting ligands functionalized to the surface of therapeutic SPIONs has been
shown several times [177, 178] and underlines its crucial role. That is why, one
objective of this thesis comprises the investigation of protein corona-associated
effects on cytotoxicity and cellular interaction with BBB-forming HBMEC. To
this end, fluidMAG-PEI and nano-screenMAG-G/PEI were equipped with pro-
tein coronas. As demonstrated by figure B.1, particle incubation within rising
concentrations of FCS induces increasing amounts of protein coronas confer-
ring gradually ascending amounts of SPION-associated proteins as described
by Gräfe et al. [157]. It has to be noted, that for the presented data SPION incu-
bation in 100% FCS corresponds to an effective FCS content of 87% and 77% due
to dilution upon addition of non-labeled and fluorochrome-labeled particles, re-
spectively. Both PrestoBlue™ and real time cell analysis (RTCA) clearly demon-
strate that progressive levels of protein corona on the surface of fluidMAG-PEI
stepwise reduce acute- as well as long-term cytotoxicity for at least 72 h (see
figure 3.4). Similar biocompatibility-inducing effects of the protein corona have
been described for other nanoparticle formulations [97, 176, 179]. Interestingly,
Wang et al. demonstrated that the presence of a protein corona on amino-
modified polystyrene nanoparticles prevent cytotoxic effects of bare particles
by avoiding early membrane permeabilization [179]. However, the authors ob-
served lysosomal swelling and damage upon enzymatic digestion of the protein
corona within the lysosome. Thus, cells exposed to protein corona-equipped
formulations entered cathepsin-induced apoptosis by a delay of approximately
8 h. Comparing these findings to long-term RTCA assays performed in this
thesis, such delayed cytotoxic events of protein corona-possessing PEI particles
are not observed, even in spite of the utilization of 100 µg/ml (corresponding
to 100 µg/cm2) particles instead of 50 µg/ml used by Wang and co-workers.
Possible explanations may be found in particle sizes different (40–50 nm) from
the ones used in this thesis (157 nm, see table 2.1). Devoting attention to the
particles’ decreasing zeta potentials during progressive protein corona forma-
tion (see figure B.2), reduced cytotoxicity might be explained, as these ham-
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per electrostatic interactions of the intrinsically cationic particles with anionic
plasma membranes. Interestingly, flow cytometry-based data reveal a protein
corona-dependent attenuation of cellular particle accumulation especially dur-
ing early incubation times but more equalized cellular SPION loading after
an 180-minute exposure (see figure 3.5). This fact supports the concept that
in presence of the protein corona, particle-cell interaction is decelerated rather
than impaired. In line with this hypothesis are microscopic observations re-
vealing that both total cell-associated and internalized PEI particles decrease
with ascending protein corona contents for early incubation times but not for
an incubation of 3 h (see figure 3.6). Moreover, correlating the protein corona-
dependent velocity for cellular interaction to cell viability, gives worthwhile
insights (see figure 3.5): during early incubation progress the fraction of viable
SYTOX® Red-negative cells is strongly reduced for intensively interacting PEI
particles without protein corona. In contrast, slower interacting PEI particles
with increasing protein corona do not show such effects. However, these differ-
ences are detectable to a minimal extend upon three-hour incubations. Further-
more, data clearly allow the direct correlation between cellular particle accu-
mulation by corona-free SPIONs and positive staining with SYTOX® Red, espe-
cially after short-term exposure (see figure 3.5 panel D), which has never been
shown before. One explanation for this phenomenon can be found in the fact
that cells heavily loaded during exposure to no-corona PEI particles are rapidly
destroyed and excluded from the cytometric detection of cellular events. In con-
sequence, only remaining vital cells are uncovered during subsequent SYTOX®
Red Dead cell staining and flow cytometric analysis. Though, as used particle
concentration were only 25 µg/cm2 (equal to 94.5 µg/ml), a more relevant rea-
son might be found in the mechanism behind the assay itself. There, dead cells
are defined by a positive stain with SYTOX® Red, which can not pass intact cell
membranes but compromised plasma membranes [180]. Hence, SYTOX® Red-
positive cells can be characterized by increased permeability, which does not
inevitably mean cell death if limited. As PEI embodies a cationic polymer vec-
tor commonly used for transfecting nucleic acids into eukaryotic cells, its tran-
sient membrane-permeabilizing effect has been described before and is utilized
for transferring nucleic acids into eukaryotic cells [181]. Moreover, Hong et al.
showed that polycationic polymers can induce temporal nanoscale hole forma-
tion within membranes increasing cell permeability [77]. The authors demon-
82
4.1 General Biological Effects of SPIONs and Impact of the Protein Corona
strated that cells recover upon exposure to low concentrations while integrated
membrane damage due to elevated polymer amounts result in cell death. Sim-
ilarly, SYTOX® Red-based data shown within the here presented thesis might
indicate the transient induction of cell permeability for highly cationic PEI par-
ticles without protein corona during early incubation. In contrast, decreasing
surface-charged particles possessing a protein corona do not. Furthermore, mi-
croscopic investigations of SPION internalization confirm the delay-inducing
effect of protein corona-possessing PEI particles in context of cellular internal-
ization processes (see figure 3.6). In line with this assumption are observations
made during both flow cytometry-based and microscopic investigations of cel-
lular particle accumulation and internalization under different incubation tem-
peratures (see figure 3.7). Results point out that the presence of a protein corona
on PEI particles essentially affects the uptake mechanism as corona-equipped
SPIONs are barely detected inside 4 °C-incubated cells, whereas no-corona pos-
sessing particles are. As during incubations at 37 °C protein corona-possessing
PEI particles are still internalized but more slowly, alternative active uptake
pathways must be taken by these SPIONs. One possible scenario might in-
clude protein corona-originated ligand binding to surface receptors, which pro-
vokes receptor-mediated endocytosis. Whether clathrin-dependent or other
endocytotic processes are involved needs to be investigated in future studies,
where changes in SPION size due to protein corona formation should be fo-
cused on too. Nevertheless, such shifts in uptake mechanisms are conceivable
and also other scientists observed similar phenomena for different particle for-
mulations. Thus, Caracciolo et al. observed that bare cationic lipoplexes are in-
ternalized into murine fibroblasts via clathrin-dependent endocytosis, while the
presence of a protein corona deflects entry mechanisms to caveolae-mediated
pathways [182]. Taken together, the comprehensive and detailed investigation
presented here provides profound insights into protein corona-induced effects
and underlying interrelations. Thus, the conclusion can be drawn that—with
regard to PEI-coated particles—the corona reduces the cationic particle surface
charge, which in turn prevents the abrupt and highly intense adsorption to the
anionic plasma membrane. Passive membrane penetration via the induction of
nanoscale holes and subsequent cell permeability are substantially diminished.
Hence, the protein corona formed on PEI particles strongly reduces cytotoxicity
and decelerates SPION uptake.
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4.2 SPIONs and the Blood-Brain Barrier Model
For a convenient and reliable assessment of the SPION passage through bio-
logical barriers and the resulting effects on barrier integrity, an appropriate and
well-characterized model system is of vital importance. Focusing on a BBB-
representing in vitro cell culture model, the well-established cell line HBMEC
was utilized for seeding on porous transwell membranes separating the up-
per donor- from the lower acceptor compartment [131, 137]. While polytetra-
fluoroethylene (PTFE) membranes show improved visibility of seeded cells, the
use of membranes made of polyethylene terephthalate (PET) were preferred,
as elevated transendothelial electrical resistance (TEER) values are detected for
cells seeded on the latter one (see figure 3.8). Besides the transwell membrane
type, the medium type and additional supplement factors can influence the for-
mation and tightness of the biological barrier. Apart from TEER measurements,
molecular permeability of small-molecular-weight sodium fluorescein (NaFl)
and microscopic evaluation of histological cross sections are performed for a
detailed evaluation of barrier integrity. According to the recommendations of
Deli and colleagues, the formation of tight junctions was analyzed by means of
immunofluorescent staining of the associated protein zonula occludens (ZO)-1 as
well [129]. Whereas Eigenmann et al. observed detrimental impacts [131], the
beneficial effect of astrocytes in co-culture with BMECs or the use of astrocyte-
conditioned medium (ACM) has been described by Siddharthan et al. [132].
Siddharthan and co-workers demonstrated that both cultivation arrangements
significantly reduced the barrier’s molecular permeability for propidium iodide
by 30% and 70%, respectively, and increased TEER by more than 100%. The un-
derlying mechanism is assumed to be based in the secretion of transforming
growth factor (TGF)-β, glial cell-derived neurotrophic factor (GDNF), and fi-
broblast growth factor (FGF) by astrocytes [103, 104, 132]. Prompted by these
findings, the integrity-enhancing impact of conditioned medium obtained from
primary mouse astrocytes on HBMEC was tested in scope of this thesis (see
figure 3.9). While ACM substantially increases the expression and peripheral
distribution of ZO-1 in HBMEC, both TEER and NaFl permeability show only
slight changes. These apparently contradictory observations may be based on
the fact that under the influence of ACM, HBMEC form a continuous but highly
tenuous cell layer as revealed by microscopic investigations of histological cross
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sections. Thus, narrow cellular layers and sporadic gaps allow the paracellular
breach of ions through these layers to a higher extend compared to compact lay-
ers of elevated thickness, which most probably would apply to SPIONs as well.
A reason for why HBMEC utilized within the here presented thesis do not suf-
ficiently respond to ACM might be found in interspecies differences between
human BMECs and mouse-obtained ACM. However, the response of immor-
talized mouse brain capillary endothelial cells on human TGF-β1 as well as the
tightness-inducing effect of human FGF-2 on bovine brain capillary endothe-
lial cells have been shown before [183, 184]. There, the molecular permeabil-
ity was significantly reduced upon presence of the molecules. According to
the UniProt database, the alignment of human and murine TGF-β1 (UniProt
identifiers P01137 and P04202) as well as GDNF (P39905 and P48540) results
in identities of 89.74% and 92.89% [185]. With regards to FGF, especially ba-
sic FGF-2 has been described as a potent factor for the induction of typical
BBB characteristics [184, 186]. Aligning protein sequences of human (P09038)
to murine (P15655) or bovine (P03969) FGF-2 gives 51.04% and 53.13% iden-
tity, predominantly based on the fact that the murine and bovine proteins are
truncated by 134 amino acids on the amino-terminal end. The resulting lack
of high-molecular-weight FGF-2, which possesses three nuclear localization se-
quences, might in turn cause the insufficient formation of highly condensed
and thick HBMEC layers in the here presented thesis. This is underpinned
by the fact that the FGF-2 isoform is thought to stimulate the mitogenic re-
sponse and survival especially under serum-reduced conditions [187, 188]. In
addition to ACM, medium supplementation with 550 nM hydrocortisone was
tested too (data not shown). Although Schrot and colleagues demonstrated a
hydrocortisone-induced increase in marginal folds of both murine and bovine
BMECs [189], the human cells used in scope of this thesis do not respond on
basis of TEER, molecular permeability, or ZO-1 expression and distribution.
This corresponds to observations made by Eigenman et al. [131]. Hence, the
usage of hydrocortisone was not pursued any further. The composition of FCS
contained within cell culture medium is highly complex and may vary from
batch to batch, which impedes reproducibility between different experiments.
Thus, its abandonment during the generation of the BBB-representing in vitro
model is verified as well. Data indicate that tight, continuous HBMEC layers
possessing both elevated TEER values, low NaFl permeability, and enhanced
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overall and peripheral ZO-1 expression could only be obtained in presence of
FCS during cell cultivation. Therefore, RPMI medium supplemented with 10%
(v/v) FCS was used for the generation of HBMEC layers of high barrier in-
tegrity. Comparing resulting TEER values of maximum 52±2Ω· cm2 to litera-
ture reveals a good agreement with experimental setups using similar human
cell models [129, 190–192]. Nevertheless, it is to be noted, that these human
models using immortalized cell lines represent tightness parameters achieving
only small fractions of the ones present in vivo, which are estimated to 1,000–
2,000Ω· cm2 [110, 191]. Although comparable in vitro models utilizing primary
cells of porcine or bovine origin generate up to 2,500Ω· cm2 [127], the transfer of
experimental outcomes to human context is limited. Thus, instead of switching
to non-human models, a further advancement of human in vitro seems reason-
able. As indicated by several studies, the shift from static to dynamic cell culture
systems does not only mimic in vivo situations present at the BBB more closely,
but also beneficially affects phenotypes of BMECs [105,132,193,194]. Moreover,
other sophisticated dynamic models utilize hollow fibers, which carry pulsatile
flow and provide the framework for scaffolding BMECs in addition to astro-
cytes on luminal and abluminal surfaces [195]. Finally, the derivation of human
BMECs from human induced pluripotent stem cells may also offer an attrac-
tive alternative, as TEER values exceeding 1,900Ω· cm2 could be reached using
these cells and the induction of further BBB characteristics including the expres-
sion of tight junction proteins could be achieved [196].
Using the established HBMEC-based model system, SPION-associated effects
on barrier integrity are investigated first (see figure 3.10). Thereby realistic
SPION concentration prevailing at the biological barrier are difficult to esti-
mate [197]. In general, particle dilution within the blood volume and clearance
by the reticuloendothelial system (RES) contribute to low global concentrations.
However, targeting strategies—either by surface functionalization or magnetic
forces—might bring on strongly elevated local particle amounts [38]. Due to
that, following investigations primarily address consequences of incubations
with elevated SPION concentrations. In agreement with cytotoxicity data from
two-dimensional cell culture experiments discussed above, neutral fluidMAG-
D hardly influences the intactness of transwell HBMEC layers with respect to
TEER values and NaFl retention, as well as microscopic analysis of histologi-
cal cross sections for incubation of up to 24 h. A related study performed by
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Thomsen and colleagues using starch-coated SPIONs made similar observa-
tions [190]. In contrast, the exposure to anionic SEONBSA reduces TEER val-
ues in a time-dependent manner, while NaFl retention is significantly increased
relative to controls before its pronounced reduction. Correlating these find-
ings to microscopic investigations provides a reasonable explanation for the ob-
served phenomenon: the rapid and comprehensive accumulation of SEONBSA
on HBMEC layers during the first three hours might obstruct the diffusion of
NaFl molecules from the upper donor- into the lower acceptor compartment,
which gives rise to an apparently elevated retention capacity for this molec-
ular dye. Following further SEONBSA incubation, NaFl permeability is finally
increased due to the barrier-disrupting nature of these anionic SPIONs. This ob-
servation seems contradictory to the previously discussed biocompatible char-
acter of SEONBSA detected with PrestoBlue™ viability assays performed on
two-dimensional HBMEC cultures. In order to evaluate this issue, attention
must be drawn to the differential growth stages prevailing in the distinct exper-
imental setups: while for PrestoBlue™ viability assays cells are in a proliferative
phase, barrier-forming cells on transwell membranes have been in confluence
for several days before SPIONs are added. Indeed, RTCA analyses of HBMEC
exposed to SEONBSA shown in figure B.3 imply that acute adverse effects in-
duced by SEONBSA exposure of proliferating HBMEC are marginal only, while
particle addition to confluent HBMEC layers evokes a rapid and concentration-
dependent reduction of relative cell indices. The RTCA-based detection of cell
indices is predicated by impedance measurements generated by adhering cells.
Thus, not only cytotoxic events reducing the number of viable cells are detected,
but alterations in cell morphology, cell-surface and cell-cell contacts influence
the experimental outcome too [198]. Taking all these factors together, data pre-
sented in this thesis strongly indicate the possibility that intensively-interacting
SEONBSA destabilizes the established cell layers by events such as disturbing
cell-cell contacts, which eventually reduces barrier integrity and elevates en-
dothelial permeability. Moreover it has to be noted, that the strongly damaged
appearance of histological HBMEC cross sections upon SEONBSA incubation is
probably strengthened by the multistep sample preparation upon barrier desta-
bilization. Do SEONBSA particles specifically bind distinct cellular structures
and surface components or are there general non-specific interactions with cells
that bring on the barrier disruption? Does immunogenicity in cells of human
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origin in response to the massive exposure to bovine albumin via the induction
of permeability-increasing cytokines play a role? Based on the protein align-
ment of human and bovine albumin (UniProt identifiers P02768 and P02769)
an identity not exceeding 76.34% leaves scope for such possibility [185]. Addi-
tionally, cytokine-inducing effects in human cell cultures have been described
before [199]. In order to answer this question further comprehensive analyses
are still pending. In general, (human) serum albumin seems highly attractive
for drug transport due to its charge-reversible feature together with its endoge-
nous origin and particle-stabilizing effects [10, 200]. With reference to cationic
fluidMAG-PEI, more pronounced diminishing impacts on HBMEC layers are
already detectable after a 3-hour incubation, which manifest in the significant
reduction of both TEER and NaFl retention and agrees to PEI particles’ cytotoxic
phenotype mentioned earlier in this chapter. Similarly in accordance with bio-
compatibility observations discussed above, an exposure to cationic fluidMAG-
DEAE entails no relevant detectable effects on barrier integrity. In spite of these
interesting aspects, both cationic particle formulations are not suitable for the
transwell test system assessing particle passage through the biological barrier.
The reason for being that—probably based on excessive particle accumulation
and agglutination within the cell culture medium with aggregates of up to 5 µm
(data not shown)—neither fluidMAG-PEI nor fluidMAG-DEAE pass cell-free
transwell membranes in an appropriate manner as demonstrated in figure B.4.
Hence, for subsequent evaluations of SPION passage through the in vitro model
representing the human BBB, neutral fluidMAG-D and anionic SEONBSA are
utilized.
Tracking of nanoparticles within biological systems is still complex, time-con-
suming, expensive, and usually provides only limited static insights into par-
ticle localization [201]. Requiring elevated resolutions, transport studies in cell
culture-based setups often use radioactive- and chromatography-based meth-
ods as well as spectroscopic detection of fluorochrome-labeled particles. Espe-
cially with respect to the latter, both disintegration of the fluorescent dye and
dye leakage are serious issues leading to critical consideration of data detect-
ing and quantifying nanoparticles in biological settings [202, 203]. The use of
SPIONs, on the one hand, hampers the application of various analytical as-
says due to their special optical properties as mentioned earlier [74, 158, 159].
On the other hand, it opens up new possibilities in specifically utilizing the
88
4.2 SPIONs and the Blood-Brain Barrier Model
iron-based character for direct particle detection [164]. Hence, SPIONs’ su-
perparamagnetic properties are exploited in scope of this thesis in order to
highly sensitively quantify particle amounts present within the distinct com-
partments of incubated HBMEC transwell systems, which in turn gives insights
into particle passage at this biological barrier. By applying MPS it is shown
that this technique based on the non-linear magnetic susceptibility response,
accurately and highly sensitively detects fluidMAG-D particles over multiple
orders of magnitude (see figure 3.11). Utilizing the MPS-based direct detec-
tion of SPIONs within such barrier interaction studies are made for the first
time in scope of this thesis and provide profound insights on the passages’ dy-
namics and underlying mechanisms [151]. Actually the comparison of MPS,
ultraviolet/visible-, atomic absorption- and atomic emission spectroscopy by
Friedrich et al. already identified MPS as the most sensitive technique [164]. Fo-
cusing on here presented experimental outcome obtained from compartment-
specific quantification of fluidMAG-D in the transwell model, data indicate that
the presence of an HBMEC layer on the transwell membrane almost entirely
prevents the translocation of fluidMAG-D from the upper into the lower com-
partment, which confirms the pronounced barrier tightness. Strikingly, the in-
crease of particle concentrations from 50 µg/cm2 to 100 µg/cm2 and 200 µg/cm2
(equal to 100–400 µg/ml) does not enhance SPION accumulation within the
cellular fraction. This fact might suggest that HBMEC can not bind and in-
ternalize more of the starch-coated particles during the first three hours of in-
cubation, potentially due to a fully stretched cellular endocytosis apparatus.
As discussed above, the slow cellular accumulation kinetics as well as the ac-
tive clathrin-dependent uptake of fluidMAG-D into HBMEC correspond well
to this assumption. Moreover, another substantial factor affecting the bioavail-
ability of SPIONs to cells must be seen in particle agglomeration. As high
SPION concentrations diminish the nanoparticles’ stability, decreased amounts
of free particles contribute to less particle-cell interaction and the generation
of false negative or false postive results, which have been discussed in liter-
ature previously [158]. The fact that within the lower acceptor compartment
a small but statistically significant amount of SPIONs is detectable after the
3-hour incubation with 100 µg/cm2 fluidMAG-D only, provides further proofs
for the active particle transport across the BBB model via transcytotic processes.
The absence of SPIONs within this compartment after 30 min implies the time-
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dependent character. Furthermore, the decrease of acceptor-specific magnetic
particles after exposure to 200 µg/cm2 fluidMAG-D compared to 100 µg/cm2
supports the hypothesis of reduced cellular uptake and transcytosis due to de-
creased bioavailability and presence of larger particle agglomerates. In order to
verify the transcytotic passage of fluidMAG-D through HBMEC layers, the in-
cubation with endocytosis inhibitors during SPION exposure can provide sub-
stantial evidence. Nevertheless, as demonstrated by figure B.5, the treatment
of stable HBMEC layers with inhibitors restricting either all active endocyto-
sis pathways (i.e., 4 °C) or clathrin-dependent mechanisms (i.e., chlorpromazine
and cytochalasin D) strongly increases endothelial permeability. Hence, such
control experiments are inappropriate, as SPIONs passaging the HBMEC layer
paracellularly interfere with an accurate assessment of transcytosed particles
present within the lower acceptor compartment. Further studies approving
transcytosis within this experimental setup in more detail are required. Time
series of high resolution microscopic techniques such as electron microscopy
may provide a possible option. In addition, the verification of exosomal mark-
ers or membrane remnants on the surface of SPIONs arriving within the lower
acceptor compartment may underline the transcytotic passage, but is intricate
due to low amounts of accessible particles. Anyway, the presence of active
transcytotic processes of SPIONs without any additional functionalization has
been suggested by different using other experimental setups, too. For instance,
using starch-coated SPIONs of 100 nm, it has been observed that particles do
not cross cell-free transwell inserts without an external magnetic field, whereas
they traverse cell-seeded inserts [190]. Another study performed by Kim and
colleagues implies that receptor mediated transcytosis seems to play a key role
during translocation of anionic polyethylene glycol (PEG)-coated nanoparticles
(140 nm) at BBBs represented by rat BMECs [204]. Remarkably, authors also
emphasize the crucial involvement of the protein corona during this process. In
addition to MPS, in this thesis AAS is used in order to spectroscopically quantify
total iron and validate particle passage through the in vitro barrier model, also
in context of SEONBSA (see figure 3.12). As MCF-7 cells have been observed
to incorporate diverse types of SPIONs to a high degree (data not shown),
these cells seeded into bottom wells are used representing underlying tissue
cells, which additionally indicate particle passage through the HBMEC layer.
Agreeing to previously discussed particle-cell interaction, AAS reveals a far
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superior role of anionic SEONBSA regarding the accumulation within barrier-
forming HBMEC layers compared to neutral fluidMAG-D. Despite this multi-
ple increased amount of SEONBSA present within HBMEC compartments, only
a low proportion proceeds into the lower acceptor compartment’s medium or
tissue-representing cells, whereas already after 3 h of particle incubation about
twice as much fluidMAG-D is found within the lower compartments. This hints
towards a constrained extend of SEONBSA penetration through HBMEC layers
and implies the cell-accumulating nature of these particles. The eventual ele-
vation of iron within lower acceptor compartments 24 h upon SEONBSA addi-
tion might result from enhanced paracellular particle passage through HBMEC
layers resting upon barrier-destabilization and disruption by these particles as
discussed earlier in this section. Indeed, Harush-Frenkel and co-workers ob-
served that in contrast to cationic NPs, anionic NPs undergo degradative lyso-
somal processes upon uptake into human epithelial cells detected by means of
fluorescence-based co-localization studies [205]. Thus, these particles hardly
underwent transcytosis in this report as well. Another study performed by Lin
et al. demonstrated that albumin nanoparticles were able to cross monolayers of
murine BMECs and finally ended up in glioblastoma cells, which highly express
the albumin-binding secreted protein acidic and rich in cysteine (SPARC) [206].
Unfortunately, the authors did not focus on the barrier-penetrating process and
its consequences for barrier integrity, therefore no data regarding barrier in-
tegrity are available in the indicated study. Thus, data obtained within the here
presented thesis provide valuable insights into ongoing processes and conse-
quences. The overall comparison of data obtained from MPS and AAS shows
elevated iron amounts for the latter. This is accounted for by the fact that MPS is
based on the specific detection of intact superparamagnetic particles, while dur-
ing AAS degraded particles or particle fragments also contribute to the deter-
mined signal. Another relevant issue can be seen in potentially altered magnetic
behavior of SPIONs during the incubation progress. Thus, pronounced particle
agglomeration modifies the magnetic susceptibility response. As such a shift
is detected by ratios of the 5th and 3rd spectrum amplitude (i.e., A5/A3 ratio)
recorded during MPS measurements, inaccuracies can be corrected by switch-
ing to references of convenient A5/A3 ratios [147]. An alternative method for
the highly sensitive in vitro quantification of SPIONs, regardless of any particle
labeling might be seen in a technique introduced by Gunn and co-workers [207].
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There, authors utilized the standardized methodology of proton nuclear mag-
netic resonance to quantitatively detect SPIONs within biological samples for
five orders of magnitude and iron concentrations of 10 ng/ml. However, the
particles’ disintegration as well as cell debris and cell digest hamper the uncon-
ditional application of this methodology [207]. Taken together, the data pre-
sented here demonstrate that the combination of the in vitro model with both
SPION quantification methods (i.e., MPS and AAS) and integrity evaluating as-
says allow the detailed investigation of SPION passage through this biological
barrier and the assessment of resulting consequences on the barrier itself.
4.3 SPIONs and Barrier-penetrating Cells
The straight passage of free SPIONs across biological barriers is one option de-
livering particles into the tissue beyond. Another possibility recently attract-
ing attention is the cell-mediated transport of nanoparticles through such bar-
riers [208]. Neutrophils constitute approximately 60% of leukocytes and are
the first immune cells immobilized from the blood pool invading respective
sites upon tissue damage and infection [209]. This dramatic neutrophilia pri-
marily provokes the typical features of an acute inflammation, as well as in-
duces the release of monocytes from bone marrow [209]. On their chemokine-
directed way, monocytes differentiate into macrophages embodying the subse-
quent type of immune cells arriving at the inflammatory site. Thereby, both
neutrophils and monocytes/macrophages are phagocytosing cells with distinct
barrier-penetrating abilities. Thus—in context of the BBB—they may shuttle
SPIONs ingested at the luminal site of circulating blood into the brain, which in
turn can deliver therapeutics [208]. Vice versa, the uptake of circulating SPIONs
into these cells might promote cell migration and their penetration through
the BBB, which might be enhanced further by an external magnetic field or
inflammatory brain conditions. In scope of this thesis the SPION-delivering
ability of monocytic and neutrophilic cells, as well as the SPION-mediated ef-
fect on their cellular transmigration across the BBB model are investigated. As
demonstrated in figure B.6, human leukemic cell lines HL-60 and THP-1 are
utilized for their differentiation into neutrophilic-like and monocytic cells as
described before [138–141]. Matching to expectations and previous observa-
tions [210] respectively, both obtained phagocytotic cell types display an aug-
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mented SPION accumulation compared to barrier-forming HBMEC, whereby
anionic SEONPAM particles are superior to neutral fluidMAG-D (see figure B.7).
While cell viability is not compromised for incubations of up to 100 µg/cm2
(corresponding to 378 µg/ml; see figure B.8), AAS reveals that incubation of
differentiated HL-60 and THP-1 with 50 µg/cm2 (corresponding to 189 µg/ml)
SEONPAM for 120 min results in total iron contents of 11.75±0.17 pg/cell and
16.63±0.07 pg/cell, respectively (data not shown). Compared to a similar study
incubating primary human macrophages with 100 µg/ml anionic caboxydex-
tran-coated SPIONs, which resulted in an iron load of approximately 8 pg/cell
[211], data are in good agreement. Transmigration experiments of SEONPAM-
loaded diffHL-60 and diffTHP-1 cells across the in vitro BBB model clearly show
a SPION-induced cellular translocation from apical donor- to basolateral accep-
tor compartments (see figures 3.13 and 3.14). Several studies already demon-
strated that SPIONs promote the differentiation of monocytes to macrophages
and in general exert immune response-inducing effects on monocyte-derived
macrophages and neutrophils [210, 212, 213]. Underlying mechanisms can be
found in the oxidative stress-inducing nature of SPIONs as well as their induc-
tion of altered gene expression of pro- and anti-inflammatory cytokines such as
interleukin (IL)-10, IL-1β, and IL-8 [210, 213, 214]. Interestingly, transmigration
in scope of the here presented experimental model is distinctly pronounced in
presence of barrier-forming HBMEC for both cell types. That seems reasonable,
as several steps of this process, such as capture, rolling, arrest, and crawling,
depend on the formation of distinct cell-cell contacts between the endothelium
and transmigrating granulocytes or monocyte/macrophages [209]. The pro-
nounced homing of SPION-ingested macrophages across the BBB into the cen-
tral nervous system has also been suggested by Tong et al., who performed ani-
mal studies with acute inflammatory mouse models [210]. This study is in line
with here presented data implying that also in absence of the chemotactic stim-
uli N-Formylmethionyl-leucyl-phanylalanine (fMLP) and monocyte chemotac-
tic protein (MCP)-1 the exposure of diffHL-60 and diffTHP-1 to SEONPAM is suf-
ficient to induce transmigration through the barrier. Furthermore, an in vivo
study performed by Alizadeh and co-workers pointed out that macrophages,
which had taken up intravenously applied nanoparticles not only crossed the
BBB but also accumulated in close proximity to glioma cells [215]. The chemoat-
tractive nature of vascular endothelial growth factor (VEGF), which is highly ex-
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pressed in glioma cells, might play a major role in this regulatory process [89].
Another work presented by Chu et al. impressively demonstrated on the basis
of an in vivo mouse lung inflammation model, that neutrophils effectively trans-
ferred drug-loaded nanoparticles into inflammatory sites and alleviated inflam-
matory symptoms [216]. Taken together, these facts emphasize both the tumor-
and immuno-attractant properties of such particle-loaded cells, which might in
turn be exploited for an enhanced delivery of therapeutic nanoparticles as well
as immuno-responsive cells during therapies such as of inaccessible brain tu-
mors. Vice versa, this migratory-inducing ability of monocytes/macrophages
and neutrophils must be given special consideration to during the therapy of
patients suffering from chronic neuroinflammatory diseases. For instance, in
multiple sclerosis the enhanced invasion of nanoparticle-incorporated mono-
cytes as well as neutrophils might exacerbate the progression of neuronal de-
myelination [217]. Hence, detailed knowledge on SPION-induced consequences
with respect on BBB’s integrity and immune cell penetration is of vital impor-
tance for a safe and efficient particle implementation, where the here presented
in vitro system offers a comprehensive test platform. IL-1β is a major mediator
of the inflammatory response and with regards to the BBB negatively regulates
barrier integrity via decreasing tight junction formation [104]. In this work,
brain inflammatory conditions are induced using IL-1β, which provokes the ele-
vation of various barrier permeability parameters (see figure B.9). Nevertheless,
transmigration experiments reveal that pre-conditioning of HBMEC layers with
this inflammatory molecule does only augment the strength of barrier penetra-
tion by neutrophil-like diffHL-60 but not monocytic diffTHP-1. As the phorbol
ester-based induction of IL-1β receptor expression, which is decisively involved
in IL-1β-mediated cell recruitment, has been described before [218], the reason
for non-responding diffTHP-1 is not clear. However, as it has been shown by sev-
eral studies, astrocytes and microglia have a substantial impact on the regula-
tion of BMEC permeability and leukocyte recruitment especially during inflam-
matory conditions [219–221]. This fact points out the need for an extension of
the here presented in vitro model of the BBB to a co- or tri-culture system along
with astrocytes and/or pericytes for detailed analyses of immune cell migration
as well as SPION passage with regards to an inflammatory status. Magnetic
(drug) targeting provides a large field of SPIONs’ application and may do great
work to overcome difficulties in efficient delivery of therapeutic substances also
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with respect to barrier passage. In context of the application of an additional
magnetic stimulus for the first 30 min of leukocyte transmigration through the
HBMEC layer, strong accelerating effects on SPION-loaded diffHL-60 and in
particular diffTHP-1 are noticeable in the work presented here. The superior
role of monocytic THP-1 to neutrophil-like HL-60 may be due to the elevated
cellular particle loading as discussed above. In line with this observation, Kong
et al. demonstrated that in a rat model the accumulation of SPIONs within brain
tissue is strongly augmented upon magnetic targeting [197]. Furthermore, the
enhanced delivery of monocyte-delivered SPIONs into the brain via magnetic
heating has been shown only in vivo before [210,222,223], where reversible BBB
permeability was induced in presence of an alternating external magnetic field.
As indicated in figure B.10 barrier transmigration of diffTHP-1 strongly impair
barrier integrities, whereas diffHL-60-penetrated HBMEC layers seem only dis-
integrated in presence of additional inflammatory stimuli. Furthermore, data
presented by this figure suggest that SPION contents within the lower acceptor
compartments are not quantitatively detectable by AAS. However, this might
be brought about by insufficient sensitivity, as microscopic images of Prussian
blue-stained HL-60 (see figure 3.13) reveal the actual presence of SPIONs asso-
ciated with these neutrophil-like cells upon transmigration. Most likely due to
the accumulation of adherent THP-1 at bottom sides of transwell membranes
no or only few cells were noticeable on the bottom or within the lower acceptor
medium compartment (see figure 3.14). Thus, no information on whether these
cells actually transported SPIONs across the BBB model are available from the
here presented data. Whether SPIONs remain within barrier-forming HBMEC
during leukocyte transmigration, which in turn might influence the barrier’s
function, needs to be investigated in future studies. Similarly, an excess SPION
loading of monocytes/macrophages or granulocytes might hamper migratory
abilities of these phagocytosing cells as suggested previously [210]. Addition-
ally, enhanced SPION binding to structures of the BBB upon particle functional-
ization and subsequent magnetic radiofrequency may irreversibly disrupt this
biological barrier. All of these factors have to be assessed in order to achieve
an efficient and safe biomedical implementation of SPIONs. Hence, both the
here presented in vitro model representing the human BBB and the indicated
experimental assays and detection methods are valuable tools contributing to
the scientific and purposeful elucidation of these objectives.
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CHAPTER 5
Conclusion & Outlook
The here presented thesis establishes an experimental in vitro tool for the de-
tailed evaluation of SPION interactions at and passage through a biological
barrier including the assessment of SPION-associated consequences for the bar-
rier integrity. By utilizing the BBB-representing HBMEC monoculture transwell
system in combination with several barrier integrity parameters and sensitive
SPION detection methods, the two distinct SPION systems of neutral starch-
coated fluidMAG-D and anionic BSA-coated SEONBSA are extensively tested.
For the first time, MPS is adopted in this experimental biological setting analyz-
ing SPION passage through biological barriers in order to achieve a direct and
highly sensitive particle detection within the distinct compartments. Hence a
profound insight into passage’s dynamics is provided. Furthermore, presented
results impressively demonstrate that free fluidMAG-D traverse the barrier sys-
tem in a time-dependent manner most likely based on clathrin-induced transcy-
totic processes. In addition, barrier integrity remains unaffected upon particle
passage, which is explained by the comparatively slow and gentle cellular ac-
cumulation and uptake. In contrast, data imply that SEONBSA intensively as-
semble within the barrier-forming cells and affect the BBB model in a barrier-
disrupting manner. Another aspect addressed within this thesis refers to cell-
mediated SPION delivery across the BBB by both neutrophils and monocytic
cells derived from HL-60 and THP-1 cell lines, respectively. On the one hand,
SPION engulfment by both cell types massively enhances barrier penetration
of indicated immune cells. On the other hand, it is implied that these phago-
cytosing immune cells can be hijacked to deliver SPIONs across this in vitro
model. These observations are made for non-functionalized SPIONs and can be
carried out for each individual SPION formulation in order to achieve a com-
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prehensive risk assessment. For applications not targeting the brain, particle
penetration into and accumulation within the CNS upon repeated administra-
tion is strictly undesirable. Though, according to purposes when transition of
SPIONs into brain is required—for instance in case of SPION-mediated drug de-
livery or hyperthermia therapy of glioblastoma—additional functionalizations
such as by ligand binding may be utilized for the enhanced particle delivery
across the BBB and need to be evaluated as well. The here presented test system
provides an appropriate platform for both instances and allows an insight into
underlying mechanisms, thus contributing to a comprehensive understanding
of particle interactions with the BBB. In consequence, gained knowledge aids
to the tailored design of SPIONs according to the particular application. Fur-
thermore, the presented investigations focusing on the impact of the protein
corona emphasize its pivotal role on biological effects and underline the need
of its consideration during SPION functionalization as it may present opsonins
or shield functional groups on the particle surface. Utilizing and extending the
here established system, the inclusion of flow conditions—for instance by trans-
ferring the system into a microfluidic biochip as previously shown for other
models [224]—might mimic the in vivo situation even closer. Also the integra-
tion of continuous SPION detection within the lower acceptor flow chamber
finally allows sustained insights into the passage’s dynamics and kinetics. The
here presented SPION detection via MPS provides an excellent methodology
for implementing this proposal. Additionally, the transfer of the presented test
system to a blood-placenta barrier-representing regime has been introduced re-
cently [225] and provides further information regarding SPION-associated im-
pacts on this biological barrier. Nevertheless, it has to be noted that the exper-
imental setup has some limitations, too. Results indicate that especially when
testing the passage of free SPIONs as well as their leukocyte-mediated trans-
port across the BBB under inflammatory conditions, an extension of the mono-
culture system to a co- or tri-culture system with astrocytes or/and pericytes
seems reasonable. Whereas such elevated models are more difficult in han-
dling and more interference-prone, they even closer represent the complexity
of this biological tissue and incorporate the eclectic interplay of BMECs with
surrounding astrocytes or microglia during inflammatory states. The detailed
analysis and magnetic characterization of SPIONs after barrier penetration is of
vital importance as this also influences tissue distribution, magnetic response
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during SPION applications such as imaging or therapeutic heating and elimi-
nation processes. Hence, the HBMEC in vitro model in line with further veri-
fications according to Barnes et al. [226] must be utilized for such clarifications
in the future. Resulting knowledge can help to improve arrangement of mag-
nets in order to achieve appropriate magnetic fields, which optimize SPION
application efficacy. Pedram et al. emphasized that the application of a mag-
netic field between 0.6–2.5 T and a minimal gradient and/or amplitude are cru-
cial for not damaging the BBB [227]. Furthermore, alternative approaches in
magnet-assisted transport of SPIONs across barriers and into deeper tissues
might solve problems in the delivery of therapeutic substances. A remarkable
example can be seen in the novel method developed by Shapiro and colleagues,
who use a two-magnet system in order to push magnetic nanomedicines into
diseased tissue [228]. Taken together, SPION-based therapies bear promising
and versatile potentials to solve major biomedical problems. For instance, the
combination of Temozolomide with radiosensitizing nanoparticles loaded with
O6-methylguanine-DNA methyltransferase (MGMT) inhibitors is a promising
approach to overcome chemotherapeutic resistance in glioblastomas [46]. A-
nalogously, hyperthermia therapy before radiotherapy reduces activation of the
protein kinase Akt, which in turn radiosensitizes glioma cells [46]. However, in
order to bring safe and efficient approved formulations on the way, data ob-
tained from the here presented in vitro tool can contribute tremendous and vi-
able knowledge.
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APPENDIX A
Materials
Table A.1: List of used chemicals.
Chemical substance Supplier
1,10-phenanthroline, ≥99%
Sigma-Aldrich Chemie GmbH, Steinheim,
Germany
Agarose BioReagent, low EEO
BSA, heat shock fraction, pH 7, ≥ 98%
Chlorpromazine hydrochloride
Cytochalasin D from Z. mansonii
EDTA trisodium salt hydrate, ≥ 96%
Filipin III from S. filipinensis
Histosec pastilles (paraffin) Merck KgaA, Darmstadt, Germany
Hydrocortisone, BioReagent Sigma-Aldrich Chemie GmbH, Stein-
heim, Germany
Iron(III) chloride hexahydrate Merck KgaA, Darmstadt, Germany
N-Formyl-Met-Leu-Phe (fMLP), ≥97% Sigma-Aldrich Chemie GmbH, Steinheim,
GermanyPMA, ≥96% (TLC)
Potassium ferrocyanide trihydrate ICN Biomedicals GmbH, Eschwege,
Germany
rh IL-1β
ImmunoTools GmbH, Friesoythe,
Germany
rh IL-8 / 1-77a.a.
rh MCP-1 / CCL2
rh MIP-1α / CCL3
rh TNF-α
Trichloroacetic acid, ≥99% Carl Roth GmbH & Co. KG, Karlsruhe,
Germany
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Table A.2: List of used reagents and media.
Reagent/Medium Supplier
20× reducing agent
Bio-Rad Laboratories, Inc., Hercules, USA20× XT MES running buffer
4× XT sample buffer
Acetic acid Sigma-Aldrich Chemie GmbH, Steinheim, Ger-
many
BD FACS Flow™ Sheath Fluid
BD Biosciences, SingaporeBD FACS™ Clean Solution
BD FACS™ Rinse Solution
Biozidal ZF™ WAK - Chemie Medical GmbH, Steinbach, Ger-
many
Coulter Isoton II Beckman Coulter GmbH, Krefeld, Germany
D-PBS Thermo Fisher Scientific Inc., Waltham, USA
DiffQuick solution II Medion Diagnostics GmbH, Düdingen
Dimethyl sulfoxide Sigma-Aldrich Chemie GmbH, Steinheim, Ger-
many
Disinfection Softasept® N B. Braun Melsungen AG, Melsungen, Germany
HCl, 32% Carl Roth GmbH & Co. KG, Karlsruhe, Germany
DMEM /HAM’s F12 Thermo Fisher Scientific Inc., Waltham,
USADMEM + GlutaMAX™
Entellan® New Merck KgaA, Darmstadt, Germany
Ethanol denatured Carl Roth GmbH & Co. KG, Karlsruhe, Germany
FBS (also denoted as FCS) Biochrom GmbH, Berlin, Germany
Formalin, neutral buffered, 10% Sigma-Aldrich Chemie GmbH, Steinheim, Ger-
many
Giemsa’s azur eosin methylene blue Merck KgaA, Darmstadt, Germany
HCl, 37% Sigma-Aldrich Chemie GmbH, Steinheim, Ger-
many
HyClone™ HyQTase™ GE Healthcare Life Sciences, Little Chalfont, UK
Kaleidoscope Precision Plus Protein
standards
Bio-Rad Laboratories, Inc., Hercules, USA
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Reagent/Medium Supplier
May-Grünwald’s eosine-methylene
blue
Merck KgaA, Darmstadt, Germany
Methanol HiPerSolv
CHROMANORM®
VWR International, Radnor, USA
Nuclear Fast Red solution Sigma-Aldrich Chemie GmbH, Steinheim, Ger-
many
Penicillin-Streptomycin (10,000 U/ml) Thermo Fisher Scientific Inc., Waltham, USA
PrestoBlue™ cell viability Reagent
Thermo Fisher Scientific Inc., Waltham,
USA
RPMI 1640 + GlutaMAX™
RPMI 1640, no phenol red
Shandon™ Immu-Mount™
Triton™ X-100 Sigma-Aldrich Chemie GmbH, Steinheim, Ger-
many
Trypsin-EDTA (0.05%) Thermo Fisher Scientific Inc., Waltham, USA
Xylene Carl Roth GmbH & Co. KG, Karlsruhe, Germany
Table A.3: List of used fluorescent dyes and antibodies.
Antibody/Dye Supplier
α-rabbit IgG, Alexa Fluor® 488 conju-
gate (goat)
Cell Signaling Technology Inc., Danvers, USA
α-ZO-1 antibody (rabbit)
Thermo Fisher Scientific Inc., Waltham,
USA
Alexa Fluor® 633 phalloidin
CellTracker™ Green BODIPY ® Dye
CellTracker™ Red CMTPX Dye
CompBeads Plus BD™ α-Mouse Ig, κ
BD Biosciences, Singapore
CD11b/Mac-1-APC, α-Human
(mouse IgG1, κ)
CD13-FITC (mouse IgG1) Immunotech Inc., Quebec, Canada
CD14-PE (Mφ P9) (mouse IgG2, κ)
BD Biosciences, SingaporeCD16-PE Mouse α-Human (mouse
IgG1, κ)
CD34-FITC Mouse α-Human (mouse
IgG1, κ)
103
Materials
Antibody/Dye Supplier
CD40-PE (mouse IgG1, κ) Immunotech Inc., Quebec, Canada
DAPI I counterstain (1,000 ng/ml) Abbott GmbH & Co. KG, Wiesbaden, Germany
Fluorescein sodium salt Sigma-Aldrich Chemie GmbH, Steinheim, Ger-
many
Hoechst 33258, Pentahydrate
10 mg/ml
Thermo Fisher Scientific Inc., Waltham,
USA
SYTOX® Red Dead Cell Stain
Table A.4: List of used consumables.
Consumable Supplier
CELLSTAR® Cell culture flask (25, 75, 175 cm2) Greiner Bio-One GmbH, Frickenhausen,
GermanyCELLSTAR® Multiwell plate (6, 12, 24 wells)
ceramic scalpel, 20mm, anti-magnetic, form 34 VWR International, Radnor, USA
Cover slips, Menzel glass, round (12 mm) Thermo Fisher Scientific Inc., Waltham,
USA
Criterion™ XT precast gel, 4-12% Bis-Tris Bio-Rad Laboratories, Inc., Hercules, USA
Cytospin adapters for glass slides Andreas Hettich GmbH & Co. KG,
Tuttingen, GermanyCytospin filters
Embedding cassettes Carl Roth GmbH & Co. KG, Karlsruhe,
Germany
FACS tubes, polystyrene, round bottom, 5 ml Corning Inc. Life Sciences, Corning, USA
gentleMACS™ M Tubes Miltenyi Biotec GmbH, Bergisch Glad-
bach, Germany
HaemoDiff® with smear rim Sarstedt AG & Co., Nümbrecht, Germany
MicroAmp® Fast Reaction Tube with Cap,
0.1ml
Thermo Fisher Scientific Inc., Waltham,
USA
Microplate, 96 wells, PS, F-bottom, µ-Clear® Greiner Bio-One GmbH, Frickenhausen,
Germany
Microtome blade R35 pfm medical, Köln, Germany
Nalgene syringe filter, SFCA, 0.2 µm Thermo Fisher Scientific Inc., Waltham,
USAPolysine™ microscopic adhesion slides
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Consumable Supplier
PP conic sample vials, 3 ml Analytik Jena AG, Jena, Germany
Symex SP slides Sysmex Deutschland GmbH, Norderstedt,
Germany
Transwell FluoroBlock™ 24 well companion
plate
Corning Inc. Life Sciences, Corning, USA
Transwell FluoroBlock™ 24 well inserts, PET,
3.0 µm
Transwell® 24 well inserts, PET, tissue culture-
treated, 3.0 µm
Transwell® 24 well insert, PTFE, collagen-
coated, 3.0 µm
Table A.5: List of used technical devices and instruments.
Instrument Supplier
Axiovert 25 inverse microscope
Carl Zeiss Microscopy GmbH, Jena,
Germany
Axioplan 2 imaging microscope
AxioCAM HRC
Cell Coulter Beckman Coulter GmbH, Krefeld, Germany
Centrifuge 5417C
Eppendorf AG, Hamburg, Germany
Centrifuge 5810R
Chop stick electrodes STX2 World Precision Instruments, Sarasota, USA
Criterion™ Vertical Electrophoresis Cell Bio-Rad Laboratories, Inc., Hercules, USA
Cytospin Rotofix 32 Andreas Hettich GmbH & Co. KG, Tuttlingen,
Germany
Dry cabinet, Dry-Line® VWR International, Radnor, USA
Epithelial voltohmmeter EVOM2 World Precision Instruments, Sarasota, USA
gentleMACS™ dissociator Miltenyi Biotec GmbH, Bergisch Gladbach,
Germany
Incubator HERAcell 240i CO2 Thermo Fisher Scientific Inc., Waltham, USA
Magnetic block NeoDeltaMagnet® (Nd-
FeB), 100×100×15mm
IBS Magnet, Berlin, Germany
Magnetic 24-well plate MagnetoFACTOR chemicell GmbH, Berlin, Germany
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Instrument Supplier
Milli-Q® Reference water purification sys-
tem
Merck KgaA, Darmstadt, Germany
Orbital Shaker Incubator GFL GmbH, Burgwedel, Germany
PowerPac 200 power supply Bio-Rad Laboratories, Inc., Hercules, USA
Steril work bench HERAsafe® HS12/2 Thermo Fisher Scientific Inc., Waltham, USA
Thermomixer comfort Eppendorf AG, Hamburg, Germany
Vacusafe Integra Biosciences GmbH, Biebertal, Germany
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B.1 Incubation Conditions Influence the
SPION-associated Protein Corona Formation
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Figure B.1: Gel electrophoretic analysis of protein corona formation on SPIONs. FluidMAG-
PEI incubated with indicated FCS concentrations were subjected to sodium dodecyl sulfate
polyacrylamide gel electrophoresis. Corona-derived proteins were visualized by highly sen-
sitive silver staining. Lanes 3–10 comprise protein bands derived from particles, lanes 12–18
show protein bands of respective FCS solutions prior to particle incubation. A Image presented
in alternative color mapping with low intensities depicted in blue and high intensities in red.
Optical density measurements of protein bands of low (<30 kDa), medium (30–100 kDa), and
high (>100 kDa) molecular weight are shown relative to 100% FCS-treated lanes (B) as well as
their distribution within respective lanes (C). Statistical significance of indicated total optical
mean densities were tested by one-way ANOVA followed by Tuckey’s multiple comparison.
Differences are considered as statistically significant for p < 0.01(**). Figure taken with permis-
sion and data extended from [157]. FCS - fetal calf serum; M - protein standard marker; PEI -
polyethylenimine.
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Figure B.2: Zeta potential measurements of SPIONs with diverse protein coronas.
FluidMAG-PEI incubated with indicated concentrations of FCS [% (v/v)] were subjected to
zeta potential measurements. Figure taken with permission from [157]. FCS - fetal calf serum;
PEI - polyethylenimine.
B.2 SPION-associated Cytotoxicity Depends on
Proliferative State
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Figure B.3: Real-time cell analysis of HBMEC exposed to SPIONs. HBMEC were seeded into
16-well plates in duplicates with a seeding density of 10,000 cells/well. After 24 h (A) or 48 h (B)
SPIONs were added during the proliferative log phase or stationary phase of confluent layers
resulting in final concentrations of 25–100 µg/cm2 (corresponding to 25–100 µg/ml). Negative
controls were treated with aqua bidest.. Shown are means of one representative of two indepen-
dent experiments with two replicates each.
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B.3 Cationic SPIONs barely Pass Transwell
Membranes
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Figure B.4: Analysis of membrane passage of cationic SPIONs by magnetic particle spec-
troscopy (MPS). HBMEC were seeded on transwell inserts and cultured for five days. DEAE-
or PEI-coated SPIONs were added resulting in a final concentration of 100 µg/cm2 (correspond-
ing to 200 µg/ml) and incubated for 3 h, whereby the first 30 min were carried out on top of a
block magnet. Distinct compartments were sampled and analyzed for magnetic iron contents
by MPS. Shown are means ± standard deviation of three independent experiments with three
replicate inserts each. DEAE - diethylamine ethyl; PEI - polyethylenimine.
B.4 Endocytosis Inhibitors Affect Barrier Integrity
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Figure B.5: Analysis of cell layer integrity under the influence of endocytosis inhibitors.
HBMEC were seeded on transwell inserts and cultured for five days. Endocytosis inhibitors
comprising 4 °C or chlorpromazine (CP) and cytochalasin D (CCD) were applied for 4-25 h.
A Cells incubated for 25 h were fixed, stained using Alexa Fluor® 633 Phalloidin (red), and
analyzed by confocal laser scanning microscopy. B Molecular restraint of cell layers to sodium
fluorescein (NaFl) upon dye incubation for 10 min relative to control cells. Shown are means of
two independent experiments with two replicate transwell inserts each.
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B.5 SPION-induced Passage of Immune Cells
trough Blood-Brain Barrier Model
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Figure B.6: Analysis of differentiation of HL-60 and THP-1 by flow cytometry and micro-
scopic investigation. HL-60 were differentiated for six days using 1.4% DMSO, whereas THP-1
were treated with 5 ng/ml PMA for five days to obtain monocytic cells. A Time-dependent
neutrophilic surface marker expression of differentiated HL-60 analyzed by flow cytometry.
B Time-dependent monocytic surface marker expression of differentiated THP-1 analyzed by
flow cytometry. C Pappenheim-stained smear preparations of HL-60 and THP-1 at day six and
five, respectively. DMSO - dimethyl sulfoxide; PMA - phorbol 12-myristate 13-acetate.
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Figure B.7: Cellular interaction of diverse types of SPIONs with HBMEC and differenti-
ated HL-60 and THP-1. HBMEC, differentiated HL-60 (diffHL-60), and differentiated THP-
1 (diffTHP-1) were seeded into 96-well plates with a seeding density of 15,000, cells/well
60,000 cells/well, and 120,000 cells/well, respectively. Cells were exposed to indicated SPION
types in final concentrations of 25 µg/cm2 or 50 µg/cm2 (corresponding to 94.5 µg/ml or
189 µg/ml). Upon incubation for 120 min cells were washed, fixed and stained using Nuclear
Fast Red. Additionally, SPIONs were stained by Prussian blue. PAM - polyacrylat-co-maleat.
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Figure B.8: PrestoBlue™ cell viability assays of HBMEC and differentiated HL-60 and THP-
1 exposed to diverse types of SPIONs. HBMEC, differentiated HL-60 (diffHL-60), and dif-
ferentiated THP-1 (diffTHP-1) were seeded into 96-well plates in triplicates with a seeding
density of 15,000, cells/well 60,000 cells/well, and 120,000 cells/well, respectively. Cells were
exposed to indicated SPION types in final concentrations of 5–100 µg/cm2 (corresponding to
19–378 µg/ml). Negative and positive control cells were treated with aqua bidest. or 0.02% triton
X-100 final concentration analogously. Upon incubation for 3 h and 24 h PrestoBlue™ assays
were performed. Shown are weighted means ± standard deviation of two to four independent
experiments. PAM - polyacrylat-co-maleat.
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Figure B.9: Analysis of cell layer integrity under the influence of inflammatory cytokines.
HBMEC were seeded on transwell inserts and cultured for five days. Inflammatory cytokines
comprising TNF-α (2 ng/ml) or IL-1β (5 ng/ml) were applied for 2–24 h. A Transendothelial
electrical resistance (TEER) measurents before and after cytokine incubation relative to control
cells. B Molecular restraint of cell layers to sodium fluorescein (NaFl) upon dye incubation
for 10 min relative to control cells. Shown are means of two independent experiments with
two replicate transwell inserts each. C Nuclear Fast Red-stained histological cross sections of
HBMEC layers after indicated treatment.
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Figure B.10: Barrier integrity of cell layers and iron content of lower acceptor compartments
after passage of differentiated HL-60 and THP-1. HL-60 (A) and THP-1 (B) differentiated with
1.4% DMSO (six days) and 5 ng/ml PMA (five days), respectively, and loaded with 50 µg/cm2
(corresponding to 189 µg/ml) of SEONPAM for 120 min. Transmigration of 500,000 HL-60/insert
or 300,000 THP-1/insert through transwell membranes seeded with HBMEC (+) or not (-) was
performed for 1,400 min. If indicated, HBMEC layers were pre-treated with 5 ng/ml IL-1β for
120 min before SPION-loaded immune cells were added. Chemical attraction of HL-60 and
THP-1 was induced by 10 nM fMLP or 100 ng/ml MCP-1 as indicated. For selected samples
the first 30 min of incubation time were carried out on top of a 24-well magnetic plate (in-
dicated as "MF"). After transmigration molecular retention of sodium fluorescein (NaFl) of
HBMEC layers was tested. Additionally, total iron contents of lower acceptor media com-
partments were determined by atomic absorption spectroscopy. DMSO - dimethyl sulfoxide;
fMLP - N-Formylmethionyl-leucyl-phenylalanine; MCP-1 - Monocyte chemoattractant protein-
1; MF - magnetic field; PAM - polyacrylat-co-maleat; PMA - phorbol 12-myristate 13-acetate.
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